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Abstract 
The development and utility of cyclopropanes is an ever-growing field within organic 
chemistry. In particular, donor-acceptor cyclopropanes have been used in a vast array of 
methods to access a variety of different hetero and carbocyclic molecular scaffolds. Recently, 
we have developed a Zn(NTf2)2 catalyzed tandem reaction consisting of a nucleophilic ring-
opening of 1,1-cyclopropanediesters by 2-alkynyl indoles followed by a Conia-ene ring 
closure, resulting in the efficient one-step synthesis of tetrahydrocarbazoles. These adducts 
may be further elaborated to carbazoles. The scope and limitations of this method were 
determined along with a mechanistic study into the function of the zinc catalyst. 
In an expansion of our work with 1,1-cyclopropanediesters, we have explored the reactivity 
and utilization of hemimalonate cyclopropanes. To this end, we have developed two unique 
methods exploring the self-activating nature of these cyclopropanes under catalyst free 
conditions. Cyclopropane hemimalonates, when treated with sodium azide, undergo a tandem 
ring-opening decarboxylation to produce γ-azidobutyric acids in good yields.  These adducts 
were hydrogenated to form γ-aminobutyric acid (GABA) methyl esters. Additionally, 
cyclopropane hemimalonates have led to the facile synthesis of -substituted butanolides. 
Under microwave irradiation, cyclopropane hemimalonates undergo rapid conversion to 
butanolides in the presence of inorganic salts with an unprecedented retention of 
stereochemistry. This unique process, in conjunction with a newly developed cross-
metathesis method, has been applied to the total synthesis of the naturally occurring, (R)-
dodecan-4-olide. 
Finally, recent efforts to develop a unified approach to piperidine-containing indole natural 
products have shown great promise. A preliminary investigation into the prospect of a 
common synthetic intermediate for the synthesis of a variety of indole alkaloids has led to a 
synthesis of substituted piperidinones and the corresponding piperidines. These common 
natural product cores are accessed via a reductive amination/lactamization sequence of 
dimethyl 3-ethyl-3-formylpimelate. The synthetic utility of this initial study has been 
displayed in the formal synthesis of ()-quebrachamine. 
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Chapter 1 : Synthesis of Tetrahydrocarbazoles from Donor-
Acceptor Cyclopropanes 
1 Kerr Group Introduction and Thesis Overview 
Organic chemistry is a wide and ever-growing field that is comprised of several different 
areas. Within the Kerr group, research is focused on two specific areas: the total synthesis 
of complex natural products and the development of new synthetic methods. Natural 
products are the driving force for many different aspects of organic synthesis as these 
molecules and their derivatives are the base components in a variety of industrial, 
pharmaceutical, and biologically active compounds. Due to the importance of these target 
molecules much research has been devoted to the development of synthetic routes that 
would allow access to natural products and their derivatives in order to study their unique 
properties. Developing routes to these molecules gives chemists the opportunity to 
discover new and innovative techniques and synthetic methods. One of the largest 
contributions the Kerr group has made in this area is through the ongoing research toward 
the reactivity of donor-acceptor cyclopropanes. To this end, chapter 1 and the beginning 
of chapter 2 of this thesis will focus on the development of donor-acceptor cyclopropane 
chemistry. This will be followed up in the end of chapter 2 and chapter 3 by the efforts 
toward total synthesis of dodecanolide, a butanolide natural product and the indole 
alkaloids aspidospermidine and quebrachamine.            
1.1 Donor-Acceptor (DA) Cyclopropanes 
The toolbox of the synthetic organic chemist benefits greatly from the development of 
new reactive molecular entities for the construction of complex architectures. In this 
light, donor-acceptor cyclopropanes have emerged to have a prominent role. The 
reactivity of these compounds and their use in the total synthesis of natural and unnatural 
targets continue to be extensively studied and have resulted in numerous reviews.1 Useful 
reactions of these molecules I include both nucleophilic ring-opening as well as 
cycloaddition (or annulation) processes to yield III or V respectively (Figure 1-1). Both 
types of transformations require an acceptor moiety and a donor moiety vicinally 
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disposed. The “donor” group can be any functional group capable of stabilizing a 
developing positive charge in the transition states (II or IV) in the ring opening event. 
 
Figure 1-1: The Reactivity of DA Cyclopropanes 
The vast majority of this latter class of reactions (annulations) involves the formation of 
heterocycles. This development is not surprising since the initial ring opening event may 
be more facile with heteroatom based nucleophilic entities. Such reactive partners are 
often dipolar in nature. In some cases however, the reaction may involve a partner that is 
all-carbon resulting in a carbocycle. This area of research is currently expanding and 
many elegant methods utilizing Lewis acid, protic acid, base, or thermal activation 
(among others) have been developed. 
1.2 Carbocycles from [3+2] Annulations of DA 
Cyclopropanes 
The cyclopentane and cyclopentene moieties are common to a wide variety of terpene 
and alkaloid natural products (Figure 1-2A).2 Due to the prevalence and importance of 
these carbocyclic structures, many strategies have been developed for their construction.3 
For over 50 years, DA cyclopropanes have been synthetically useful 1-3 carbon 
dipolarophile starting materials for the synthesis of highly substituted 5-membered 
carbocycles via annulation reactions with alkenes, alkynes, and allenes (Figure 1-2B). 
Although much of the seminal research in this area has been developed with the 
previously mentioned dipoles, herein, we discuss the most recent syntheses of 
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cyclopentane and cyclopentene compounds via the annulation of enol ethers and 
enamines with DA cyclopropanes. 
 
Figure 1-2: Cyclopentane and Cylopentene Containing Target Molecules 
1.2.1 Reactions with Enol Ethers 
Over the last 25 years, there has been significant interest in the use of enol ethers and 
ketene acetals as dipoles for the annulation reaction with cyclopropanes. Studies have 
revealed successful reactivity with a large array of different DA cyclopropanes, and both 
diastereoselective and enantioselective methods have been developed. One of the first 
reports in this field was presented in 1990, showcasing the use of 2,2-
dialkoxycyclopropanes 1-2 with a series of silyl ketene acetals to access the desired 
cyclopentenone 1-3 or 1-4 depending on the cyclopropane used (Scheme 1-1).4 While 
TiCl4 mediated conditions allowed for practical conversion to the desired products, the 
reaction conditions proved to be non-selective, typically leading to a mixture of four 
diastereomers. In some cases, when excess ketene acetal was used, addition product 1-5 
was also observed in small quantities.   
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Scheme 1-1: Preliminary Investigations into the Reaction of DA Cyclopropanes and 
Silyl Enol Ethers 
Shortly after this seminal work, Kuwajima and co-workers published two papers on the 
exploration of the use of alkoxy and phenylsulfide activated cyclopropanes as reaction 
partners with silyl enol ethers (Scheme 1-2A/B). In the case of alkoxycyclopropane esters 
1-6, product formation (1-9) could be attained in good overall yields as a mixture of 
stereoisomers with stoichiometric amounts of SnCl4 (Scheme 1-2A).5 These conditions 
were accepting of a wide range of silyl enol ethers including disubstituted and cyclic 
examples (from cyclohexanone etc.); however, trisubstituted enol ethers proved 
unreactive. In the same report, it was determined that alkoxycyclopropane ketones 1-7 
were too reactive for the use of stoichiometric amounts of SnCl4 leading to dimerization 
of the starting material. To overcome this issue, catalytic amounts of the Lewis acid were 
used allowing for low to moderate product conversion with silyl enol ethers. While this 
report did show the first Lewis acid catalysed addition of enol ethers and DA 
cyclopropanes, the selectivity of the reaction was poor leading to complex mixtures of 
stereoisomers.  
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Scheme 1-2: Reactions of Alkoxy- and Phenylsulfide-subsituted Cyclopropanes with 
Silyl Enol Ethers 
Kuwajima next showed a diastereoselective process using 2-phenylthiocyclopropane 1-11 
(Scheme 1-2B).6 It was determined that increasing the steric bulk of the silyl group (TIPS 
or TBDPS) led to diastereoselective product formation (1-13) up to 99:1. Additionally, 
the rate of starting material dimerization could be minimized using aluminum reagents 
instead of tin, leading to overall higher yields and larger substrate scopes than previously 
reported.   
 
Scheme 1-3: Triflimide Catalysed Reactivity of Cyclopropylketones 
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In a similar manner to the work of Kuwajima, the Ihara group showed the triflic imide 
catalysed annulation of silyl enol ethers and p-methoxyphenyl (PMP) activated 
cyclopropanes 1-15 to access cyclopentanes 1-16 (Scheme 1-3).7 The conditions were 
favourable for cyclic silyl enol ethers (cyclohexanone derived) and diminished yields 
were seen for acetophenone derived enol ethers. These results paralleled those of 
Kuwajima’s first report, showing little to no diastereoselectivity under these reaction 
conditions. To showcase the diversity of their catalytic conditions, the group applied 
them to a multi-component sequential Diels-Alder/[3+2] annulation reaction to produce 
highly substituted 1-20 in a modest overall yield (Scheme 1-4).   
 
Scheme 1-4: Multi-component Sequential Diels-Alder/[3+2] Annulation Reaction 
In 1999, Sugita et al. highlighted the use of catalytic TMSOTf conditions in the synthesis 
of bridged[4.2.1]bicyclic products. This catalytic method allowed a range of silyl enol 
ethers to react with fused cyclopropane 1-22 to give low to serviceable isolated yields of 
the desired product 1-23 with usable cis/trans ratios up to 18:1 (Scheme 1-5).8 The report 
gave a small substrate scope indicating that substitution on the cyclopropane greatly 
decreased the yield of the desired product and increased yields of the ring-opened 
product. 
 
Scheme 1-5: TMSOTf Catalysed Reaction of 1-21 and 1-22 
Near the end of 2008, investigations by Wang9 showed the annulation of 1,1-
cyclopropanediesters 1-25 with silyl enol ethers to be rather difficult, as the cyclic 
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products 1-26 readily underwent retro-aldol reactions to produce high yields of the 
acyclic product 1-27 under Lewis acid conditions (Scheme 1-6). Under optimal 
conditions, only a few cyclic products could be isolated and in very low yields.    
 
Scheme 1-6: Initial Investigations into the Reaction of 1,1-Cyclopropanediesters 
with Enol Ethers 
The Tang group began investigations on the reactivity of 1,1-cyclopropanediesters in the 
hopes of developing a highly enantioselective process for the [3+2] annulation reaction 
with silyl enol ethers. Their initial exploration into this field required finding ideal 
conditions for the suppression of acyclic by-product 1-27 (Scheme 1-6). It was quickly 
discovered that the acyclic by-product of the annulation process could be minimized by 
modifying two simple aspects of the reaction: 1) by changing the Lewis acid, and 2) by 
increasing the steric bulk of the silyl group.10 Making both of these modifications showed 
a significant increase in yield and the selectivity now favoured the desired cyclopentane 
ring over the acyclic product. Finally, they discovered that if both changes were made 
along with the addition of a bulky bisoxazoline dimer ligand (A), not only was the acyclic 
product suppressed completely but the desired products 1-30 were isolated with good to 
excellent diastereomeric ratios (Scheme 1-7). The reaction conditions were compatible 
with a variety of aromatic substituted cyclopropanes with lower yields observed for the 
less stable vinyl and heteroaromatic substituted cyclopropanes. The silyl enol ether could 
also be changed; however, when cyclic examples were employed (cyclohexanone 
derived), a decrease in yield and loss of diastereoselectivity was observed.           
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Scheme 1-7: Tang’s Work Toward the Enantioselective Reaction of Cyclopropanes 
and Silyl Enol Ethers 
In hopes of overcoming this selectivity problem and gaining access to fused bicyclic 
cyclopentane derivatives, the Tang group needed to develop a new set of reaction 
conditions.11 Once again, they exploited the idea of steric bulk. By surveying an 
assortment of different ester-substituted cyclopropanes, they found that when sterically 
bulky 2-adamantyl diester cyclopropanes 1-28 were employed with silyl enol ethers 
containing large silyl groups (TDBPS), smooth annulation occurred with excellent 
diastereoselectivity (Scheme 1-7). Again, by utilizing a bisoxazoline ligand (B), the 
bicyclic products 1-31 could be isolated in high yields and near perfect 
diastereoselectivity. The conditions were tolerant of a range of aromatic cyclopropanes 
with lower yields again being observed for the less stable vinyl and heteroaromatic 
substituted cyclopropanes. A variety of different ring sized silyl enol ethers could also be 
used with the trend that the smaller ring sizes gave higher product yields.  
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The most recent stage of Tang’s research focused on enantioselective conditions for the 
synthesis of cyclopentanes from cyclopropanes and silyl enol ethers. In 2013, such 
enantioselective conditions for the dynamic kinetic asymmetric transformation (DYKAT) 
were discovered (Scheme 1-7).12 The conditions worked well for highly activated 
electron rich aromatic cyclopropanes (almost exclusively) allowing access to 
cyclopentanes 1-32 in good to excellent yields with moderate to excellent 
diastereoselectivity and overall excellent enantiomeric excess. Again, a similar trend was 
shown for the cyclic silyl enol ethers, where the smaller ring sizes gave overall higher 
yields and greater diastereoselectivity. Additionally, the conditions that were developed 
worked for less electron rich aromatic cyclopropanes (1-34); however, they proceeded in 
a kinetic resolution fashion and typically required increased reaction times (Scheme 1-8). 
Further exploration into this process is currently underway.    
 
Scheme 1-8: Kinetic Resolution of Less Activated DA Cyclopropanes with Silyl Enol 
Ethers (for ligand C see Scheme 1-7) 
Recently, Waser became engaged in investigating the reactivity of amino activated 
cyclopropanediesters toward the same [3+2] reaction process with enol ethers. In 2011, 
the first of two papers in this area were published showing the first catalytic [3+2] 
annulation of aminocyclopropanes (Scheme 1-9).13 The appropriate 
phthalimidecyclopropane 1-37 was discovered to be the ideal cyclopropane starting 
material for this transformation. Unlike previous reports by Kuwajima5,6 and Ihara,7 it 
was found that the mono-carbonyl cyclopropanes were unreactive to a variety of reaction 
conditions. Initial Lewis acid screening proved very important to find a suitable catalyst 
that would minimize the formation of any unwanted acyclic products. SnCl4 was selected 
as the best catalyst allowing for great conversion to the corresponding cyclopentanes 1-38 
in excellent yields with modest to great diastereoselectivity up to 20:1. The reaction 
conditions were tolerant of many different substituted silyl enol and alkyl enol ethers, and 
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in contrast to Tang’s work, the size of the silyl group had little to no effect on the 
selectivity of the reaction. Although a large substrate scope was evaluated, a few 
examples resulted in diminished yields and selectivities, including trisubstituted, aliphatic 
substituted, and cyclic silyl enol ethers, as well as 3,4-dihydropyran enol ethers. It was 
also shown that when optically enriched phthalimidecyclopropane 1-37 was subjected to 
the reaction conditions with a series of silyl enol ethers, little to no erosion of 
enantiomeric purity was observed.     
 
Scheme 1-9: Diastereoselective Annulation of Enol Ethers and Aminocyclopropanes 
Waser next explored a DYKAT method for the synthesis of amino-substituted 
cyclopentanes. The result of this exploration was realized in early 2014 by utilizing a 
succinimidocyclopropane 1-40, a bulky bisoxazoline ligand (D), and by replacing the 
silyl group on the enol ether with an alkyl group (Scheme 1-10).14 Parallel to Tang’s 
result, the overall [3+2] annulation worked well with a variety of different enol ethers, 
giving high yields, moderate to excellent diastereomeric ratios, and excellent 
enantiomeric excess in most cases. The reaction could be performed on gram scale 
without significant loss of yield or stereocontrol. Further experiments are underway to 
establish the origin of asymmetric induction.  
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Scheme 1-10: DYKAT Reaction of Aminoactivated Cyclopropanes and Enol Ethers 
Finally, 2,5-dimethylfuran had also been shown to be a suitable dipole for the [3+2] 
annulation of cyclopropanes, although only a limited substrate scope had been displayed 
(Scheme 1-11A). In fact, only 2-thienyl and phenyl substituted cyclopropanes 1-42 
underwent cyclization with furan 1-43 to give the desired cycloadduct 1-44 under 
Yb(OTf)3 or SnCl4 conditions, respectively.15 Additionally, it was shown that when 
thienyl cyclopropane 1-45 was subjected to SnCl4 conditions, the desired cycloadduct 
underwent a subsequent electrophilic aromatic substitution reaction with the dihydrofuran 
ring to give 1-46 (Scheme 1-11B).  
 
Scheme 1-11: Reactions with 2,5-dimethylfuran 
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1.2.2 Reactions with Enamines 
Since the historical discovery of the thermal enamine annulation with cyclopropanes 
reported by Dolfini (Scheme 1-12),16 this field of research has been dominated by one 
type of enamine: the highly reactive indole.  
 
Scheme 1-12: Seminal Reaction of Enamines with Cyclopropanes 
During the development of a follow up project on the alkylation of indoles with ,–
unsaturated ketones,17 Kerr and co-workers explored the use of DA cyclopropanes as a 
homologous evolution of this work. Their preliminary results showed that when using 
catalytic Yb(OTf)3 under high pressure conditions, indole 1-50 could open cyclopropane 
1-51 (Scheme 1-13A);18 however, a trace amount of the 1-53 was formed as well, 
presumably through nucleophilic ring-opening followed by Mannich type trapping by the 
corresponding malonic enolate (Scheme 1-13B).19 
 
Scheme 1-13: Preliminary Investigation into the Annulation of Indoles with 
Cyclopropanes 
Encouraged by the formation of 1-53, the Kerr group next set out to optimize this [3+2] 
annulation process. It was discovered that placing a substituent on the three position of 
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the indole allowed for direct conversion to the annulated 1-57 product using both thermal 
and hyperbaric conditions (Scheme 1-14A).20 Although the reaction proceeded well with 
2- and 3-substituted indoles and various substituted cyclopropanes to access the cyclic 1-
57 as the major product, when high temperature conditions were utilized, the formation 
of migration product 1-60 became a competing and sometimes major product (Scheme 
1-14B). It was later determined that when cyclic product 1-57 was heated under Lewis 
acid conditions, conversion to 1-60 was observed providing evidence for the reversibility 
of this process.20b 
 
Scheme 1-14: Annulation of DA Cyclopropanes with 3-substituted Indoles 
When less activated cyclopropanes were used (R4 = Me or H), hyperbaric conditions 
resulted in the highest yields. When more activated cyclopropanes were used (R4 = 
phenyl, vinyl, or styrenyl), ambient pressure conditions resulted in higher yields. To 
display the utility of this transformation, the key tetracyclic subunit of the kopsane 
alkaloid 1-64 was synthesized by the reaction of cyclopropane 1-62 with 
tetrahydrocarbazole 1-61 (Scheme 1-15). 
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Scheme 1-15: Synthesis of Kopsane’s Core 
The groups of Ila and Pagenkopf then showed expansions of this chemistry with different 
DA cyclopropanes. In 2006, Ila showed that trans cyclopropylketones 1-66 could 
undergo annulations with indoles to give high diastereoselective products 1-67 under 
BF3Et2O mediated conditions (Scheme 1-16).21 Electron rich aromatic substituents on 
the cyclopropane led to isolated products as a single diastereomer, while electron neutral 
(Ar = phenyl) cyclopropanes led to diastereomeric mixtures, similar to the results seen by 
Kerr. When highly activated (Ar = 3,4-dimethoxyphenyl) cyclopropanes were used, 
modified TiCl4 conditions were required. To expand the scope of their study, the reaction 
conditions were applied to the 1,1-cyclopropanediester starting material and similar 
results to those of Kerr were observed. It is noteworthy that under these reaction 
conditions, little to no migration product was observed as in the case with Yb(OTf)3. This 
result can presumably be attributed to the low reaction temperatures employed. 
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Scheme 1-16: Reactivity of Cyclopropylketones with Indoles 
In 2007, Pagenkopf showed that alkoxy-activated cyclopropanes could undergo 
annulation reactions with indoles in the presence of TMSOTf.22 In contrast to previous 
reports, the annulation of cyclopropanes 1-69 was achieved in high yields using 2,3-
unsubstituted and 2-substituted indoles 1-68 (Scheme 1-17); in fact, when 3-substituted 
indoles were employed under these reaction conditions, only the migration and 
elimination products were observed. The reaction conditions were suitable for a series of 
alkoxy-activated cyclopropanes with highest diastereoselectivities (single diastereomer) 
coming from conformationally restricted cyclopropanes (e.g. 1-70a). In general, the 
unfused cyclopropanes resulted in the lowest yields (e.g. 1-70c) while the fused 
cyclopropanes gave good to excellent yields of the product. Additionally, the reaction 
conditions were tolerant of many different substituents on the benzenoid ring of the 
indole. 
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Scheme 1-17: Reactivity of Alkoxycyclopropanes with Indoles 
The next progression in this vein was the development of asymmetric reaction conditions 
for the synthesis of enantioenriched cyclopentan[b]indoles. While continuing their work 
on dynamic kinetic asymmetric transformation reactions of DA cyclopropanes,23 Johnson 
reported the first asymmetric synthesis of indole homo-Michael adducts via 
cyclopropanes.24 This DYKAT method using pybox ligand (E) and catalytic MgI2 was 
very efficient for the alkylation of indoles with cyclopropanes (er up to 97:3). While not 
the focus of this work, Johnson did show that this process could be applied to the 
annulation process when 3-methyl indole was employed (Scheme 1-18).  
 
Scheme 1-18: Preliminary Results for the Asymmetric Reaction of Indoles and 
Cyclopropanes 
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In 2013, the Tang group was able to develop a highly enantioselective 
cyclopentannulation reaction of indoles and DA cyclopropanes (Scheme 1-19).25 Much 
like their work with enol ethers, this process worked well with activated (p-
methoxyphenyl) cyclopropanes 1-75 in almost all cases giving good diastereoselectivity 
and high enantioselectivity of 1-76. Lower yields and selectivities were observed when 
less activated cyclopropanes were utilized (e.g. 2-furyl, vinyl, p-iodophenyl). To 
showcase this method, Tang devised a short synthesis to the core of Borreverine, in very 
high yield and as a single diastereomer.  
 
Scheme 1-19: Synthesis of 1-76 via a DYKAT Reaction of Cyclopropanes and 
Indoles 
In a recent expansion of this work, Tang has developed a highly switchable 
diastereoselective intramolecular [3+2] annulation of cyclopropanes and indoles.26 
Extensive optimization led to the use of diimine ligand (G) and catalytic copper, which 
provided modest diastereoselectivity of the products 1-78 (83:17 dr). Upon further 
optimization, when the esters were changed from methyl to isopropyl, an increase in 
diastereoselectivity was observed (90:10). Additionally, when larger adamantyl groups 
were used, the selectivity reversed to the other diastereomer 1-79. Both esters were tested 
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with a variety of benzenoid substitutions, leading to high yields and excellent selectivities 
of both isomers of the unique pentacyclic structure (Scheme 1-20).  
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Scheme 1-20: Diastereoselective Intramolecular Annulations of Indole 
1.3 Carbocycles from [3+3] Annulations of DA 
Cyclopropanes 
Much like their five membered counterparts, the cyclohexane ring is an important 
structural moiety in natural products. Its structure is ubiquitous in a variety of naturally, 
pharmaceutically, and historically relevant molecules (Figure 1-3)27 and thus synthetic 
methods devoted to the synthesis of cyclohexanes are of high interest and value. In 
contrast to cyclopentanes, less research has been devoted to the [3+3] annulation of 
cyclopropanes to access cyclohexanes. 
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Figure 1-3: Cyclohexane Containing Target Molecules 
Yadav reported the addition of two equivalents of alkynes with cyclopropane 1-84 to 
access spirocyclic compounds 1-90 (Scheme 1-21).28 Ring-opening of cyclopropane 1-84 
with SnCl4 led to silicon stabilized cation 1-85 which could react with an alkyne to give 
arylvinyl cation 1-87 followed by trapping with the newly formed olefin. Styrenyl cation 
1-88 could then be attacked by another equivalent of alkyne to give arylvinyl cation 1-89, 
which in turn could then be trapped by the aromatic ring (from the cyclopropane) to give 
the observed product. 
 
Scheme 1-21: Mechanism for the Formation of Spirocycle 1-90 
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The conditions worked well for electron neutral aromatic cyclopropanes reacting with a 
series of electron neutral alkynes giving diastereomerically pure products 1-90 in 
reasonable yields (Scheme 1-22A). The stability of the vinyl cation intermediates was 
presumably the reason electron poor alkynes were ineffective. When TMS phenyl alkyne 
1-91 was used under the standard reaction conditions, cyclohexadiene 1-92 was formed 
in a modest yield (Scheme 1-22B). It is proposed that 1-92 was formed through the 
elimination of a 1-88 type intermediate followed by a subsequent reaction with another 
equivalent of alkyne. 
 
Scheme 1-22: Reactivity of Cyclopropane 1-84 
In 2009, Kerr and co-workers reported the reaction of 1,1-cyclopropanediesters 1-94 with 
2-(chloromethyl)-3-trimethylsilyl-1-propene 1-93 as a trimethylenemethane (TMM)29 
equivalent in the synthesis of exo-methylenecyclohexanes 1-95 (Scheme 1-23).30 After 
various attempts to promote this reaction via one-step palladium catalysis had proven 
unsuccessful, a sequential two-step Lewis acid mediated ring-opening followed by a base 
mediated ring closure was invoked to access the cyclohexane 1-95.  
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Scheme 1-23: Reactions with 2-(chloromethyl)-3-trimethylsilyl-1-propane (1-93) 
Ring-opening worked in modest yields with a variety of aromatic and vinyl 
cyclopropanes, while ring closure worked in excellent yields for almost all substrates. 
Lower yields were seen for the ring-opening of 2-thienyl cyclopropane presumably due to 
the stability of the cyclopropane under TiCl4 conditions. Alkyl substituted cyclopropanes 
did not undergo ring-opening/allylation due to the lack of stability of the putative ring-
opened intermediate.31 In the same paper, the utility of this reaction was displayed in the 
rapid synthesis of tronocarpine’s core 1-98 (Scheme 1-24). 
 
Scheme 1-24: Synthesis of Tronocarpine’s Core 
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Recently, a highly diastereoselective tandem ring-opening/Michael addition has been 
reported by Ghorai.32 Reaction of indole 1-100 with 1,1-cyclopropanediester 1-101 under 
Yb(OTf)3 catalysis yielded the corresponding tetrahydrocarbazole 1-102 in average to 
excellent yields with good diastereoselectivity (in most cases as a single diastereomer) 
(Scheme 1-25). It was proposed that the selectivity was achieved after ring-opening in 
which the Michael acceptor favoured the pseudoaxial half-chair conformation leading to 
the cis isomer. Overall, the reaction conditions were efficient for a variety of aromatic 
cyclopropanes with lower yields and selectivity when styrenyl substituted cyclopropanes 
were used. In general, the malonate acceptor groups gave higher yields than the 
corresponding nitro acceptors.      
 
Scheme 1-25: Highly Diastereoselective Tandem Ring-opening/Michael additions 
1.4 Indoles and Carbazoles 
It is unarguable that indoles rank among the most important heterocyclic compounds. 
They remain prime scaffolds for pharmaceutical drug discovery and their prominence in 
natural products is prodigious; as such, there continues to be a large degree of activity 
devoted to the efficient chemical elaboration of the benzopyrrole ring system.33 A subset 
of the indoles are the carbazoles and their hydro-derivatives. The preparations of these 
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structures has seen significant interest among the chemical community due in part to the 
carbazoles and the presence of their hydro-derivatives in naturally occurring and 
bioactive compounds.34 Of additional interest, the carbazole structure has been shown to 
exhibit material properties as optoelectronic materials,35 conducting polymers,36 and 
synthetic dyes.37 Figure 1-4, for example, shows a sampling of carbazole natural products 
isolated in recent years.38 
 
Figure 1-4: Representative Carbazole Natural Products 
1.4.1 Selected Recent Syntheses of Carbazoles 
In 2013 Samanta and co-workers showed the facile synthesis of substituted carbazoles 
through a one pot Henry reaction/aerial oxidation (Scheme 1-26).39 Michael acceptor 
1-103 underwent smooth conversion to carbazole 1-104 in the presence of nitromethane, 
catalytic DBU, and air. The transformation was successful with a range of substituted 
Michael acceptors resulting in good to excellent yields of the product, with the highest 
yields observed when R=alkyl (e.g. 1-104c). From a synthetic standpoint, this method is 
particularly interesting as it excludes the use of acids, toxic reagents, metals, or strong 
oxidants. 
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Scheme 1-26: Synthesis of Carbazoles via a Henry/aerial Oxidation Process 
In a similar search for mild conditions capable for the synthesis of carbazoles, Xu and Shi 
have shown the unique conversion of alkynylcyclopropane 1-105 to the corresponding 
carbazole 1-106 via mild gold catalysis in dichloromethane (Scheme 1-27).40 
Nucleophilic addition of indole onto the activated alkyne could give spirocyclic 
intermediate 1-108 which could undergo a migration to give stabilized cation 1-109. 
Aromatization and protonation followed by elimination of H2O would lead to gold 
carbene intermediate 1-111. Intermediate 1-111 could then undergo cyclopropane ring 
expansion and subsequent elimination to produce carbazole 1-106. The reaction 
conditions were suitable for an array of alkyne substituted starting materials (including 
aromatic and alkyl) leading to the desired product in low to modest yields. Interestingly, 
when alcohol solvents were employed, cyclopropane ring-opening of intermediate 1-111 
with the alcohol was observed leading to high yields of the corresponding ether 
substituted carbazole product.        
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Scheme 1-27: Carbazole Formation from Cyclopropane 1-105 
With the ever growing development and interest in C-H activation methods, Hirano and 
Miura have displayed an intramolecular C-H/N-H coupling of substituted anilines (1-113) 
to produce carbazoles.41 This recently reported method allowed for efficient access to a 
variety of substituted carbazoles 1-114 in moderate to excellent isolated yields (Scheme 
1-28). Overall, the reaction worked well for electron donating aromatic substituents (R1 
and R2 = EDG) while electron withdrawing substituents gave lower yields.  
 
Scheme 1-28: Carbazoles from Cu-Catalyzed C-H Amination Reaction 
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While only a few synthetic methods were discussed within this section, the 
overwhelming development of new synthetic methods for the synthesis of carbazoles is a 
testament to the overall importance of these molecules.42    
1.5 The Conia-ene Reaction 
Developed in the mid-1970s, the Conia-ene reaction is a powerful intramolecular carbon-
carbon bond forming reaction between an enol and a tethered “ene” system. Early work 
in this area favored thermal conditions for the cyclization of unsaturated carbonyl 
compounds (Scheme 1-29).43 Although this seminal work provided a functional route to 
carbocycles, the method suffered from major limitations. The reaction conditions 
typically employed high temperatures, which severely limited the synthetic utility of the 
approach and also resulted in only low to modest yields of the product. Additionally, the 
transformation was biased toward the formation of smaller ring systems (five-membered 
rings being the most common) with larger ring systems being formed in only small 
amounts. 
 
Scheme 1-29: Conia-ene Reaction 
Since the initial discovery of this transformation, the literature has overflowed with new 
and improved reaction conditions for this cyclization.44 These new methods utilizing 
alkyne substituted carbonyl starting materials have allowed for lower temperatures to be 
used when transition metals are employed. Also these methods produce overall increases 
in yield, and allow for the formation of larger ring systems. Most recently asymmetric 
variations of this chemistry have been explored and have shown great promise. 
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1.5.1 Selected Recent Advances in Conia-ene Chemistry 
Although there has been much effort toward finding the ideal catalyst system to promote 
the Conia-ene reaction, it was not until recently that boronic acid was found to be an 
efficient catalyst for this cyclization. Building from the seminal work of Dixon,45 Shibata 
and co-workers have shown the use of a new organocatalyst 1-119 in the cyclization of 
1,3-dicarbonyl compounds (Scheme 1-30).46 In contrast to the more common transition 
metal mediated approach which activates the alkyne toward cyclization, it is proposed 
that the boronic acid catalyst has little effect on activation of the alkyne and is simply 
used to promote enolization. These results will undoubtedly promote subsequent research 
into the development of mild reaction conditions predominately focused on the activation 
of the carbonyl species rather than the activation of the alkyne. 
 
Scheme 1-30: Boronic Acid Catalyzed Conia-ene 
Recent advances in this area have reported the enantioselective Conia-ene reaction by the 
use of optically enriched ligands and pre-catalysts. Dixon has recently shown a 
cooperative catalyst system between a cinchona-derived amino-urea pre-catalyst (1-123) 
and copper salts which has led to very high yields and enantioselectivities of cyclized 
product 1-122 (up to 93% ee) (Scheme 1-31A).47 The use of these two catalysts together 
not only led to high yields, but they allowed for significantly decreased reaction 
temperatures for most all keto-ester explored substrates. Following Dixon’s report, the 
White group has displayed the enantioselective cyclization of keto-substituted starting 
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materials 1-121 utilizing an iron-salen catalyst system (Scheme 1-31B).48 This method 
was effective for a variety of substituted keto-esters leading to excellent 
enantioselectivities. Interestingly, this method could be expanded to include different 
electron withdrawing groups, including R2 = NO2, PO(OMe)2, Tosyl, and CN; however, 
reaction times were typically increased for the non keto-ester starting materials.  
 
Scheme 1-31: Enantioselective Conia-ene Reactions 
1.5.2 Tandem Reactions Involving the Conia-ene Cyclization 
During the long sought-after search for optimal conditions to increase yields, minimize 
byproducts, decrease reaction times, and allow for asymmetric conversion of the Conia-
ene cyclization, another promising area of research utilizing this powerful reaction began 
to appear: one-pot tandem reactions incorporating the Conia-ene cyclization. The first 
work reported to display a tandem reaction utilizing the Conia-ene cyclization was 
reported by Malacria in 199649 using the previously established cobalt mediated 
cyclization method.44x This seminal work displayed the cobalt catalyzed Conia-
ene/[2+2+2]/[4+2] cascade of triyne 1-125 and bis(trimethylsilyl)acetylene (BTMSA) 
(Scheme 1-32). This unique reaction led to tetracyclic carbocycle 1-126 in a serviceable 
42% yield. These remarkable initial results certainly would have left an impression on 
this research field, while at the same time opening the door for many others to utilize the 
facile Conia-ene cyclization in tandem fashion to access unique and complex scaffolding.     
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Scheme 1-32: Cobalt Catalyzed Cascade Involving the Conia-ene Cyclization 
Not too long after Malacria’s preliminary report, Balme and co-workers described two 
different conditions for the synthesis of tetrahydrofurans via a tandem oxy-Michael 
addition/Conia-ene reaction (Scheme 1-33A).50 Initial results showed that catalytic butyl 
lithium and palladium could not only mediate the Michael addition between propargyl 
alcohol 1-127 and 1-128, but also catalyzed the Conia-ene cyclization to give a range of 
substituted tetrahydrofurans (THF) in excellent yields. It was later determined that copper 
iodide could be used in place of palladium and the THF products could be isolated in an 
overall higher yield. In a follow up to this work, Balme was able expand this method to 
the synthesis of pyrrolidines, via the tandem reaction of propargyl amines and Michael 
acceptors (Scheme 1-33B).51 Interestingly, although the pyrrolidines could be isolated 
(intermediate 1-132), they were subjected, in the same pot, to an additional palladium 
catalyzed phenol coupling reaction to give highly functionalized pyrrolidine 1-133. This 
three-step one-pot process lead to modest overall yields of the product; however, in most 
cases the products were isolated as a mixture of double bond isomers (1-133 and 1-134). 
The development of these unique tandem heteroatom-Michael addition/Conia-ene 
processes (synthesis of tetrahydrofurans and pyrrolidines) have since been improved to 
allow for single catalyst conditions, as well as diastereoselective product formation.52     
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Scheme 1-33: Tandem Michael Addition/Conia-ene Reactions 
In the same theme of research, utilizing the Conia-ene transformation, Zhang disclosed 
the synthesis of polycyclic scaffold 1-136 via the one-pot tandem Navarov 
cyclization/Conia-ene reaction of alkyne 1-135 (Scheme 1-34A).53 In(OTf)3 and DBU 
conditions provided rapid access to an array of polycyclic products in great yields; 
however, it was shown that electron withdrawing phenyl ketones did not undergo the 
transformation with much success. It is noteworthy that the Conia-ene reaction can be 
performed on disubstituted alkynes, a task not regularly observed with this type of 
reaction. Furthermore, Zhang has displayed the reliability of this reaction by applying it 
to the three step one-pot reaction of aldehyde 1-138 and 1,3-dicarbonyl 1-137 (Scheme 
1-34B).   
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Scheme 1-34: Tandem Nazarov/Conia-ene Reactions 
In a similar manner to the three step one-pot reaction of Zhang, Ramachary was able to 
show a one-pot sequential multicatalysis cascade condensation/reduction/Conia-ene 
method for the synthesis of indenes (Scheme 1-35).54 Initial proline catalyzed 
condensation followed by an in situ Hantzsch ester hydrogenation gave 1-142, which, in 
the same pot, could be cyclized providing 1-143 in the presence of catalytic copper. This 
method allowed quick access to indenes in excellent yields; however, due to the 
specificity of the starting material, only a small scope varying the EWG was presented. 
 
Scheme 1-35: Ramachary's Tandem Conia-ene Reaction 
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With the ever-growing success in the field of tandem reactions involving the Conia-ene 
reaction, Lee next entered the field showcasing a Michael/Conia-ene cascade reaction in 
the synthesis of natural product targets.55 This new reaction was first displayed in the 
formal synthesis of (±)-Clavukerin A (1-146) starting from readily available alkyne 1-144 
(Scheme 1-36A). Amine-induced Michael addition was readily achieved in the presence 
of diethylamine and the corresponding enol formed initiated the Conia-ene reaction in the 
presence of a zinc catalyst to give carbocycle 1-145. Lee was further able to display this 
method in the total synthesis of a more complex natural product (-)-teucvidin (1-149) 
(Scheme 1-36B).       
 
Scheme 1-36: Tandem Michael Addition/Conia-ene Reactions in Total Synthesis 
In 2011, extending their tandem reaction approach to total synthesis, Lee was also able to 
showcase the one-pot Prins/Conia-ene reaction in the synthesis of the core skeleton of 
Phomactin A.56 Indium mediated intermolecular reaction between aldehyde 1-151 and 
1,3-ketoester 1-150 led to oxonium intermediate 1-152 that underwent a subsequent Prins 
type reaction. In the same pot, indium mediated the conversion to 1-153 via the Conia-
ene cyclization (Scheme 1-37A). The reaction conditions were well accepted for different 
substitutions on the ketoester and chain lengths of the aldehyde, allowing for this process 
to be employed in target oriented synthesis (Scheme 1-37B).       
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Scheme 1-37: Tandem Prins/Conia-ene Reaction 
Finally, one of the most recent explorations into this area of research was reported by 
Hatakeyama in 2014 who showed the mutli-catalyst tandem O-H insertion/Conia-ene 
cyclization reaction to access formal [4+1] cycloadducts 1-161 (Scheme 1-38).57 This 
unique reaction showed the facile rhodium catalyzed insertion of diazomalonate 1-159 
with homo-propargyl alcohols to give acyclic intermediate 1-160. Insertion product 1-160 
then underwent a Conia-ene cyclization in the presence of catalytic ZnCl2. Interestingly, 
tetrahydrofurans 1-161 could be accessed using only a rhodium catalyst; however, 
increased reaction times were required and significantly lower yields of the product were 
observed. These preliminary results will certainly have a profound effect on this area of 
research giving leeway to develop new and improved methods for tandem 
insertion/Conia-ene reactions with a variety of different tethered alkynyl starting 
materials.  
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Scheme 1-38: Tandem O-H Insertion/Conia-ene Reaction 
1.5.3 Previous Tandem Cyclopropane Ring-Opening/Conia-ene 
Reactions Developed by the Kerr Group 
With interest building in the area of tandem reactions involving the Conia-ene reaction, 
the Kerr group entered the field in hopes of utilizing the reactivity of donor-acceptor 
cyclopropanes in conjunction with the Conia-ene cyclization. It was envisioned that any 
nucleophilic moiety (1-162) with a tethered alkynyl group could, in principle, participate 
in a two-step sequence involving a nucleophilic cyclopropane ring-opening reaction to 
yield a pendent malonate 1-164 and a subsequent Conia-ene reaction could proceed with 
the malonate and the acetylenic group to give cyclic compounds 1-165 (Scheme 1-39). 
 
Scheme 1-39: General Nucleophilic Cyclopropane Ring-Opening/Conia-ene 
Cyclization 
In 2009, this concept was realized when propargyl amines 1-166 and 1,1-
cyclopropanediesters 1-163 were reacted in the presence of a zinc catalyst to give the 
corresponding piperidine 1-167 (Scheme 1-40A).58 This process was efficient for a 
variety of substituted cyclopropanes resulting in excellent yields of the desired product. 
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This tandem process was once again achieved later in 2009 by the use of propargyl 
alcohols 1-168 to access tetrahydropyrans 1-170 (Scheme 1-40B).59 In contrast to the 
previous method with propargyl amines, the tandem cyclopropane ring-opening/Conia-
ene reaction with propargyl alcohols required a sequential dual catalyst system. This 
interesting result is presumably due the ability of the nucleophile to open the 
cyclopropane ring thus requiring a stronger Lewis acid to efficiently activate the 
cyclopropane. The use of In(OTf)3 allowed for ring opening to give intermediate 1-169 
which then underwent cyclization upon the addition of a zinc catalyst furnishing 1-170. 
The development of these two methods has demonstrated the generality of this tandem 
process and has sparked the interest of the Kerr group to expand this process to different 
systems. 
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Scheme 1-40: Tandem Cyclopropane Ring-Opening/Conia-ene Reactions with 
Propargyl Amines and Alcohols 
1.6 The Synthesis of Tetrahydrocarbazoles via a Tandem 
Cyclopropane Ring-opening/Conia-ene Reaction 
With the Kerr group’s interest in the ongoing development and utility of donor-acceptor 
cyclopropanes along with the initial progress in the area of ring-opening/Conia-ene 
reactions, we next looked to probe other nucleophiles for use in the tandem process. 
Having already established the superior cyclopropane ring-opening capabilities of indole 
(see section 1.2.2) we envisioned this to be an appropriate nucleophile to combine with 
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the Conia-ene process. It was hypothesized having an alkyne tethered to the indole 
(1-171) could allow for nucleophilic ring-opening (1-173) followed by a subsequent 
Conia-ene reaction to give tetrahydrocarbazoles (Scheme 1-41). The results of this 
project are discussed herein.60 
 
Scheme 1-41: Hypothesized General One Pot Tetrahydrocarbazole Synthesis 
1.6.1 Results and Discussion – Synthesis of Starting Materials 
With a library of cyclopropanes available through traditional methods, the initial focus of 
this project was directed toward the synthesis of the substituted 2-alkynyl indole starting 
materials. The synthesis of 1-171a was first attempted by employing standard Corey-
Fuchs conditions (Scheme 1-42A).61 Ramirez type product 1-17562 was isolated in good 
yield from the commercially available aldehyde 1-174; however, treatment of this 
compound led to quick decomposition of the starting material. Gratifyingly, when 
aldehyde 1-174 was subjected to trimethylsilyldiazomethane and lithium 
diisopropylamide (LDA) alkyne was isolated in a 76% yield (Scheme 1-42B). While this 
method proved successful, the use of explosive reagents along with the expensive cost of 
starting material (TMSCHN2) caused us to abandon this route in search for a cheaper, 
more scalable method. 
 37 
 
 
Scheme 1-42: Initial Synthesis of Alkyne 1-171a 
To this end, a gram scale synthesis of 1-171a was achieved utilizing an Ohira-Bestmann63 
protocol in an excellent 89% yield (Scheme 1-43A). While this procedure worked well 
with several N-substituted indoles, the availability of benzenoid-substituted indole-2-
carbaldehydes was limited; in order to obtain a series of 2-alkynyl indoles, another 
procedure was required. A series of benzenoid-substituted alkynes 1-171d-f were 
efficiently prepared following a procedure developed by Lautens (Scheme 1-43B).64 
Finally, disubstituted alkynes could be prepared via 1) Sonogashira cross coupling (1-
171g) or 2) base mediated alkylation and acylation (1-171h,j) with 2-alkynyl indole 1-
171a (Scheme 1-43C/D).      
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Scheme 1-43: Synthesis of Substituted 2-Alkynyl Indoles 
1.6.2  Optimization and Scope 
Readily accessible indole starting material 1-171a was chosen as the nucleophilic partner 
for the initial investigation into the tetrahydrocarbazole synthesis via a tandem Conia-ene 
process. The main challenges for the implementation of the strategy are twofold: i) The 
nucleophiles’ reactivity must be orthogonal to that of the acetylenic group (i.e., they must 
not react with each other), and ii) a Lewis acid must be found which can activate the 
cyclopropane toward ring-opening and also activate the acetylene in the Conia-ene 
process. This last issue is somewhat complicated by the fact that it is the harder, 
oxophilic Lewis acids which are usually required for chelation with the geminal diester 
moiety on the cyclopropane, while softer metals are usually most successful in the Conia-
ene reaction. In this vein, phenyl substituted cyclopropane 1-163a, chosen for its well-
known reactivity in nucleophilic ring-opening chemistry, was subjected with 1-171a and 
a variety of different reaction conditions in order to determine the ideal conditions 
required to access the tetrahydrocarbazole 1-173a (Table 1-1).  
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Table 1-1: Optimization of the Synthesis of Tetrahydrocarbazoles 
 
entry  indole (equiv)  catalyst  solvent  time (h)  yield (%) 
1  1.1  Sc(OTf)3 (10 mol %) then ZnBr2 (3 equiv), NEt3 (1 equiv)  Benzene  1.5  63 
2  1.1  Zn(NTf2)2 (20 mol %)  Benzene  2.0  84 
3  1.4  Zn(NTf2)2 (10 mol %)  Benzene  2.0  87 
4  1.4  Zn(NTf2)2 (5 mol %)  Benzene  4.0  88 
5  1.4  Zn(NTf2)2 (5 mol %)  Toluene  24.0  decomp. 
6  1.4  Zn(NTf2)2 (5 mol %)  CH2Cl2  23.0  84 
7  1.4  Zn(NTf2)2 (5 mol %)  Cl(CH2)2Cl  1.5  84 
Initial observations using Sc(OTf)3 (an oxophilic catalyst) proved efficient for ring-
opening; however as predicted, sequential ring closure was not achieved. To invoke the 
Conia-ene cyclization, a sequential dual catalyst system was explored in a similar manner 
to that of the tetrahydropyran synthesis.59 The addition of ZnBr2 and NEt3 after the 
cyclopropane ring-opening event allowed for smooth cyclization in a one-pot to give the 
desired tetrahydrocarbazole 1-173a in 63% yield (Table 1-1, entry 1). Building on 
knowledge gained from our previous work allowed us to arrive quickly at optimal 
reaction conditions; in fact, Zn(NTf2)2 at a loading of 5 mol % in dichloroethane at reflux 
emerged as the reaction conditions of choice, giving tetrahydrocarbazole 1-173a in an 
84% isolated yield (entry 7). It should be noted that benzene (entry 4) and 
dichloromethane (entry 6) were also effective media for the reaction; however, starting 
materials were only sparingly soluble in benzene, while dichloromethane required 
extended reaction times. 
With optimal conditions in hand, we set out to investigate the substrate scope. 
Gratifyingly, a variety of cyclopropanes underwent the desired cyclization in excellent 
yields. Table 1-2 shows the results of several indoles (varying in the N-substitution) with 
a variety of 1,1-cyclopropanediesters. As seen from the table, there was a wide tolerance 
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for the substituents on the cyclopropanediester. Both electron-rich (1-173b, c, n) and 
electron-poor (1-173e, f, o) aryl substituents performed with equal efficiency.  
Heterocycles were also well tolerated, although the furan substituted adduct 1-173g 
decomposed somewhat under the reaction conditions. This result is common when using 
nucleophilic aromatic substituted cyclopropanes as they are very reactive and can 
participate in unwanted side reactions.65 Both styrenyl and vinyl cyclopropanediesters 
gave good yields of products (1-173j, k, q).  As expected, the parent cyclopropane (no 
substituent) produced 1-173l in greatly diminished yield, due to the absence of a π-donor 
group vicinal to the geminal diester moiety. Typically, harder Lewis acids, not 
compatible with Conia-ene chemistry, are required to activate this cyclopropane 
successfully. If the cyclopropane used was optically enriched, this was transferred with 
stereochemical fidelity to the adducts (1-173a and 1-173k). 
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Table 1-2: Substrate Scope Varying the Cyclopropane 
 
In an expansion of the substrate scope, a short array of products using benzenoid-
substituted indoles were explored (Table 1-3). The purpose of this study was to see 
whether electron withdrawing groups on the benzenoid ring would attenuate the indoles’ 
nucleophilicity. We were happy to observe that the presence of a trifluoromethyl or 
carbomethoxy moiety were not only tolerated, but produced these adducts in superb 
yields (1-173s, t).   
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Table 1-3: Substrate Scope Varying the Indole Substitution 
 
We next investigated the effects of substitution on the 2-alkynyl moiety in the hopes of 
furthering functional group inclusion for application to the synthesis of complex target 
molecules. To our disappointment, we found that internal alkynes (Table 1-4) produced 
solely the acyclic products (1-172b-c), despite an exhaustive study of reaction conditions. 
In addition to the formation of 1-172d, an additional 25% of 1-173a was isolated, 
presumably via in situ desilylation. To overcome this drawback in reaction scope, a 
methyl ester was used as the alkyne substituent. With the ester present, we obtained 
product 1-173v in a 95% yield. Tetrahydrocarbazole 1-173v was most likely the product 
of a conjugate addition reaction rather than a Conia-ene cyclization. However, the ability 
to form 1-173v allowed a strategy for further structural elaboration. We believed the 
geometry of the alkene in 1-173v to be as shown based on the absence of an nOe 
correlation, which is always apparent between the indole N-methyl group and a proximal 
vinyl hydrogen. Further exploration of the tandem cyclopropane ring-opening/Michael 
additions has recently been reported by Ghoria.32  
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Table 1-4: Substrate Scope Varying Alkyne Substiution 
 
1.6.3 Short Mechanistic Study 
A plausible mechanistic description is shown in Scheme 1-44 where initial coordination 
of diesters allows nucleophilic ring-opening of the cyclopropanediester. Following the 
ring opening, it is postulated that the Conia-ene ring closure could occur through one of 
two mechanistic paths. Pathway a occurs by having the Zn species coordinate to not only 
the alkyne, but to the oxygen of the ester (1-179) as well. This arrangement sets the 
alkynyl hydrogen of the starting material cis to the N-methyl group of the indole in the 
intermediate product (1-180). Alternatively, pathway b has the Zn species coordinate 
specifically to the alkyne (1-181) and has the malonic nucleophile perform an attack on 
the activated alkyne anti to the zinc. The end result would see the alkenylzinc moiety cis 
to the N-methyl group of the indole in the penultimate intermediate (1-182). It should be 
noted that the nature of the Conia-ene ring closure (specifically the role of the metal) is 
somewhat ambiguous. Our depiction in Scheme 65 is reminiscent of that shown by Toste 
in 2004 in which the role of the gold catalyst in a Conia-ene ring closure was probed.44g 
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In Toste’s case, the two options put forth are gold activation similar to pathway b in 
Scheme 44 and a carbometalation similar to pathway a. 
 
Scheme 1-44: Proposed Mechanistic Pathways 
In hopes to shed some light on the mechanistic possibilities of this reaction, a deuterium 
labelling study was performed (Scheme 1-45). The hydrogen on the alkyne compound 1-
171a was replaced with a deuterium (1-171k) by deprotonation and quenching with D2O. 
A standard reaction with compound 1-163a was performed, leading to product 1-173w, 
the identity of which was determined by comparison to the nOe spectra of the fully 
protonated species. In 1-173w, the relevant nOe observed in the protio species 1-173a 
was absent, leading us to assign the olefin geometry as shown. Since the deuterium was 
determined to be cis to the N-methyl group on the indole, the results support pathway a 
as the operational process. 
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Scheme 1-45: Deuterium Labelling Study 
1.6.4 Carbazole Synthesis 
Finally, to show that the tetrahydrocarbazole adducts could be elaborated, 1-173a was 
subjected to Krapcho dealkoxycarbonylation to yield the mono-ester 1-183. 
Unsurprisingly, conjugation of the alkenyl moiety occurred under these conditions, 
leading to a mixture of products. Treatment of this mixture (1-183) with catalytic 
palladium on charcoal in refluxing mesitylene resulted in dehydrogenation to the 
carbazole (1-184) (Scheme 1-46). This expedient method as a whole (starting from 
readily available cyclopropanes) should be useful, given the ubiquity of carbazole natural 
products. 
 
Scheme 1-46: Elaboration to Carbazoles 
1.7 Summary and Future Outlook 
The reactivity and utilization of donor-acceptor cyclopropanes and Conia-ene cyclization 
is a highly valuable and growing approach toward the synthesis of carbocyclic 
compounds. The use of cyclopropanes together with the Conia-ene reaction has allowed 
access to a variety of interesting and useful scaffolds. We have successfully developed an 
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efficient method for producing substituted tetrahydrocarbazoles using a tandem 
nucleophilic ring-opening/Conia-ene reaction. 
It is envisioned that future development of this area of chemistry (cyclopropane ring-
opening/Conia-ene) could follow three different paths. First, in a direct expansion of the 
above discussed research, optimal conditions should be developed for the cyclization of 
disubstituted alkynes or additional methods should be explored to access these 
functionalized products. An example method could be the exploration of an additional 
sequential third cross-coupling step, similar to that displayed by Blame (Scheme 1-47A). 
The second avenue this research area could follow is simply in the search for different 
orthogonal nucleophilic alkynes capable of undergoing both cyclopropane ring-opening 
and the Conia-ene cyclization. Finally, the third path this research area could follow is 
switching the location of the alkyne from nucleophile to cyclopropane, thus allowing 
access to new exo methylene products (Scheme 1-47B). 
 
Scheme 1-47: Possible Future Directions of this Research 
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1.8 Experimental 
General Considerations 
Infrared spectra were obtained as thin films on NaCl plates using a Bruker Vector 33 FT-
IR instrument. NMR experiments were performed on Varian Mercury 400, Varian Inova 
600 and Inova 400 instruments, and samples were obtained in CDCl3 (referenced to 7.26 
ppm for 1H and 77.0 ppm for 13C). 19F spectra were externally referenced to neat 
trifluorotoluene (referenced to   -63.9 ppm).  Coupling constants (J) are in Hz. The 
multiplicities of the signals are described using the following abbreviations: s = singlet, d 
= doublet, t = triplet, q = quartet, sept = septuplet, m = multiplet, br = broad. High 
resolution mass spectra (HRMS) were obtained on a Finnigan MAT 8200 spectrometer at 
70 eV. Optical rotations were recorded in cells of 10 cm path length using a Perkin-Elmer 
241 digital polarimeter.  
All reagents and solvents were used as purchased from Aldrich, Strem, Caledon or VWR.  
Reaction progress was followed by thin layer chromatography (TLC) (EM Science, silica 
gel 60 F254) visualizing with UV light, and the plates developed using acidic 
anisaldehyde. Flash chromatography was performed using silica gel purchased from 
Silicycle Chemical Division Inc. (230-400 mesh).   
General Experimental Procedure for the Synthesis of Tetrahydrocarbazoles: 1,1-
cyclopropane diester (1 equivalent) and 2-ethynyl-N-methylindole (1.4 equivalent) were 
dissolved in dichloroethane.  Zinc(II) bistriflamide (0.05 equivalent) was then added and 
a reflux condenser was attached.  The reaction vessel was then purged with argon and the 
reaction brought to reflux. Upon completion by TLC analysis, the reaction mixture was 
purified by flash chromatography (EtOAc/Hexanes) to yield the desired 
tetrahydrocarbazoles. 
THC 1-173a was prepared using general experimental procedure. 
Reagents employed: dimethyl (R)-2-phenylcyclopropane-1,1-
dicarboxylate 1-163a (82 mg, 0.35 mmol, 91% ee), 2-ethynyl-N-
methylindole 1-171a (77 mg, 0.50 mmol), zinc(II) bistriflamide (11 
N
Me
CO2Me
CO2Me
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mg, 0.018 mmol), and DCE (4.0 mL). Yielded THC 1-173a as a pale yellow foam, 84% 
(115 mg, 0.29 mmol, 93% ee). Rf  = 0.25, 10% EtOAc in hexanes;  1H-NMR (400 MHz, 
CDCl3): δ = 7.32-7.56 (m, 6H), 6.84 (ddd, J = 8.0, 6.8, 0.8 Hz, 2H), 6.72 (d, J = 8.0 Hz, 
1H), 5.57 (s, 1H), 5.17 (s, 1H), 4.28 (dd, J = 10.4, 5.6 Hz, 1H), 3.91 (s, 3H), 3.77 (s, 3H),  
3.70 (s, 3H), 2.98 (dd, J = 13.2, 5.8 Hz, 1H), 2.56 (dd, J = 13.2, 10.4 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ = 170.4, 170.3, 144.4, 140.0, 135.4, 134.6, 128.5, 128.2, 126.6, 
125.6, 122.8, 120.6, 119.3, 114.7, 111.3, 109.4, 62.8, 53.0, 52.8, 41.8, 38.4, 32.1; IR (thin 
film): 3027, 2951, 1734, 1669, 1630, 1608, 1533, 1467, 1436, 1369, 1343, 1240, 1175, 
1105, 1081, 1060, 1025, 968, 939, 895, 735, 702; HRMS calc’d for C24H23NO4 = 
389.1627, found = 389.1621. The enantiomeric excess was determined to be 93% by 
chiral HPLC, Chiralcel OD-H, 250 x 4.6 mm2, Diacel Chemical Industries; 9:1 Hexanes / 
iPrOH at 1 mL/min; 220 nm the retention time for the enantiomers were rl (+) = 11.86 
mins, rl (-) = 15.00 mins 
 
THC 1-173b was prepared using general experimental procedure. 
Reagents employed: 2-piperonylcyclopropane-1,1-dicarboxylate 1-
163b (98 mg, 0.35 mmol), 2-ethynyl-N-methylindole 1-171a (77 
mg, 0.50 mmol), zinc(II) bistriflamide (12 mg, 0.019 mmol), and 
DCE (4.0 ml). Yielded THC 1-173b as a yellow foam, 68% (104 mg, 0.24 mmol). Rf  = 
0.23, 30% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3): δ = 7.31 (d, J = 8.4 Hz, 1H), 
7.20 (ddd, J = 8.3, 6.8, 1.8 Hz, 1H), 6.89 (ddd, J = 8.4, 8.4, 1.2 Hz, 1H), 6.84 (d, J = 8.4 
Hz, 1H), 6.76-6.73 (m, 2H), 6.65 (s, 1H), 5.92 (d, J = 1.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 
1H),  5.56 (s, 1H), 5.16 (s, 1H), 4.21 (dd, J = 10.5, 5.7 Hz, 1H), 3.90 (s, 3H), 3.80 (s, 3H), 
3.69 (s, 3H), 2.95 (dd, J = 13.8, 5.4 Hz, 1H), 2.52 (dd, J = 13.5, 10.5 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ =  170.4, 170.2, 147.7, 146.2, 139.9, 138.5, 135.3, 134.5, 125.6, 
122.8, 121.2, 120.6, 119.3, 114.7, 111.3, 109.4, 108.4, 100.8, 62.9, 53.0, 52.8, 41.93, 
41.90, 38.2, 32.0; IR (thin film): 3053, 3003, 2952, 2903, 735, 1668, , 1630, 1609, 1503, 
1486, 1440, 1364, 1245, 1097, 1079, 1039, 935, 812, 736; HRMS calc’d for C25H23NO6 
= 433.1525, found = 433.1530.  
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THC 1-173c was prepared using general experimental procedure. 
Reagents employed: 2-p-methoxycyclopropane-1,1-dicarboxylate 
1-163c (94 mg, 0.36 mmol), 2-ethynyl-N-methylindole 1-171a (78 
mg, 0.50 mmol), zinc(II) bistriflamide (12 mg, 0.019 mmol), and 
DCE (4.0 mL). Yielded THC 1-173c as a yellow oil, 74% (111 mg, 0.27 mmol). Rf  = 
0.26, 30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.32 (d, J = 8.0 Hz, 1H), 
7.20 (ddd, J = 8.0, 8.0, 1.0 Hz, 1H), 7.17 (d, J = 8.4 Hz, 2H), 6.90-6.84 (m, 3H), 6.79 (d, 
J = 7.6 Hz, 1H), 5.59 (s, 1H), 5.19 (s, 1H), 4.26 (dd, J = 10.6, 5.8 Hz, 1H), 3.92 (s, 3H),  
3.81 (s, 3H), 3.80 (s, 3H), 3.72 (s, 3H), 2.98 (dd, J = 13.6, 5.8 Hz, 1H), 2.57 (dd, J = 13.6, 
10.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 170.5, 170.3, 158.3, 140.0, 136.5, 135.5, 
134.5, 129.1, 125.6, 122.7, 120.7, 119.3, 115.1, 113.8, 111.2, 109.4, 62.9, 55.2, 53.0, 
52.8, 42.0, 37.6, 32.1; IR (thin film): 3053, 3029, 2999, 2952, 2837, 1735, 1669, 1610, 
1585, 1511, 1467, 1437, 1367, 1339, 1319, 1277, 1246, 1211, 1175, 1134.9, 1109, 1079, 
1064, 1033, 1016, 968, 940, 895, 832, 784, 748, 736, 702, 658; HRMS calc’d for 
C25H25NO5 = 419.1733, found = 419.1730.  
 
THC 1-173d was prepared using general experimental procedure. 
Reagents employed: 2-p-chlorocyclopropane-1,1-dicarboxylate 1-
163d (97 mg, 0.36 mmol), 2-ethynyl-N-methylindole 1-171a (78 
mg, 0.50 mmol), zinc(II) bistriflamide (12 mg, 0.019 mmol), and 
DCE (4.0 mL). Yielded THC 1-173d as a yellow foam, 89% (135 mg, 0.32 mmol). Rf  = 
0.21, 15% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.32 (d, J = 8.0 Hz, 1H), 
7.26-7.24 and 7.17-7.14 (2m, AA’BB’, 4H), 7.20 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 6.88 
(ddd, J = 8.0, 7, 1 Hz, 1H), 6.73 (d, J = 8.0 Hz, 1H), 5.58 (s, 1H), 5.18 (s, 1H), 4.27 (dd, J 
= 10.6, 5.8 Hz, 1H),  3.91 (s, 3H), 3.78 (s, 3H), 3.70 (s, 3H), 2.96 (dd, J = 13.6, 6.0 Hz, 
1H), 2.50 (dd, J = 13.8, 10.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 170.3, 170.1, 
143.0, 139.9, 135.2, 134.6, 132.2, 129.5, 128.6, 125.4, 122.9, 120.4, 119.5, 114.0, 111.6, 
109.5, 62.7, 53.1, 52.8, 41.6, 37.8, 32.1; IR (thin film): 3053, 3027, 3002, 2952, 2879, 
2844, 1900, 1739, 1631, 1608, 1535, 1489, 1467, 1436, 1410, 1369, 1338, 1305, 1271, 
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1174, 1134, 1105, 1079, 1064, 1015, 967, 940, 896, 830, 784, 735, 704, 562, 532; HRMS 
calc’d for C24H22ClNO4 = 423.1237, found = 423.1243.  
 
THC 1-173e was prepared using general experimental procedure. 
Reagents employed: 2-p-methylestercyclopropane-1,1-
dicarboxylate 1-163e (103 mg, 0.350 mmol), 2-ethynyl-N-
methylindole 1-171a (78 mg, 0.50 mmol), Zinc(II) bistriflamide 
(12 mg, 0.019 mmol), and DCE (4.0 mL). Yielded THC 1-173e as a yellow film, 90% 
(141 mg, 0.32 mmol). Rf  = 0.24, 30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3): δ 
= 7.98 (d, J = 9.2 Hz, 2H), 7.34-7.31 (m, 3H), 7.20 (ddd, J = 8.0, 8.0, 0.8 Hz, 1H), 6.86 
(t, J = 7.4 Hz, 1H), 6.69 (d, J = 7.6 Hz, 1H), 5.61 (s, 1H), 5.21 (s, 1H), 4.39 (dd, J = 10.2, 
5.8 Hz, 1H), 3.93 (s, 3H), 3.91 (s, 3H), 3.78 (s, 3H), 3.72 (s, 3H), 3.02 (dd, J = 13.4, 5.8 
Hz, 1H), 2.57 (dd, J = 13.6, 10.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 170.2, 170.1, 
167.0, 149.9, 139.9, 135.1, 134.6, 129.9,  128.5, 128.2, 125.3, 122.9, 120.3, 119.5, 113.6, 
111.6, 109.5, 62.6, 53.0, 52.8, 51.9, 41.3, 38.4, 32.0; IR (thin film): 3053, 3030, 2999, 
2951, 2845, 1724, 1610, 1467, 1436, 1368, 1281, 1224, 1177, 1111, 1078, 1065, 1018, 
967, 939, 896, 855, 778, 736, 704; HRMS calc’d for C26H25NO6 = 447.1682, found = 
447.1685.  
 
THC 1-173f was prepared using general experimental procedure. 
Reagents employed: 2-p-cyanocyclopropane-1,1-dicarboxylate 1-
163f (91 mg, 0.35 mmol), 2-ethynyl-N-methylindole 1-171a (77 mg, 
0.50 mmol), Zinc(II) bistriflamide (12 mg, 0.019 mmol), and DCE 
(4.0 mL). Yielded THC 1-173f as a yellow oil, 84% (122 mg, 0.30 mmol). Rf  = 0.25, 
30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.59 (d, J = 6.4 Hz, 2H), 7.34 
(d, J = 8.4 Hz, 3H), 7.22 (ddd, J = 8.0, 8.0, 0.6 Hz, 1H), 6.89 (t, J = 7.6 Hz, 1H), 6.65 (d, 
J = 8.0 Hz, 1H), 5.61 (s, 1H), 5.21 (s, 1H), 4.38 (dd, J = 10.2, 5.8 Hz, 1H),  3.93 (s, 3H), 
3.78 (s, 3H), 3.70 (s, 3H), 3.00 (dd, J = 14.6, 7.0 Hz, 1H), 2.50 (dd, J = 13.4, 10.6 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δ = 170.0, 169.9, 150.1,139.8, 134.8, 134.76, 132.3, 
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128.9, 125.0, 123.0, 119.9, 119.6, 118.9, 112.7, 112.0, 110.4, 109.6, 62.5, 53.1, 52.8, 
41.1, 38.4, 32.0; IR (thin film): 3055, 3003, 2953, 2852, 2228, 1734, 1670, 1608, 1525, 
1502, 1469, 1436, 1417, 1370, 1340, 1321, 1307, 1266, 1245, 1176, 1134, 1107, 1077, 
1065, 1017, 996, 969, 931, 907, 839, 784, 748, 736, 702, 563; HRMS calc’d for 
C25H22N2O4 = 414.1580, found = 414.1575.  
 
THC 1-173g was prepared using general experimental procedure. 
Reagents employed: 2-p-furanocyclopropane-1,1-dicarboxylate 1-
163g (85 mg, 0.35 mmol), 2-ethynyl-N-methylindole 1-171a (77 
mg, 0.50 mmol), Zinc(II) bistriflamide (12 mg, 0.019 mmol), and 
DCE (4.0 mL). Yielded THC 1-173g as a yellow oil, 49% (65 mg, 0.17 mmol). Rf  = 
0.25, 30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.34-7.30 (m, 2H), 7.22 
(ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.12 (d, J = 7.6 Hz, 1H), 6.98 (ddd, J = 7.6, 7.6, 0.8 Hz, 
1H), 6.28 (dd, J = 2.8, 2.0 Hz, 1H), 6.01, (d, J = 3.2 Hz, 1H), 5.56 (s, 1H), 5.17 (s, 1H), 
4.48 (dd, J = 8.4, 6.0 Hz, 1H), 3.90 (s, 3H), 3.72 (s, 3H), 3.69 (s, 3H), 2.97 (dd, J = 13.8, 
6.2 Hz, 1H), 2.86 (dd, J = 13.6, 8.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ =  170.2, 
156.2, 143.4, 141.4, 139.8, 135.0, 134.1, 125.5, 122.9, 119.9, 119.5, 111.9, 111.7, 110.1, 
109.5, 106.6, 62.1, 53.0, 52.8, 37.4, 32.1, 31.4; IR (thin film): 2949, 1735, 1605, 1468, 
1365, 1245, 1073, 1007, 902, 737; HRMS calc’d for C22H21NO5 = 379.1420, found = 
379.1446. 
 
THC 1-173h was prepared using general experimental procedure. 
Reagents employed: dimethyl 2-(1-tosyl-1H-indol-3-
yl)cyclopropane-1,1-dicarboxylate 1-163h (136 mg, 0.320 mmol), 2-
ethynyl-N-methylindole 1-171a (70 mg, 0.45 mmol), Zinc(II) 
bistriflamide (10 mg, 0.016 mmol), and DCE (4.0 mL). Yielded 
THC 1-173h as a yellow foam, 67% (125 mg, 0.21 mmol). Rf  = 0.35, 40% EtOAc in 
hexanes; 1H-NMR (400 MHz, CDCl3): δ = 8.02 (d, J = 8.2 Hz, 1H), 7.68 (d, J = 8.6 Hz, 
2H), 7.40 (bs, 1H), 7.31-7.27 (m, 1H), 7.23 (d, J = 7.8 Hz, 3H), 7.21-7.14 (m, 2H), 6.77 
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(d, J = 3.5 Hz, 2H), 5.62 (s, 1H), 5.20 (s, 1H), 4.57 (dd, J = 9.0, 6.2 Hz, 1H), 3.94 (s, 3H), 
3.72 (s, 3H), 3.64 (s, 3H), 3.06 (dd, J = 13.4, 5.8 Hz, 1H), 2.72 (dd, J = 13.2, 9.2 Hz, 1H), 
2.38 (s, 3H); 13C NMR (100 MHz, CDCl3) δ =  179.2, 170.1, 144.7, 143.3, 139.8, 135.5, 
135.0, 134.8, 134.2, 129.7, 126.8, 125.2, 125.0, 124.6, 124.0, 123.1, 122.8, 120.2, 119.7, 
119.1, 113.8, 112.4, 111.8, 109.6, 62.1, 53.1, 52.7, 38.4, 32.1, 28.9, 21.6; IR (thin film): 
3053, 2952, 1736, 1670, 1597 1448, 1369, 1267, 1122, 1019, 972, 908, 813, 733, 704; 
HRMS calc’d for C33H30N2O6S = 582.1825, found = 582.1807. 
 
THC 1-173i was prepared using general experimental procedure. 
Reagents employed: 2-thiocyclopropane-1,1-dicarboxylate 1-163i 
(51 mg, 0.21  mmol), 2-ethynyl-N-methylindole 1-171a (48 mg, 
0.31 mmol), Zinc(II) bistriflamide (6.0 mg, 0.010 mmol), and DCE 
(3.0 mL). Yielded THC 1-173i as a yellow foam, 74% (62 mg, 0.16 mmol). Rf  = 0.13, 
15% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.32 (d, J = 5.2 Hz, 1H), 7.21 
(ddd, J = 5.6, 4.8, 0.8 Hz, 1H), 7.18 (dd, J = 3.6, 0.8 Hz, 1H), 6.99 (d, J = 5.2 Hz, 1H), 
6.94-6.91 (m, 3H), 5.58 (s, 1H), 5.19 (s, 1H), 4.66 (dd, J = 6.4, 4.0 Hz, 1H),  3.91 (s, 3H), 
3.77 (s, 3H), 3.71 (s, 3H), 3.07 (dd, J = 9.0, 3.8 Hz, 1H), 2.71 (dd, J = 8.8, 6.8 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ = 170.2, 170.1, 148.4, 139.8, 135.1, 134.0, 126.3, 125.6, 
125.0, 123.9, 122.9, 120.4, 119.5, 114.2, 111.7, 109.5, 62.6, 53.0, 52.8, 42.2, 33.5, 32.1; 
IR (thin film): 3105, 3055, 3002, 2952, 2850, 1735, 1667, 1613, 1529, 1469, 1435, 1361, 
1303, 1267, 1245, 1178, 1132, 1103, 1078, 1065, 1023, 968, 927, 907, 831, 784, 736, 
702; HRMS calc’d for C22H21NO4S = 395.1191, found = 395.1192.  
 
THC 1-173j was prepared using general experimental procedure. 
Reagents employed: 2-styrenylcyclopropane-1,1-dicarboxylate 1-
163j (81 mg, 0.31 mmol), 2-ethynyl-N-methylindole 1-171a (68 mg, 
0.44 mmol), Zinc(II) bistriflamide (10 mg, 0.016 mmol), and DCE (4.0 mL). Yielded 
THC 1-173j as a yellow foam, 70% (91 mg, 0.22 mmol). Rf  = 0.33, 30% EtOAc in 
hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.57 (d, J = 8.4 1H), 7.37-7.18 (m, 7H), 6.98 
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(ddd, J = 8.0, 8.0, 1 Hz, 1H), 6.66 (d, J = 15.6 Hz, 1H), 6.25 (dd, J = 15.6, 8.4 Hz, 1H), 
5.52 (s, 1H), 5.13 (s, 1H), 3.95-3.89 (m, 1H), 3.87 (s, 3H), 3.78 (s, 3H), 3.67 (s, 3H), 2.83 
(dd, J = 13.6, 6.0 Hz, 1H), 2.51 (dd, J = 13.6, 9.4 Hz , 1H); 13C NMR (100 MHz, CDCl3) 
δ = 170.5, 170.3, 139.9, 137.3, 135.3, 133.5, 133.1, 130.9, 128.5, 127.2, 126.2, 126.1, 
122.9, 120.6, 119.5, 113.7, 111.3, 109.5, 60.3, 53.0, 52.9, 38.6, 35.7, 32.1; IR (thin film): 
3056, 3026, 2952, 2845, 1736, 1666, 1612, 1468, 1434, 1397, 1246, 1175, 1099, 1072, 
1024, 968, 748, 698; HRMS calc’d for C26H25NO4 = 415.1784, found = 415.1796.  
 
THC 1-173k was prepared using general experimental procedure. 
Reagents employed: (R)-2-vinylcyclopropane-1,1-dicarboxylate 1-
163k (61 mg, 0.33 mmol, 100% ee), 2-ethynyl-N-methylindole 1-
171a (71 mg, 0.46 mmol), Zinc(II) bistriflamide (10 mg, 0.017 mmol), and DCE (4.0 
mL). Yielded THC 1-173k as a yellow foam, 77% (87 mg, 0.26 mmol, 99% ee). Rf  = 
0.17, 20% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3): δ = 6.62 (d, J = 7.2 Hz, 1H), 
7.31 (d, J = 8.4 Hz, 1H), 7.25 (ddd partially obscured by solvent peak at 7.26 ppm, J = 
9.0, 7.8, 1.5 Hz, 1H), 7.06 (ddd, J = 8.4, 1.2 Hz, 1H), 5.86 (ddd, J = 16.8, 10.2, 8.4 Hz, 
1H), 5.50 (s, 1H), 5.31 (dd, J = 17.1, 1.2 Hz, 1H), 5.19 (dd, J = 10.2, 1.8 Hz, 1H), 5.12 (s, 
1H), 3.87 (s, 3H), 3.83 (s, 3H), 3.79-3.73 (m, 1H), 3.67 (s, 3H), 2.78 (dd, J = 13.5, 6.3 
Hz, 1H), 2.43 (dd, J = 13.5, 9.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 170.5, 170.3, 
141.1, 139.8, 135.3, 133.5, 126.0, 122.8, 120.5, 119.3, 115.7, 113.3, 111.2, 109.4, 62.2, 
52.9, 52.7, 38.3, 36.4, 32.0; IR (thin film): 3055, 3001, 2953, 2846, 1735, 1668, 1613, 
1469, 1435, 1369, 1267, 1245, 1161, 1132, 1072, 1016, 917, 737, 702; HRMS calc’d for 
C20H21NO4 = 339.1471, found = 339.1460. The enantiomeric excess was determined to 
be 99% by chiral HPLC, Chiralcel OD-H, 250 x 4.6 mm2, Diacel Chemical Industries; 
92:8 Hexanes / iPrOH at 10 mL/min; 220 nm the retention time for the enantiomers were 
rl (+) = 11.95 mins. 
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THC 1-173l was prepared using general experimental procedure. 
Reagents employed: cyclopropane-1,1-dicarboxylate 1-163l (62 mg, 
0.39 mmol), 2-ethynyl-N-methylindole 1-171a (85 mg, 0.55 mmol), 
Zinc(II) bistriflamide (12 mg, 0.019 mmol), and DCE (4.0 mL). Yielded THC 1-173l as a 
yellow foam, 14% (18 mg, 0.056 mmol). Rf  = 0.10, 10% EtOAc in hexanes;  1H-NMR 
(400 MHz, CDCl3): δ = 7.48 (d, J = 7.6 Hz, 1H), 7.30 (ddd, J = 7.8, 7.8, 1.2 Hz, 1H), 
7.25 (dd, J = 8.4, 2.8 Hz, 1H), 7.10 (ddd, J = 7.8, 6.6, 1.2 Hz, 1H), 5.51 (s, 1H), 5.09 (s, 
1H), 3.87 (s, 3H), 3.76 (s, 6H), 2.89 (t, J = 6.4 Hz, 2H), 2.67 (t, J = 6.4 Hz, 2H); 13C 
NMR (100 MHz, CDCl3) δ = 170.7, 139.7, 135.6, 126.0, 123.0, 121.4, 119.3, 119.0, 
112.8, 110.5, 109.4, 62.6, 52.8, 41.8, 31.2, 18.5; IR (thin film): 2951, 2848, 1734, 1668, 
1615, 1468, 1436, 1373, 1313, 1246, 1169, 1076, 929, 887, 775; HRMS calc’d for 
C18H19NO4 = 313.1314, found = 313.1311. 
 
THC 1-173m was prepared using general experimental procedure. 
Reagents employed: 2-phenylcyclopropane-1,1-dicarboxylate 1-
163a (25 mg, 0.11 mmol), 2-ethynylindole 1-171b (21 mg, 0.15 
mmol), Zinc(II) bistriflamide (4.0 mg, 0.0060 mmol), and DCE (2.0 mL). Yielded THC 
1-173m as a yellow foam, 76% (31 mg, 0.083 mmol). Rf  = 0.18, 20% EtOAc in hexanes;  
1H-NMR (600 MHz, CDCl3): δ = 8.35 (bs, 1H),  7.31-7.21 (m, 6H), 7.11 (t, J = 7.5 Hz, 
1H), 6.81 (t, J = 7.2 Hz, 1H), 6.65 (d, J = 7.8 Hz, 1H), 5.52 (s, 1H), 5.06 (s, 1H), 4.21 
(dd, J = 10.5, 5.1 Hz, 1H), 3.78 (s, 3H), 3.70 (s, 3H), 2.92 (dd, J = 13.8, 5.4 Hz, 1H), 2.59 
(dd, J = 13.5, 10.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 170.6, 170.4, 143.4, 137.3, 
133.9, 132.4, 128.4, 128.3, 126.7, 123.2, 120.6, 119.5, 115.4, 110.9, 108.3, 98.3, 60.9, 
53.1, 52.8, 41.3, 38.2; IR (thin film): 3388, 3058, 3028, 3003, 2951, 2853, 1732, 1633, 
1612, 1493, 1453, 1436, 1328, 1277, 1241, 1201, 1196, 1065, 1045, 901, 738, 701; 
HRMS calc’d for C23H21NO4 = 375.1471, found = 375.1466. 
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THC 1-173n was prepared using general experimental procedure. 
Reagents employed: 2-phenylcyclopropane-1,1-dicarboxylate 
1-163c (103 mg, 0.390 mmol), 2-ethynylindole 1-171b (77 mg, 
0.55 mmol), zinc(II) bistriflamide (12 mg, 0.020 mmol), and DCE 
(4.0 mL). Yielded THC 1-173n as a yellow foam, 71% (112 mg, 0.28 mmol). Rf = 0.06, 
20% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3): δ = 8.68 (bs, 1H), 7.26 (d, J = 8.4 
Hz, 1H), 7.16 (d, J = 7.8 Hz, 2H), 7.11 (ddd, J = 8.1, 8.1, 1.2 Hz, 1H), 6.86 (d, J = 8.4 
Hz, 2H), 6.84 (t, J = 7.8 Hz, 1H), 6.72 (dd, J = 8.4 Hz, 1H), 5.51 (s, 1H), 5.02 (s, 1H), 
4.21 (dd, J = 10.2, 3.6 Hz, 1H), 3.83 (s, 3H), 3.82 (s, 3H), 3.74 (s, 3H), 2.93 (dd, J = 13.8, 
5.4 Hz, 1H), 2.60 (dd, J = 13.5, 9.9 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 170.7, 
170.5, 158.3, 137.3, 135.7, 133.9, 132.4, 129.3, 126.7, 123.1, 120.7, 119.4, 115.7, 113.8, 
110.9, 108.3, 61.0, 55.2, 53.1, 52.8, 41.5, 37.4; IR (thin film): 3387, 3057, 3032, 3001, 
2952, 2837, 1732, 1611, 1511, 1452, 1438, 1326, 1279, 1246, 1176, 1071, 1037, 902, 
832, 738; HRMS calc’d for C24H23NO5 = 405.1576, found = 405.1569.  
 
THC 1-173o was prepared using general experimental procedure. 
Reagents employed: 2-p-methylestercyclopropane-1,1-
dicarboxylate 1-163e (86 mg, 0.29 mmol), 2-ethynylindole 
1-171b (64 mg, 0.45 mmol), zinc(II) bistriflamide (10 mg, 0.016 
mmol), and DCE (4.0 mL). Yielded THC 1-173o as a yellow foam, 61% (78 mg, 0.18 
mmol). Rf  = 0.10, 20% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3): δ = 8.47 (bs, 
1H), 7.98 (d, J = 8.4 Hz, 2H), 7.30 (dd, J = 8.2, 3.0 Hz, 3H), 7.12 (ddd, J = 8.0, 8.0, 0.8 
Hz, 1H), 6.81 (t, J = 7.6 Hz, 1H), 6.61 (d, J = 7.6 Hz, 1H), 5.55 (s, 1H), 5.08 (s, 1H), 4.29 
(dd, J = 10.2, 5.0 Hz, 1H), 3.91 (s, 3H), 3.79 (s, 3H), 3.70 (s, 3H), 2.93 (dd, J = 13.4, 5.0 
Hz, 1H), 2.56 (dd, J = 13.6, 10.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ =  170.4, 
170.2, 167.0, 149.0, 137.3, 133.7, 132.6, 129.8, 128.7, 128.4, 126.4, 123.3, 120.4, 119.7, 
114.4, 111.0, 108.7, 60.8, 53.2, 52.8, 52.0, 40.9, 38.2; IR (thin film): 3375, 3032, 3002, 
2952, 2846, 1723, 1610, 1452, 1436, 1326, 1280, 1242, 1198, 1178, 1113, 1070, 1045, 
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1018, 967, 854, 778, 738, 703; HRMS calc’d for C25H23NO6 = 433.1525, found = 
433.1517.  
  
THC 1-173p was prepared using general experimental procedure. 
Reagents employed: 2-thiocyclopropane-1,1-dicarboxylate 1-163i 
(77 mg, 0.32 mmol), 2-ethynylindole 1-171b (64 mg, 0.45 mmol), 
zinc(II) bistriflamide (10 mg, 0.016 mmol), and DCE (4.0 mL). 
Yielded THC 1-173p as an orange foam, 86% (105 mg, 0.28 mmol). Rf  = 0.13, 20% 
EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3): δ = 8.42 (bs, 1H), 7.28 (d, J = 8.0 Hz, 
1H), 7.20 (dd, J = 4.8, 1.2 Hz, 1H), 7.14 (ddd, J = 8.2, 5.8, 2.2 Hz, 1H), 6.94 (dd, J = 5.0, 
3.4 Hz, 1H), 6.91-6.87 (m, 3H), 5.51 (s, 1H), 5.06 (s, 1H), 4.60 (dd, J = 9.4, 5.0 Hz, 1H), 
3.79 (s, 3H), 3.70 (s, 3H), 3.01 (dd, J = 13.4, 5.0 Hz, 1H), 2.72 (dd, J = 13.4, 9.4 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ =  170.5, 170.3, 147.4, 137.2, 133.5, 131.9, 126.6, 126.4, 
125.3, 124.0, 123.3, 120.3, 119.7, 115.0, 111.0, 108.7, 60.7, 53.1, 52.8, 41.6, 33.3; IR 
(thin film): 3392, 3056, 3002, 2952, 2852, 1732, 1633, 1614, 1453, 1436, 1324, 1266, 
1173, 1072, 1044, 900, 853, 831, 738, 702; HRMS calc’d for C21H19NO4S = 381.1035, 
found = 381.1039.  
 
THC 1-173q was prepared using general experimental procedure. 
Reagents employed: 2-vinylcyclopropane-1,1-dicarboxylate 1-163k 
(59 mg, 0.32 mmol), 2-ethynylindole 1-171b (64 mg, 0.45 mmol), 
zinc(II) bistriflamide (10 mg, 0.016 mmol), and DCE (4.0 mL). Yielded THC 1-173q as a 
yellow foam, 59% (61 mg, 0.19 mmol). Rf  = 0.17, 20% EtOAc in hexanes; 1H-NMR 
(400 MHz, CDCl3): δ = 8.43 (bs, 1H), 7.60 (d, J = 8.0 Hz, 1H), 7.28 (d partially obscured 
by solvent peak at 7.26 ppm, J = 8.0 Hz, 1H) 7.17 (ddd, J = 8.4, 7.2, 1.2 Hz, 1H), 7.03 
(ddd, J = 8.0, 8.0, 1.2 Hz, 1H), 5.91 (ddd, J = 17.2, 10, 8.0 Hz, 1H), 5.43 (s, 1H), 5.29 
(dd, J = 17.0, 1.4 Hz, 1 H), 5.21 (dd, J = 10.2, 1.0 Hz, 1H), 4.99 (s, 1H), 3.81 (s, 3H), 
3.77 (s, 3H), 3.75-3.69 (m, 1H), 2.73 (dd, J = 13.4, 5.0 Hz, 1H), 2.46 (dd, J = 13.6, 9.2 
Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 170.8, 170.6, 140.5, 137.2, 133.8, 131.5, 
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127.1, 123.2, 120.5, 119.5, 116.1, 114.1, 111.0, 108.2, 60.3, 53.0, 52.8, 38.0, 36.3; IR 
(thin film): 3388, 3058, 3001, 2952, 2851, 1732, 1634, 1612, 1452, 1436, 1326, 1278, 
1242, 1070, 1046, 923, 739; HRMS calc’d for C19H19NO4 = 325.1314, found = 325.1309.  
THC 1-173r was prepared using general experimental procedure. 
Reagents employed: 2-phenylcyclopropane-1,1-dicarboxylate 1-
163a (50 mg, 0.21 mmol), 2-ethynyl-N-benzylindole 1-171c (68 mg, 
0.29 mmol), zinc(II) bistriflamide (7.0 mg, 0.010 mmol), and DCE 
(3.0 mL). Yielded THC 1-173r as a yellow foam, 76% (76 mg, 0.16 mmol). Rf  = 0.23, 
20% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3): δ = 7.37 (t, J = 7.5 Hz, 2H), 7.35-
7.27 (m, 6H), 7.21 (d, J = 7.8 Hz, 2H), 7.18 (d, J = 8.4 Hz, 1H), 7.13 (t, J = 7.8 Hz, 1H), 
6.89 (t, J = 7.5 Hz, 1H), 6.80 (d, J = 7.8 Hz, 1H), 5.63 (d, J = 17.7 Hz, 1H), 5.49 (d, J = 
17.7 Hz, 1H), 5.28 (s, 1H), 5.01 (s, 1H), 4.36 (dd, J = 10.5, 5.7 Hz, 1H), 3.74 (s, 3H), 
3.72 (s, 3H), 3.03 (dd, J = 14.1, 5.7 Hz, 1H), 2.62 (dd, J = 13.2, 10.8 Hz, 1H); 13C NMR 
(100 MHz, CDCl3) δ = 170.4, 170.3, 144.4, 140.2, 138.1, 134.8, 134.6, 128.9, 128.5, 
128.2, 127.2, 126.6, 125.9, 125.8, 123.1, 120.7, 119.8, 115.1, 111.4, 110.0, 62.9, 53.0, 
52.7, 48.1, 41.8, 38.5; IR (thin film): 3060, 3029, 3004, 2952, 2855, 1735, 1670, 1605, 
1495, 1453, 1436, 1346, 1323, 1265, 1237, 1202, 1175, 1082, 1074, 1062, 1029, 910, 
736, 701; HRMS calc’d for C30H27NO4 = 465.1940, found = 465.1958.  
 
THC 1-173s was prepared using general experimental 
procedure. Reagents employed: 2-phenylcyclopropane-1,1-
dicarboxylate 1-163a (33 mg, 0.14 mmol), 2-ethynyl-6-
trifluoromethylindole 1-171d (40 mg, 0.19 mmol), zinc(II) 
bistriflamide (5.0 mg, 0.0070 mmol), and DCE (2.0 mL). Yielded THC 1-173s as a 
yellow oil, 93% (58 mg, 0.13 mmol). Rf  = 0.2, 20% EtOAc in hexanes; 1H-NMR (400 
MHz, CDCl3): δ = 9.01 (bs, 1H), 7.33-7.27 (m, 4H), 7.19 (d, J = 0.017 Hz, 2H), 6.85 (dd, 
J = 8.8, 1.2 Hz, 1H), 6.51 (d, J = 8.4 Hz, 1H), 5.62 (s, 1H), 5.13 (s, 1 H), 4.15 (dd, J = 
10.8, 4.8 Hz, 1H), 3.92 (s, 3H), 3.77 (s, 3H), 2.93 (dd, J = 13.6, 4.8 Hz, 1H), 2.62 (dd, J = 
13.8, 10.6 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ =  171.2, 170.4, 143.0, 136.0, 134.6, 
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133.3, 128.6, 128.2, 127.0, 120.6, 115.9, 115.8, 115.1, 110.1, 108.04, 108.01, 61.0, 53.4, 
52.9, 41.2, 38.3 (Note: one carbon missing  presumably due to overlap); IR (thin film): 
3369, 3029, 2954, 2854, 1726, 1511, 1444, 1338, 1280, 1229, 1202, 1164, 1141, 1115, 
1083, 1065, 1052, 925, 815, 701; HRMS calc’d for C24H20F3NO4 = 443.1344, found = 
443.1339. 
 
THC 1-173t was prepared using general experimental 
procedure. Reagents employed: 2-phenylcyclopropane-1,1-
dicarboxylate 1-163a (59 mg, 0.25 mmol), 2-ethynyl-6-
methylester indole 1-171e (70 mg, 0.35 mmol), zinc(II) 
bistriflamide (8.0 mg, 0.013 mmol), and DCE (3.5 mL). Yielded THC 1-173t as a yellow 
film, 92% (99 mg, 0.23 mmol). Rf  = 0.11, 20% EtOAc in hexanes; 1H-NMR (400 MHz, 
CDCl3): δ = 9.00 (bs, 1H), 8.00 (s, 1H), 7.43 (d, J = 8.8 Hz, 1H), 7.32-7.25 (m, 3H), 7.20 
(d, J = 6.8 Hz, 2H), 6.56 (d, J = 8.8 Hz, 1H), 5.71 (s, 1H), 5.18 (s, 1H), 4.20 (dd, J = 
10.4, 4.8 Hz, 1H), 3.91 (s, 3H), 3.86 (s, 3H), 3.74 (s, 3H), 2.93 (dd, J = 13.4, 5.0 Hz, 1H), 
2.61 (dd, J = 13.2, 10.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 170.6, 170.4, 168.0, 
143.1, 136.5, 135.4, 133.5, 130.1, 128.5, 128.2, 126.9, 124.3, 120.4, 120.0, 115.4, 113.1, 
110.2, 60.8, 53.3, 51.9, 41.8, 41.1, 38.1; IR (thin film): 3355, 2952, 1718, 1603, 1486, 
1436, 1276, 1222, 1089, 1050, 871, 774, 692; HRMS calc’d for C25H23NO6 = 433.1525, 
found = 433.1517.  
 
THC 1-173u was prepared using general experimental procedure. 
Reagents employed: 2-phenylcyclopropane-1,1-dicarboxylate 1-
163a (38 mg, 0.16 mmol), 2-ethynyl-1,5-dimethyl-1H-indole 1-
171f (38 mg, 0.22 mmol), zinc(II) bistriflamide (5.0 mg, 0.0080 
mmol), and DCE (2.0 mL). Yielded THC 1-173u as a yellow foam, 70% (46 mg, 0.11 
mmol). Rf  = 0.23, 20% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3): δ = 7.30-7.19 
(m, 6H), 7.01 (dd, J = 12.0, 6.0 Hz, 1H), 6.51 (s, 1H), 5.54 (s, 1H), 5.14 (s, 1H), 4.26 (dd, 
J = 10.0 5.8 Hz, 1H), 3.88 (s, 3H), 3.75 (s, 3H), 3.69 (s, 3H), 2.98 (dd, J = 14.0, 5.8 Hz, 
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1H), 2.55 (dd, J = 13.5, 10.0 Hz, 1H), 2.21 (s, 3H); 13C NMR (150 MHz, CDCl3) δ = 
170.1, 170.5, 144.6, 138.7, 135.7, 134.9 128.7, 128.6, 128.3, 126.6, 126.0, 124.6, 120.3, 
114.3, 111.2, 109.3, 63.0, 53.2, 52.9, 42.0, 38.5, 36.8, 32.3; IR (thin film): 3026, 2951, 
2857, 1736, 1668, 1629, 1488, 1436, 1370, 1265, 1241, 1174, 1074, 1060, 1027, 900, 
793, 773, 736, 702; C25H25NO4 = 403.1784, found = 403.1758. 
 
Acyclic adduct 1-172b was prepared using general experimental 
procedure. Reagents employed: 2-phenylcyclopropane-1,1-
dicarboxylate 1-163a (58 mg, 0.25 mmol), 2-ethynyl-2-
phenylethynylindole 1-171g (80 mg, 0.35 mmol), zinc(II) 
bistriflamide (8.0 mg, 0.012 mmol), and DCE (4.0 mL). Yielded acyclic adduct 1-172b 
as a orange oil, 84% (98 mg, 0.21 mmol). Rf  = 0.26, 15% EtOAc in hexanes; 1H-NMR 
(400 MHz, CDCl3): δ = 7.49-7.46 (m, 2H), 7.44 (s, 1H), 7.36 (d, J = 7.4 Hz, 2H), 7.30-
7.24 (m, 3H), 7.17-7.11 (m, 4H), 7.06-7.02 (m, 1H), 6.95 (ddd, J = 8.0, 5.9, 2.0 Hz, 1H), 
4.47 (dd, J = 10.5, 6.2 Hz, 1H), 3.73 (s, 3H), 3.52 (s, 3H), 3.47 (s, 3H), 3.32 (dd, J = 9.8, 
5.5 Hz, 1H), 3.0-2.84 (m, 2H); 13C NMR (100 MHz, CDCl3) δ = 169.8, 169.7, 143.7, 
137.5, 131.2, 128.6, 128.5, 128.3, 127.6, 126.2, 125.8, 123.2, 122.7, 121.1, 120.5, 119.9, 
119.7, 109.4, 98.2, 80.7, 52.4, 52.3, 50.2, 40.6, 33.2, 30.7; IR (thin film): 3057, 2951, 
2202, 1734, 1599, 1490, 1435, 1405, 1359, 1227, 1152, 1028, 910, 848, 755, 742, 691; 
HRMS calc’d for C30H27NO4 = 465.1940, found = 465.1918. 
  
Acyclic adduct 1-172c was prepared using general experimental 
procedure. Reagents employed: 2-phenylcyclopropane-1,1-
dicarboxylate 1-163a (120 mg, 0.510 mmol), 1-methyl-2-prop1-yn-
1ylindole 1-171h (120 mg, 0.710 mmol), zinc(II) bistriflamide (16 
mg, 0.026mmol), and DCE (6.0 mL). Yielded acyclic adduct 1-172c as a yellow foam, 
97% (199 mg, 0.49 mmol). Rf  = 0.16, 25% EtOAc in hexanes; 1H-NMR (600 MHz, 
CDCl3): δ = 7.56 (d, J = 8.2 Hz, 1H), 7.5 (d, J = 7.6 Hz, 2H), 7.34 (t, J = 7.5 Hz, 2H), 
7.29 (t, J = 9.0 Hz, 2H), 7.23 (t, J = 7.0 Hz, 1H), 7.11 (ddd, J = 8.2, 6.2, 1.8 Hz, 1H), 4.56 
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(dd, J = 10.8, 5.6 Hz 1H), 3.82 (s, 3H), 3.80 (s, 3H), 3.66 (s, 3H), 3.49 (dd, J = 10.0, 5.3 
Hz, 1H), 3.12-3.07 (m, 1H), 3.02-2.97 (m, 1H), 2.26 (s, 3H); 13C NMR (150 MHz, 
CDCl3) δ = 169.91, 169.90, 144.0, 137.0, 128.3, 127.6, 126.1, 125.8, 122.7, 121.5, 119.8, 
119.5, 119.4, 109.3, 94.7, 71.1, 52.44, 52.40, 50.3, 40.5, 33.3, 30.6, 4.8; IR (thin film): 
3027, 2950, 1734, 1606, 1265, 1370, 1232, 1156, 1019, 743, 704; HRMS calc’d for 
C25H25NO4 = 403.1784, found = 403.1438. 
 
Acyclic adduct 1-172d was prepared using general experimental 
procedure. Reagents employed: 2-phenylcyclopropane-1,1-
dicarboxylate 1-163a (78 mg, 0.33 mmol), 2-
(trimethylsilyl)ethynylindole 1-171i (100 mg, 0.47 mmol), zinc(II) 
bistriflamide (10 mg, 0.017 mmol), and DCE (4.0 mL). Yielded acyclic adduct 1-172d as 
a yellow oil, 72% (106 mg, 0.24 mmol). Rf  = 0.29, 30% EtOAc in hexane; 1H-NMR (600 
MHz, CDCl3): δ = 8.16 (bs, 1H), 7.6 (d, J = 8.2 Hz, 1H), 7.47 (d, J = 7.0 Hz, 2H), 7.29 
(m, 3H), 7.23 (dd, J = 7.0, 1.2 Hz, 1H), 7.20 (d, J = 8.2 Hz, 1H), 7.09 (ddd, J = 8.2, 8.2, 
1.2 Hz, 1H), 4.49 (dd, J = 10.5, 6.4 Hz, 1H), 3.73 (s, 3H), 3.65 (s, 3H), 3.41 (dd, J = 9.4, 
5.9 Hz, 1H), 3.10-3.05 (m, 1H), 2.98-2.93 (m, 1H), 0.32 (s, 9H); 13C NMR (150 MHz, 
CDCl3) δ = 169.70, 169.66, 143.6, 135.8, 128.3, 127.7, 126.2, 126.1, 123.8, 123.1 120.2, 
119.8, 116.8, 110.9, 101.7, 96.7, 72.4, 52.3, 50.2, 40.4, 33.0, 0.3; IR (thin film): 3053, 
2953, 2929, 2855, 1736, 1668, 1614, 1468, 1435, 1375, 1266, 1244, 1166, 1075, 745; 
HRMS calc’d for C26H29NO4Si = 447.1866, found = 447.1858.  
 
THC 1-173v was prepared using general experimental procedure. 
Reagents employed: 2-phenylcyclopropane-1,1-dicarboxylate 1-
163a (59 mg, 0.25 mmol), methyl 3-(1-methylindol-2-yl)propiolate 
1-171j (74 mg, 0.35 mmol), zinc(II) bistriflamide (8.0 mg, 0.013 
mmol), and DCE (2.5 mL). Yielded THC 1-173v as an orange foam, 95% (106 mg, 0.24 
mmol). Rf  = 0.33, 20% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3): δ = 7.33-7.27 
(m, 7H), 6.93-6.88 (m, 2H), 5.78 (s, 1H), 4.51 (dd, J = 10.0, 6.4 Hz, 1H), 3.84 (s, 3H), 
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3.78 (s, 3H) 3.60 (s, 3H), 3.59 (s, 3H), 3.15 (dd, J = 14.0, 6.4 Hz 1H), 2.59 (dd, J = 10.0, 
14.0 Hz 1H); 13C NMR (150 MHz, CDCl3) δ = 169.3, 169.2, 166.1, 144.4, 141.9, 141.0, 
134.0, 128.6, 127.9, 126.7, 125.4, 123.8, 120.7, 119.6, 117.2, 114.5, 110.2, 64.5, 53.2, 
53.1, 51.8, 42.2, 38.3, 31.7; IR (thin film): 2925, 2854, 1733, 1627, 1464, 1436, 1334, 
1276, 1230, 1177, 1082, 1020, 747, 701; HRMS calc’d for C26H25NO6 = 447.1682, found 
= 447.1676.  
 
2-ethynyl-N-methylindole 1-171a was prepared using the following 
procedure. Commercially available 1-methylindole-2-carboxaldehyde (1.0 
g, 6.3 mmol) was dissolved in a MeOH:THF solution (8.0 mL : 5.0 mL), and cooled to 
zero for 10 min.  K2CO3 (2.6 g, 19 mmol) was then added to the solution, directly 
followed by the drop wise addition of dimethyl(1-diazo-2-oxopropyl)phosphonate in a 
1:1 solution of MeOH:THF (2.0 mL). The yellow mixture was stirred at room 
temperature until completion which was determined by TLC (5 hours).  The mixture was 
worked up using EtOAc and water; the organic was washed with brine and dried with 
MgSO4. The compound was purified by flash chromatography in 5% EtOAc/Hexanes to 
yield a yellow solid, 89% (860 mg, 5.6 mmol); The data for this compound matched that 
of the commercially available material. 
 
2-((TMS)ethynyl)-1H-indole 1-171i was prepared according to the 
procedure of Lautens.64  The data for this compound matched the previously reported.  
 
2-ethynyl-1H-indole 1-171b was prepared using the following procedure: 
2-((TMS)ethynyl)-1H-indole (840 mg, 3.90 mmol) was dissolved in THF 
(30 mL) under a balloon of argon, and cooled to zero for 10 min. 1.0 M TBAF (5.9 mL, 
5.9 mmol) in THF was then added drop wise to the solution.  The dark solution was 
stirred at room temperature until completion which was determined by TLC (20 min).  
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The mixture was worked up using EtOAc and water. The compound was purified by 
flash chromatography in a gradient solvent (0 %, 10 %, 20 %) EtOAc/Hexanes to yield a 
brown solid, 95% (520 mg, 3.7 mmol).  The data for this compound matched that of the 
commercially available material.    
 
Methyl 2-ethynyl-1H-indole-6-carboxylate 1-171d was prepared in 
a two-step fashion.  Methyl 2-((TMS)ethynyl)-1H-indole-6-
carboxylate was first prepared according to the procedure of Lautens64.  Crude methyl 2-
((TMS)ethynyl)-1H-indole-6-carboxylate (290 mg, 1.10 mmol) was dissolved in THF (10 
mL) under a balloon of argon, and cooled to zero for 10 min. 1.0 M TBAF (1.6 mL, 1.6 
mmol) in THF was then added drop wise to the solution.  The dark solution was stirred at 
room temperature until completion which was determined by TLC (30 min).  The mixture 
was worked up using EtOAc and water.  The compound was purified by flash 
chromatography in 20 % EtOAc/Hexanes to yield the product as a yellow film, 73% (159 
mg, 0.80 mmol). Rf  = 0.29, 25% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3): δ = 
8.70 (bs, 1H), 8.11 (s, 1H), 7.82 (d, J = 8.8 Hz, 1H), 7.61 (d, J = 8.2 Hz, 1H), 6.84 (s, 
1H), 3.95 (s, 3H), 3.37 (s, 1H); 13C NMR (150 MHz, CDCl3) δ = 168.0, 135.2, 130.9, 
125.2, 121.4, 120.8, 120.6, 113.2, 109.6, 81.9, 75.6, 52.1; IR (thin film): 3368, 3257, 
3033, 2998, 2950, 1691, 1618, 1515, 1434, 1386, 1322, 1307, 1272, 1220, 1090, 992, 
882, 835, 801, 760, 742, 716, 639; HRMS calc’d for C12H9NO2 = 199.0633, found = 
199.0635  
 
1-methyl-2-(phenylethynyl)-1H-indole 1-171g was prepared using the 
following procedure: 2-ethynyl-N-methylindole 1-171a (155 mg, 1.0 
mmol) and iodobenzene (1.3 mL, 1.2 mmol) were dissolved in NEt3 (5.0 mL) and purged 
with argon.  Pd(PPh3)4 (27 mg, 0.020 mmol) and CuI (10 mg, 0.050 mmol) were added 
and the solution was heated to reflux.  The solution stirred at reflux until completion 
which was determined by TLC (3 h).  The mixture was worked up using ether and water.  
The compound was purified by flash chromatography in 20 % EtOAc/Hexanes to yield 
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an orange solid, 95% (220 mg, 0.95 mmol); The data for this compound matched that of 
the commercially available material.     
 
Methyl 3-(1-methyl-1H-indol-2-yl)propiotate 1-171j was prepared 
using the following procedure: 2-ethynyl-N-methylindole 1-171a 
(100 mg, 0.640 mmol) was dissolved in ether (2.0 mL) and cooled to -30oC.  2.5 M n-
BuLi (0.5 mL, 1.3 mmol) in hexanes was added drop wise and the solution mixed at zero 
for 30 min.  The solution was then re-cooled to -30oC and methyl chloroformate (0.2 mL, 
2.6 mmol) was added and the mixture was stirred at room temperature for 1.5 hours.  The 
mixture was then quenched with NH4Cl and worked up with EtOAc and water.  The 
compound was purified by flash chromatography in 20 % EtOAc/Hexanes to yield an 
orange film, 63% (85 mg, 0.40 mmol). Rf  = 0.36, 20% EtOAc in hexanes;  1H-NMR 
(400 MHz, CDCl3): δ = 7.73 (d, J = 8.2 Hz, 1H), 7.31 (ddd, J = 8.0, 6.7, 1 Hz, 1H), 7.26 
(dd, J = 8.2, 0.8 Hz, 1H), 7.13 (ddd, J = 8.0, 6.8, 1.2 Hz, 1H) 7.03 (d, J = 0.8 Hz, 1H), 
3.84 (s, 3H), 3.80 (s, 3H); 13C NMR (100 MHz, CDCl3) δ =  154.2, 138.0, 126.6, 124.8, 
121.7, 120.7, 118.2, 112.5, 109.7, 87.1, 79.1, 52.7, 30.7; IR (thin film): 3118, 2996, 2212, 
1700, 1459, 1436, 1381, 1363, 1254, 1146, 806, 736;  
 
Deuterated 2-ethynyl-N-methylindole 1-171k was prepared using the 
following procedure: 2-ethynyl-N-methylindole 1-171a (60 mg, 0.39 
mmol) was dissolved in THF (3.0 mL), purged with argon and cooled to zero in an ice 
bath for 10 mins. 2.0 M BuLi (0.40 mL, 0.70 mmol) was added and the solution mixed at 
zero for 1.5 h.  D2O (approx. 1 mL) was then added and the solution mixed at zero for an 
additional 2 h.  The mixture was then quenched with NH4Cl and worked up with EtOAc 
and water. The organic layer was dried using magnesium sulfate, filtered, and 
concentrated to yield the product as a brown film, 92% (56 mg, 0.36 mmol). Rf  = 0.55, 
20% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3): δ = 7.64 (d, J = 8.2 Hz, 1H), 7.33-
7.30 (m, 2H), 7.17 (ddd, J = 7.9, 5.9, 2.1 Hz, 1H), 6.88 (s, 1H), 3.84 (s, 3H); 13C NMR 
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(150 MHz, CDCl3) δ = 137.1, 126.9, 123.3, 121.1, 120.9, 120.2, 109.5, 108.3, 83.4, 75.2, 
30.6.  
 
Carbazole 1-184 was prepared in a two-step procedure from THC 
1-173a.  THC 1-173a (110 mg, 0.280 mmol), LiCl (24 mg, 0.56 
mmol), and NEt3-HCl (27 mg, 0.28 mmol) were dissolved in DMF 
(2.0 mL) and placed in microwave reactor at 120oC for 1.5 h.  The solution was added to 
water and extracted with ether three times and concentrated.  The mixture was purified by 
flash chromatography in 10 % EtOAc/Hexanes to yield the crude monoester as a mixture 
of endo and exo methylene products (68 mg, 0.21 mmol).  The monoester mixture (48 
mg, 0.14 mmol) was then dissolved in mesitylene (4.5 mL) with 10% activated carbon 
(5.0 mg).  The solution was heated to reflux (180oC) for 1 h.  The solution was cooled 
and applied directly to a column and was purified in 20% EtOAc/Hexanes to yield the 
product as a yellow film, 95% (65 mg, 0.20 mmol). Rf  = 0.55, 20% EtOAc in hexanes; 
1H-NMR (600 MHz, CDCl3): δ = 7.56 (dd, J = 7.9, 1.5 Hz, 2H), 7.52 (d, J = 7.0 Hz, 2H) 
7.50-7.48 (m, 2H), 7.42 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.4 (d, J = 8.2 Hz, 1H), 7.33 (d, J 
= 8.2 Hz, 1H), 6. 96 (ddd, J = 8.0, 8.0, 1.2 Hz, 1H), 4.19 (s, 3H), 3.94 (s, 3H), 3.07 (s, 
3H); 13C NMR (100 MHz, CDCl3) δ =  169.3, 143.6, 141.0, 140.6, 134.9, 129.2, 128.7, 
128.4, 127.6, 123.7, 122.8, 122.7, 121.9, 121.5, 119.1, 108.9, 52.0, 33.8, 17.1; IR (thin 
film): 3055, 2948, 2836, 1717, 1613, 1489, 1464, 1434, 1375, 1322, 1242, 1200, 1111, 
1060, 1023, 972, 933, 875, 749, 704, 662; HRMS calc’d for C22H19NO2 = 329.1416, 
found = 329.1405. 
  
Deuterated THC 1-173w was prepared using general experimental 
procedure. Reagents employed: 2-phenylcyclopropane-1,1-
dicarboxylate 1-163a (50 mg, 0.21 mmol), deuterated 2-ethynyl-N-
methylindole 1-171k (68 mg, 0.29 mmol), Zinc(II) bistriflamide 
(7.0 mg, 0.010 mmol), and DCE (3.0 mL). Yielded deuterated THC 1-173w as a yellow 
foam, 76% (76 mg, 0.16 mmol). Rf  = 0.23, 20% EtOAc in hexanes.  Data for this 
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compound was consistent with that of THC 1-173a with the exception of the 
disappearance of the alkene singlet at 5.58, thus indicating that the substitution on the 
alkyne will end up syn to the methyl group on the nitrogen.  The overall conformation 
can once again be confirmed by referring to the nOe experiments.  
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Chapter 2 : -Aminobutyric Acids and -Butanolides from 
Cyclopropane Hemimalonates  
2 Introduction and Overiew 
The study of donor-acceptor cyclopropanes within the Kerr group has focused on the 
development and reactivity of vicinally substituted 1,1-cyclopropanediesters. Recent 
exploits have discovered a new type of cyclopropane which displays a unique mode of 
reactivity: donor-acceptor hemimalonate cyclopropanes. This chapter will focus on the 
preliminary work directed toward the development and use of hemimalonate 
cyclopropanes in the synthesis of unique molecular scaffolds. In particular, a brief 
discussion on the synthesis of γ-aminobutyric acid derivatives will be presented, along 
with a detailed account of the synthesis of butanolides from donor-acceptor 
hemimalonate cyclopropanes.  
In addition, this chapter will discuss the development of a new synthetic method for the 
functionalization of donor-acceptor cyclopropanes. The synthetic usefulness of these 
cyclopropanes will be explored, specifically in the access of cycloaddition products 
containing substitution patterns that were previously inaccessible with prior cyclopropane 
annulation methods. Finally, the instrumental utility of this method will be exploited in 
the total synthesis of (R)-dodecan-4-olide in conjunction with previous methods. 
2.1 Butanolides and Butenolides 
The butanolide and butenolide cores have been isolated from a variety of natural sources 
(Figure 2-1)1 and are common compounds in flavourings2 and insect pheromones.3 Due 
to their broad spectrum of bioactivities, these molecules and their derivatives have been 
ideal candidates for drug development.4 Their abundance in nature and potent 
bioactivities leave no question; these molecules are highly desirable and have attracted 
considerable synthetic attention. While a vast array of new elegant methods for the 
synthesis of these small molecules have been developed, only a few methods have been 
reported utilizing cyclopropanes as a core starting material.    
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Figure 2-1: Selected Butanolide and Butenolide Natural Products 
2.1.1 Selected Synthesis of Butanolides from Cyclopropanes 
One of the earlier entries in the field of butanolide synthesis from cyclopropanes was 
developed by Theodorakis in 2004 while investigating strategies for the formation of 
fused bicyclic systems. Highly activated alkoxy cyclopropanes 2-1 underwent smooth 
ring expansion to the desired bicyclic lactone 2-2 in the presence of methanesulfonic acid 
in moderate yields (Scheme 2-1).5 While a small scope was developed for this unique 
transformation, the reaction suffered from several drawbacks including minimal 
functional group (R and R1) variation due to the required meticulous synthesis of the 
starting materials. Nonetheless, this method was instrumental in showcasing rather mild 
conditions for the synthesis of substituted butanolides.     
 
Scheme 2-1: Alkoxy Cyclopropane Ring Expansion 
In a similar manner, Reiser et al. showed that alkoxy cyclopropane 2-4 could be made 
from simple furan starting materials 2-3 and could undergo the same ring expansion with 
HCl at room temperature to give the fused lactone 2-5a (Scheme 2-2A).6 This method 
allowed for great diversity in substitution patterns of the product based on the ease of the 
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cyclopropane synthesis. Interestingly, when these reactions were heated to reflux, the 
opposite diastereomer was observed. The utility of this method was applied to the total 
synthesis of (-)-paeonilide (Scheme 2-2B).7 
 
Scheme 2-2: Synthesis of (-)-paeonilide 
In 2007, Chandrasekaran displayed a variation of this reaction utilizing 1,2-
cyclopropanated sugar derivatives 2-9 (Scheme 2-3). This two-step synthesis was 
efficient for the conversion of several different substituted cyclopropanes giving excellent 
yields and perfect diastereoselectivity of the products 2-10.8 Interestingly, in contrast to 
the previous reports, initial LiOH hydrolysis of the ester was required to get good 
conversion of the NIS mediated ring opening. The advantage to this method as opposed 
to the previous acid catalyzed rearrangement strategies was the incorporation of a new 
functionalized chiral center.      
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Scheme 2-3: Butanolides from 1,2-Cyclopropanated Sugar Derivatives 
Shortly after Chandrasekaran’s NIS conditions were developed, Mead showed it was 
possible to perform this transformation using catalytic Lewis acid.9 The transformation of 
cyclopropane 2-11 to tricyclic butanolides 2-12 was achieved utilizing a variety of Lewis 
acid catalysts (BF3.OEt2, Sn(OTf)2, and Cu(OTf)2) with the tin catalyst giving the highest 
yields (72%) and copper giving the lowest yields overall (Scheme 2-4). Although this 
method only gave low to modest yields over a small substrate scope, it was a significant 
advancement in this research area because it showed that non alkoxy activated 
cyclopropanes (albeit high strained and fused) could undergo the one-pot transformation 
to butanolides.    
 
Scheme 2-4: Lewis Acid Catalyzed Synthesis of Butanolides 
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More recently, Boysen and co-workers showed the two-step synthesis of butanolides 2-16 
from indole derived cyclopropane 2-14 (Scheme 2-5).10 Similar to the seminal work in 
this area, acid mediated conditions were employed allowing for cyclopropane ring-
opening of amine activated cyclopropane 2-14 to give imine 2-15 which was then 
subjected to saponification conditions to give butanolide 2-16. Boysen was able to show 
the usefulness of this reaction by applying it to the synthesis of (-)-desoxyeseroline 2-17. 
 
Scheme 2-5: Butanolides from Indole Derived Cyclopropanes 
Reissig, a well-known and common contributor to the development of cyclopropane 
chemistry,11 recently revisited a previously developed method for the synthesis of 
perfluoroalkyl-substituted butanolides 2-20. Reissig’s interest in the synthesis of these 
molecules stemmed from high biological activity of butanolides paired with the 
remarkable changes in bioactivity that can be brought about by the introduction of a 
fluorinated substitution; accessing molecules of these types would be of great interest to 
the pharmacological industry.12 First, protic solvent ring-opening of silyl cyclopropane 
2-18 liberated the corresponding -oxo ester 2-19. 2-19 then underwent lactonization, 
following an in situ reduction and then acid cyclization to give butanolides 2-20 (Scheme 
2-6).13 The reducing conditions allowed access to several different fluoroalkyl substituted 
butanolides in modest overall yields. 
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Scheme 2-6: Synthesis of Fluoroalkyl Substituted Butanolides 
The most recent effort in this field came from the Corey group in 2013. In hopes of 
developing routes to unique structural moieties of natural and biologically active 
compounds, the group directed a focus toward the synthesis of butanolides due to their 
ability to serve as versatile intermediates in synthesis. They first showed the TMSOTf 
mediated transformation of comformationally restricted cyclopropanes 2-21 to give 
complex fused bicyclic butanolides 2-22 (Scheme 2-7A).14 While these skeletal 
rearrangements produced interesting molecular scaffolds, this method required large 
excesses of reagents and led to modest yields of the desired product. However, in the 
same paper, Corey was able to perform a skeletal rearrangement of fused carbonyl 
cyclopropanes 2-23 to butanolides 2-24 which were achieved in higher yields, although 
excess TMSOTf was still required (Scheme 2-7B). With the quick access to complex 
molecular framework, it is surely just a matter of time until this method is utilized in 
target oriented synthesis.    
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Scheme 2-7: TMSOTf Mediated Skeletal Rearrangement of Cyclopropanes 
In contrast to the synthesis of butanolides from fused cyclopropanes, little recent work 
has been reported on the synthesis of butanolides from monocyclic cyclopropanes. In 
fact, most of the recent reports in this area record the butanolide compound as a minor 
byproduct in the synthesis of different structural motifs (Scheme 2-8). Such examples can 
be seen in the work of Yang15 in the synthesis of diastereomerically pure tetrahydrofurans 
2-27 (Scheme 2-8A), Tomilov16 in the synthesis of cyclopropane dimer 2-30 (Scheme 
2-8B), and Melnikov17 in the synthesis of ring opened adduct 2-32 (Scheme 2-8C). 
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Scheme 2-8: Synthesis of Fused Butanolides from Cyclopropanes 
2.2 Naturally Occurring (R)-Dodecan-4-olide 
Among the vast array of butanolide-containing natural products, (R)-dodecan-4-olide 
(dodecanolide) displays a simple mono-lactone core perfect for showcasing developing 
methodologies (Figure 2-2). 18 Isolated from an array of natural sources including the 
pygidial glands of rove beetles,19 fruits,20 butterfat,21 and the territorial marking fluid of 
the Bengal tiger,22 dodecanolide is a small natural product which plays a role in many 
different biological processes.23 Many of the recent syntheses of this molecule have 
focused on enzymatic resolutions, optically enriched epoxide openings, and optically 
enriched reductive lactonizations.  
 
Figure 2-2: (R)-Dodecan-4-olide 
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2.2.1 Selected Previous Syntheses of Dodecanolide 
A prime example of an enzymatic type approach to dodecanolide was displayed by Utaka 
in 1987.24 The enantioselective baker’s yeast reduction of a variety of -keto acids 2-34 
gave intermediate alcohol 2-35 in moderate yields and high ee (Scheme 2-9). Alcohol 
intermediate 2-35 was then subjected to acid catalyzed cyclization during work-up to 
furnish butanolide 2-33. This process worked with a variety of different chain lengths in 
excellent selectivities and gave dodecanolide 2-33 in a 71% yield. This method allowed 
for quick access to the natural product and an array of substituted derivatives, and has 
since spurred forward several different enzymatic approaches to this product.     
 
Scheme 2-9: Baker's Yeast Reduction Approach to Dodecanolide 
Another generalized approach to dodecanolide can be illustrated by the work of Boland, 
utilizing epoxides. Optically enriched epoxide 2-36 (synthesized through a Jacobson 
hydrolytic kinetic resolution) underwent ring opening with allyl Grignard to give alcohol 
2-37 as the penultimate intermediate (Scheme 2-10).25 The opening of the epoxide was 
achieved with stereochemical transfer resulting in no erosion of enantiomeric excess. 
Oxidative cleavage of the terminal olefin of 2-37 was achieved with OsO4 to give the 
corresponding acyclic hydroxyl acid which, readily cyclized upon acidic workup to give 
2-33. Starting from a readily available epoxide, dodecanolide was synthesized in a two-
step 75% overall yield in 99% ee. 
 
Scheme 2-10: Epoxide Opening Approach to Dodecanolide 
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In early 2013, Matsumoto reported a combination of the previous two methods in the 
synthesis of dodecanolide. The first step employed an enzymatic hydrolysis to access 
optically enriched starting materials; the second step involved an epoxide opening 
allowing the synthesis to be finished in a similar manner to that of Boland. The synthesis 
of optically enriched epoxide 2-36 was achieved via a lipase hydrolysis to give a mixture 
of (S)-2-39 and 2-40 (Scheme 2-11).26 The mixture was then subjected to a polymer 
supported Mitsunobu reaction to convert 2-40 to the desired enantiomer giving (S)-2-39 
in an isolated 81% yield and 97% ee. This approach was interesting as kinetic resolution 
methods can give a theoretical maximum of 50% of each enantiomer, but by applying a 
simple second inversion step to one enantiomer, the authors have, in principle, increased 
their total theoretical yield from 50% to 100% of one enantiomer. The unfortunate 
drawback of this approach toward (R)-dodecan-4-olide is that the wrong enantiomer ((S)-
2-39) was given. Thus a second inversion had to be performed via a DIBAL reduction of 
the acetate followed by another Mitsunobu inversion of the secondary alcohol and finally 
an acetate cleavage to give 2-40. 2-40 was then converted in epoxide 2-36 which could be 
carried forward using a two-step sequence similar to that of Boland, giving (R)-dodecan-
4-olide in a 44% yield over the two steps. Matsumoto also showed the synthesis of (S)-
dodecan-4-olide using (S)-2-39 and following a similar epoxide forming and opening 
route. 
 
Scheme 2-11: Matsumoto's Approach to Dodecanolide 
While the two-step epoxide opening approach to butanolides allowed quick access to 
dodecanolide, Jacobsen showed that butanolides could be accessed directly through a 
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one-step reaction of ynamines 2-42 and epoxides 2-41 (Scheme 2-12).27 The strategy 
utilized an electron rich alkyne to invoke epoxide ring-opening followed by an 
intramolecular oxy-Mannich type reaction to give cyclic ketenaminal 2-43. The cyclic 
intermediate then underwent a subsequent hydrolysis and protodesilylation in the 
presence of KHF2 to give the corresponding butanolide 2-44. In the exploration of the 
substrate scope of this reaction, it was determined that the use of optically enriched 
epoxides allowed for efficient stereotransfer throughout the transformation, giving 
optically enriched butanolides without the loss of enantiomeric excess (eg. 2-44a, 2-44b). 
Finally, to display the utility of this transformation, Jacobsen applied it to the one-pot 
synthesis of ()-dodecan-4-olide using the appropriate racemic epoxide and ynamine 
2-42 in an 86% isolated yield. Future advancements of this chemistry to include different 
substituted ynamines would allow access to highly substituted butanolides which would 
certainly find significant use in target oriented synthesis.  
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Scheme 2-12: Butanolide Synthesis from Ynamines and Epoxides 
Moving away from the many epoxide opening methods developed for the synthesis of 
dodecanolide, Snyder showed the use of cycloaddition chemistry to access the target 
molecule.28 First, the asymmetric cycloaddition between 2-46 and anthracene gave 2-47 
plus a small amount of the regioisomer (Scheme 2-13). The desired stereochemistry was 
obtained presumably through the steric effects of the trifluoromethyl handle. Subsequent 
testing with other anthracenes proved that 2-45 gave the highest yields and best 
selectivities. Treatment of 2-47 with octyl magnesium bromide gave the desired 
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substituted butanolide 2-48 in excellent yield presumably through nucleophilic addition 
to an oxonium intermediate in a stereoselective fashion. Cycloreversion of 2-48 at high 
temperatures led to a moderate yield of butenolide 2-49 which could then be reduced to 
the natural product following known procedures.29 This method displayed the unique 
capabilities of a chiral diene to produce an enantiomerically enriched product through a 
cycloaddition/retro-cycloadditon sequence.    
 
Scheme 2-13: Cycloaddition Approach to Dodecanolide 
Finally, in another interesting approach to this molecule, Fukumoto showed the use of an 
advanced cyclopropane intermediate in the synthesis of dodecanolide via two ring 
expansion reactions.30 Cyclopropane 2-50, prepared from commercially available starting 
materials, was subjected to a two-step ring expansion via sequential mesylation and 
desilylation to give cyclobutanone 2-51 (Scheme 2-14). NaBH4 reduction and protection 
of the corresponding secondary alcohol followed by oxidative solvolysis furnished 
cyclobutane 2-52 in 84% yield over three steps. The desired octyl chain was installed via 
a three-step reduction, tosylation, displacement sequence to give 2-53. Reinstallation of 
the ketone of the cyclobutanone was achieved through a two-step procedure followed by 
a ring expanding Baeyer-Villiger oxidation to give dodecanolide 2-33 in a 65% yield 
over three steps. Although lengthy, this synthesis displayed the overall utility of 
cyclopropanes in butanolide target oriented synthesis.  
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Scheme 2-14: The use of Cyclopropanes in the Synthesis of Dodecanolide 
2.3 Cyclopropane Hemimalonates (Seminal Investigations) 
In 2010, while continuing to explore the reactivity of 1,1-cyclopropanediesters 2-54, the 
Kerr group also looked into modified donor-acceptor cyclopropanes, in hopes of 
discovering a new mode of reactivity (Figure 2-3). The synthesis of these cyclopropanes 
comes from the mild saponification of the readily available cyclopropanediester in a 
highly diastereoselective manner. 
 
Figure 2-3: Hemimalonate Cyclopropane 2-55 
Inspired by the boronic acid mediated Diels-Alder results of Hall,31 it was envisioned that 
the donor-acceptor hemimalonate cyclopropanes could be activated under similar 
conditions (Scheme 2-15A). Coordination of boronic acid with the acid moiety (2-59) 
could potentially polarize the cyclopropane C-C bond thus allowing for nucleophilic ring-
opening ultimately to give ring opened adduct 2-60 (Scheme 2-15B).  
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Scheme 2-15: Boronic Acid Activation of Cyclopropanes Hypothesis 
Initial investigations utilizing indoles as nucleophiles under hyperbaric conditions (for 
previously successful conditions see 1.2.2) with cyclopropane hemimalonate 2-55a and 
2-bromophenyl boronic acid 2-62 showed great promise giving ring opened adduct 2-63a 
a 52% yield (Scheme 16A). While these primary results indicated that the boronic acid 
was activating the cyclopropane toward ring-opening, it was later determined when 
running a control experiment that the boronic acid was not required in the reaction 
(Scheme 16B).32   In fact, in the absence of boronic acid, a higher yield of the isolated 
product 2-63a was observed. 
 
Scheme 2-16: Initial Investigation into the Ring-Opening of Cyclopropane 
Hemimalonates 
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Based on our previous knowledge in the area of activating 1,1-cyclopropanediesters 2-54, 
it was unusual to see a cyclopropane be opened without the addition of a catalyst. It was 
proposed that the hemimalonate cyclopropane could be self-activating. In particular, 
under the hyperbaric conditions, a potential high pressure induced hydrogen bonding 
effect (2-55) could take place activating the cyclopropane toward ring-opening (Figure 
2-4). This result is particularly interesting as it could allow a more atom economical 
approach to cyclopropane chemistry where no catalysts are required.    
 
Figure 2-4: Postulated Cyclopropane Hemimalonate Activation 
The scope of these high pressure reaction conditions was investigated varying 
substitution on the indole 2-64 and on the cyclopropane 2-55 (Scheme 2-17). The 
conditions were suitable for a variety of different substituted indoles with trends 
indicating higher yields when R2 = H. Cyclopropane substitution was also well tolerated 
for aromatic substituted cyclopropanes while alkyl substituted cyclopropanes showed no 
reactivity under these conditions. Interestingly, vinyl cyclopropane 2-55b was extremely 
reactive under the high pressure conditions leading only to cyclopropane polymerization. 
Overall, the results were very comparable to previously developed methods utilizing 1,1-
cyclopropanediesters and a Lewis acid catalyst.    
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Scheme 2-17: Indole Opening Substrate Scope 
2.4 The Synthesis of -Aminobutyric Acids and -
Butanolides from Hemimalonate Cyclopropanes 
Based on the initial success displayed for the opening of cyclopropane hemimalonates 
with indoles, we were encouraged to continue studying these interesting molecules in 
hopes of accessing different molecular scaffolds. While determining which direction to 
explore with these cyclopropanes, it occurred to us that an ideal starting point may be 
investigating different nucleophiles and dipoles that proved to be incompatible or 
efficient when reacted with our standard 1,1-cyclopropanediesters. To this end, we set out 
to first explore the reactivity of the cyclopropane hemimalonates with azides, as this 
reaction with the cyclopropanediesters 2-54 provided pyrrolidines 2-66 via a desirable 
fragmentation pathway (Scheme 2-18). We envisioned the unique activation of the 
hemimalonate cyclopropanes may give the desired ring opened product which could be 
used to make derivatives of -aminobutyric acid (GABA), an inhibitory neurotransmitter 
in the central nervous system.33  
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Scheme 2-18: Reaction of Sodium Azide and Cyclopropanediesters 
2.4.1 Results and Discussion – Aminobutyric Acid Synthesis  
(Note this project was initiated by Michael Emmett and the majority of the optimization 
was performed by him. The remainder of the project was completed with joint 
contributions from Dr. Emmett and myself. Division of labor has been indicated in the 
following schemes and tables.) 
The primary investigation into this reaction employed sodium azide, cyclopropane 2-55a, 
and ammonium chloride in a solvent mixture of 2-methoxyethanol and water. These 
conditions were chosen due to their previous success in the azido epoxide opening 
reported by Bäckvall (Scheme 2-19A).34 The results from the initial reaction with 
cyclopropane hemimalonates were rather interesting for several distinct reasons. First, not 
only was the desired ring opened product isolated, but in contrast to the reaction with 
indoles, a tandem decarboxylation occurred in situ giving azidobutyric acid ester 
derivative 2-69a (Scheme 2-19B).35 In the current case, the decarboxylation is 
presumably due to the elevated reaction temperatures whereas the opening with indoles 
was performed at lower temperatures, thus suppressing the decarboxylation pathway. The 
second interesting finding from this initial reaction was that the reaction proceeded in an 
aqueous medium, a result not very commonly seen in cyclopropane chemistry. Finally, a 
third interesting finding was that the ring-opening proceeded once again without the use 
of a catalyst. A quick optimization of solvent/co-solvent ratios and reagent stoichiometry 
revealed the optimal conditions for the tandem ring-opening/decarboxylation to be 1.2 
equivalents of sodium azide and 1.4 equivalents of ammonium chloride in a refluxing 
10:1 mixture of a 2-methoxyethanol:water solution leading to an isolated 78% yield of 
2-69a. 
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Scheme 2-19: Initial Reaction Between Hemimalonate Cyclopropane 2-55a and 
Sodium Azide 
With optimal conditions in hand along with a variety of readily available cyclopropane 
hemimalonates, we next set out to determine generality of this method with different 
substituted cyclopropanes (Table 2-1). In general, the reaction proceeded effectively with 
aromatic or heteroaromatic substituents on the cyclopropane. Note, that electron 
withdrawing groups on the phenyl ring attenuated the reactivity and resulted in lower 
yields (adducts 2-69g and 2-69h). Electron donating groups had the opposite effect, 
producing adducts in excellent yields (adducts 2-69c and 2-69d). While a styrenyl 
substituent was well tolerated (adduct 2-69i), cyclopropanes where R = alkyl or R = H 
were unreactive under these conditions and starting material was recovered intact. It is of 
note that the optically enriched phenyl cyclopropane (S)-2-55a (90% ee) underwent this 
transformation with full retention of enantiopurity to give (S)-2-69a.  
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Table 2-1: Azide Ring-Opening Substrate Scope 
CO2Me CO2Me
N3
CO2Me
N3
CO2Me
N3
CO2Me
N3
CO2Me
N3
CO2Me
N3
CO2Me
N3
CO2Me
N3
CO2Me
N3
MeO
Br Cl NC
O
O
O2N
TsN
CO2Me
N3
S
CO2Me
N3
O
2-69a: 78%a
90% ee
2-69d: 95%
2-69g: 56%a
2-69j: 58%a
2-69b: 76%a
2-69e: 62% 2-69h: 46%a
2-69k: 79%a
2-69c: 87%
2-69f: 60%
2-69i: 78% 2-69l: 63%
R
CO2Me
CO2H R
OMe
N3
O2-55a-l 2-69a-l
MeOCH2CH2OH: H2O
NaN3, NH4Cl
reflux
N3
a Reactions were performed by Dr. Emmett  
Interestingly, when vinyl cyclopropane hemimalonates were subjected to the reaction 
conditions, polymerization was not observed as in the previous indole opening method. 
However, instead of direct ring-opening, the use of vinyl cyclopropane resulted in an 
inseparable mixture of 2-69m and 2-70 (Scheme 2-20). 2-69m was achieved through the 
standard ring-opening method while 2-70 was formed via a SN’ type opening event, a 
result that has never before been observed in previous reaction of dimethyl 2-
vinylcyclopropane-1,1-dicarboxylate. All attempts to increase the formation of either 
product always resulted in equal amounts of the inseparable mixture.  
 
Scheme 2-20: Vinyl Cyclopropane Opening with Azide 
Finally, as proof that the azidoesters 2-69 could be viable precursors to GABA esters, a 
representative example (2-69a) was subjected to reduction under a balloon of hydrogen 
gas with catalysis by palladium on carbon. GABA ester 2-71 was produced in 93% yield 
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(Scheme 2-21). In addition to directed reduction with palladium on carbon, more mild 
Staudinger reduction conditions could be employed albeit a lower yield of the desired 
product was obtained.  
 
Scheme 2-21: Synthesis of GABA Derivatives via an Azide Reduction 
In summary, we have reported a technically simple and catalyst free method for the 
nucleophilic ring-opening of cyclopropane hemimalonates with azides.  The products 
underwent concomitant decarboxylation to yield 4-azido carboxylic acid esters.  Simple 
reduction yields γ-aminobutyric acid (GABA) methyl esters. 
2.4.2 Synthesis of -Butanolides via Cyclopropane Hemimalonates 
While trying to expand the substrate scope of our previously developed methodology to 
include substituted azides, we encountered an interesting result. When benzyl azide was 
used instead of sodium azide, a skeletal rearrangement of the cyclopropane 
hemimalonates was observed, giving butanolide 2-72a as the major product (Scheme 2-
22). Due to the modest isolated yield of butanolide 2-73a and the lack of current methods 
to access simple butanolides in high yields from non-structurally biased cyclopropanes, 
we decided to explore this transformation fully.36 
 
Scheme 2-22: Initial Synthesis of Butanolides 
2.4.3 Results and Discussion - Optimization 
The optimization process was initially directed to the formation of butanolide 2-72a 
Attempts to optimize this cyclopropane reorganization proved quite fruitful allowing 
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access to butanolide 2-72a in an 82% yield upon heating in 2-methoxyethanol in the 
presence of a slight excess of ammonium chloride (Table 2-2 entry 1). Although the use 
of ammonium chloride gave a high yield of 2-72a, it also led to a trace amount of 
inseparable butanolide 2-73a, a product of a dealkoxycarbonylation. In hopes of 
preventing the formation of 2-73a, lower temperatures were evaluated; however, no 
reaction was observed (entry 2). While changing the solvent to 2-MeO(CH2)2OH, polar 
DMSO, and DMF resulted is slightly higher yields, inseparable 2-73a was still formed 
(entry 3, 4, and 6). In the absence of the salt, the reaction failed to proceed (entry 5). Less 
polar and non-polar solvent proved to be ineffective, recovering only starting material 
from the reaction (entry 7 and 8). Next, different additives were investigated. While a 
variety of salts promoted the reaction (entry 9-12), ammonium chloride salts seemed to 
be superior. It was never possible to obtain 2-72a as the sole product in our hands. 
Table 2-2: Optimization for Butanolide 2-72a 
 
entry  additive (1.4 equiv)  solvent  temp (°C) time (h) product (%) 
1  NH4Cl  2‐MeO(CH2)2OH/H2O  reflux  2  82% 2‐72a, trace 2‐73a 
2  NH4Cl  2‐MeO(CH2)2OH/H2O  rt  24  no rxn 
3  NH4Cl  2‐MeO(CH2)2OH  reflux  2  84% 2‐72a, trace 2‐73b 
4  NH4Cl  DMSO  135  1  87% 2‐72a, trace 2‐72b 
5    DMSO  135  16  no rxn 
6  NH4Cl  DMF  135  2  mixturea 
7  NH4Cl  Cl(CH2)2Cl  reflux  16  no rxn 
8  NH4Cl  Toluene  reflux  16  no rxn 
9  NaCl  DMSO  135 1  mixturea
10  KCl  DMSO  135 1  mixturea
11  LiCl  DMSO  135 24  mixturea
12  Me3N.HCl  DMSO  135 24  mixturea
a1:1 mixture of compounds 2‐72a and 2‐73a 
Frustrated with the inability to form 2-72a cleanly, it was decided to focus on pushing the 
reaction toward the formation of 2-73a. (Table 2-3). Reaction conditions were modified 
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by using DMSO and H2O, a solvent mixture commonly used in Krapcho 
dealkoxycarbonylation reactions. The use of ammonium chloride in DMSO (entry 2) 
yielded both 6 and 7 as an inseparable 1:1 mixture. The reaction temperature was 
increased to reflux in DMSO/H2O; however, this led to slow decomposition of the 
starting material (entry 3). We next turned our attention to the use of sodium cyanide as 
an additive due to its common use in Krapcho dealkoxycarbonylation reactions. 
Unfortunately, when sodium cyanide was employed, no reaction occurred (entry 4). It 
was at this point that a one-pot, two-step process was engaged, using ammonium chloride 
to promote initial butanolide formation followed by the addition of sodium cyanide to 
facilitate the dealkoxycarbonylation (entry 5). We were pleased to find that the two step 
process worked, giving 2-73a in a 65% yield as the sole product. Interestingly, when 
ammonium chloride and sodium cyanide were used in a non-sequential fashion, only 
slow conversion to a mixture of 2-72a and 2-73a was observed (entry 6).  
Spurred by this success (entry 5), we next examined the use of standard 
dealkoxycarbonylation salt systems, which could also promote the butanolide formation. 
The use of lithium chloride and trimethyl ammonium chloride together at 135 oC and 
reflux both unfortunately led to a 1:1 mixture of 2-72a and 2-73a even after extended 
reaction times (entry 7 and 8). In order to circumvent the problem with incomplete 
conversion, microwave irradiation was employed. Gratifyingly, the reaction proceeded 
well at 150 oC in both DMSO and DMF giving rise to adduct 2-73a in excellent yields at 
71% and 82% respectively (entry 9 and 10). Finally, the cyclopropanediester was 
subjected to the optimized reaction conditions of lithium chloride, and trimethyl 
ammonium chloride in DMF at 150 oC. However, only a small amount of the desired 
product could be isolated, along with a significant amount of starting material 
decomposition (entry 11). 
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Table 2-3: Optimization for Butanolide 2-73a 
 
entry  additive (1.4 equiv)  solvent 
temp 
(°C)  time (h)  product (%) 
1  NH4Cl  DMSO  135  1  87% 2‐72a, trace 2‐73a 
2  NH4Cl  DMSO/H2O  135  1  mixturea 
3  NH4Cl  DMSO/H2O  reflux  3  Slow decomp. 
4  NaCN  DMSO  135  24  no rxn 
5  NH4Cl then NaCN  DMSO  135  1/6  65% 2‐73a 
6b  NH4Cl/NaCN  DMSO  135  24  mixturea 
7  LiCl/ Me3N.HCl  DMSO  135  24  mixturea 
8  LiCl/ Me3N.HCl  DMSO  reflux  24  mixturea 
9c  LiCl/ Me3N.HCl  DMSO  150  40  71% 2‐73a 
10c  LiCl/ Me3N.HCl  DMF  150  40  82% 2‐73a 
11c,d  LiCl/ Me3N.HCl  DMF  150  40  45% 2‐73a 
a1:1 mixture of compounds 2‐72a and 2‐73a. breaction conditions gave a low yield of the 
mixture. cperformed in microwave reactor. dthe corresponding methyl diester was used. 
2.4.4 Substrate Scope 
With successful reaction conditions determined and a variety of cyclopropane 
hemimalonates readily available, we set forth to determine the scope of this 
transformation (Table 2-4). Both electron-donating and halogen substituted phenyl 
cyclopropanes effectively underwent the butanolide conversion in moderate to excellent 
yields (adducts 2-73b-e). In contrast, electron-withdrawing phenyl cyclopropanes 
decreased the reactivity of butanolide production, resulting in lower isolated yields 
(adducts 2-73f-g), a trend common to donor-acceptor cyclopropane reactivity. The 
heteroaromatic substituted cyclopropanes (3-N-tosylindolyl and 2-thienyl) underwent the 
transformation with great success leading to isolated yields of 85% and 74% of 
butanolides 2-73h, and 2-73i, respectively. Alkenyl substituted cyclopropanes were able 
to withstand the reaction conditions allowing access to the -styrenyl substituted adduct 
2-73j in 80% yield. Interestingly, when the vinyl cyclopropane hemimalonate was 
subjected to the reaction conditions, vinyl adduct 2-73k was isolated in 60% yield. The 
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lower yield of 2-73k can be attributed to the highly reactive nature of this cyclopropane 
toward polymerization. Finally, alkyl substituted cyclopropanes were subjected to the 
reaction conditions (not in table); however, no product formation was achieved. 
Table 2-4: Butanolide Substrate Scope 
 
2.4.5 Reaction Mechanism 
To shed light onto the mechanism, optically enriched phenyl cyclopropane (-)-2-55a was 
subjected to the reaction conditions (Scheme 2-23). Smooth transformation led to an 
isolated 82% yield of enriched butanolide (-)-2-73a, with only slight erosion of 
enantiomeric excess (determined by a Mosher’s ester sequence). Optical rotation analyses 
of the product support the (S) isomer butanolide being isolated (when compared to the 
literature compound).37 This outcome suggests that the reaction occurs with retention of 
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stereochemistry, a result unusual in donor-acceptor cyclopropane chemistry. A proposed 
mechanism for this transformation can be seen in Scheme 24. 
 
Scheme 2-23: Optically Enriched Example 
There appeared to be two possible mechanistic explanations for this transformation 
(Scheme 2-24).  First, solvolytic cleavage of the cyclopropane bond in 2-55a may occur 
to produce a benzylic carbocation and a malonate ion in an intimate ion pair 2-74.38 The 
cation moiety would undergo attack by the malonate in an O-alkylation event to produce 
the lactone 2-72a as the observed mixture of diastereomers.  Subsequent Krapcho 
dealkoxycarbonylation would yield 2-73a.  Alternatively, the cyclopropane 2-55a may 
undergo nucleophilic attack by chloride with inversion of configuration to yield the 
benzylic chloride 2-75.  O-Alkylation of the putative malonic anion with a second 
inversion would yield lactone 2-72a, again as a mixture of diastereomers. Any small 
erosion of stereochemistry could be rationalized in the first case by bond rotation of the 
cationic moiety in 2-74 or a Finkelstein inversion of the chloride in 2-75.  We are unsure 
at this time of the most likely scenario. 
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Scheme 2-24: Proposed Mechanisms 
We next envisioned applying this method to the total synthesis of a commonly targeted 
butanolide natural product, (R)-dodecan-4-olide. Attempts to access the target molecule 
directly from cyclopropane 2-55l proved unsuccessful due to the lack of reactivity 
typically displayed by alkyl substituted cyclopropanes (Scheme 2-25A).39 In our 
experience, the substrates which behave the best toward nucleophilic ring-opening (or 
annulations) are those bearing an aryl or vinyl group vicinal to the geminal diester 2-76 
(Scheme 2-25B). While simple alkyl moieties at this position are sometimes tolerated, the 
reaction times are longer and the yields are typically lower. Thus, in order to synthesize 
(R)-dodecan-4-olide, a new method to access alkyl substituted products from 
cyclopropane reactions was required.  
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Scheme 2-25: Initial Attempt to Synthesize Dodecanolide 
2.4.6 Advancing the Reactivity of Dimethylcyclopropane-1,1-
dicarboxylates via Cross Metathesis 
One strategy to circumvent the lack of reactivity of cyclopropanes bearing a simple alkyl 
substituent is to employ the corresponding alkenyl cyclopropane 2-79 (Scheme 2-26) and 
to saturate the double bond in 2-80 after the cycloaddition to yield 2-81. This procedure 
would obviate the use of the less reactive cyclopropane 2-82. Cyclopropanes 2-79 
bearing a variety of alkenyl groups may be difficult to prepare using typical 
cyclopropanation methods (Corey-Chaykovsky40 or carbenoid insertion41). The simple 
parent 2-vinyl cyclopropane-1,1-dicarboxylate (R = H) is, on the other hand, very readily 
available in large quantities and in racemic42 or enantioenriched43 form. Herein, we 
present a divergent strategy involving cross-metathesis for the synthesis of a wide variety 
of dimethyl 2-alkenylcyclopropane-1,1-dicarboxylates from simple starting materials and 
their use in circumventing difficulties in cycloaddition chemistry.44 
 
Scheme 2-26: Two cycloaddition strategies to adduct 2-81 
 97 
 
Quick optimization of the cross metathesis reaction varying solvent, temperature, 
catalyst, and stoichiometry led to ideal conditions of 1 equivalent of cyclopropane 2-83, 
1.4 equivalents of alkene 2-84, and 1 mol % Grubbs 2nd Generation Catalyst in refluxing 
dichloromethane. It should be noted that when lower temperatures were employed in 
hopes of increasing E:Z selectivity, incomplete conversion was observed. With our best 
conditions in hand, we examined the scope of olefins that would undergo metathesis with 
dimethyl 2-vinylcyclopropane-1,1-dicarboxylate 2-83 (Table 2-5). 
Table 2-5: Cross Methathesis Scope 
 
We first studied the use of readily available alkyl substituted olefins (Table 2-5). 
Gratifyingly, 1-hexene, 1-octene, and 1-dodecene underwent the cross metathesis 
smoothly giving vinyl cyclopropanes 2-79a, 2-79b, and 2-79c in 67%, 74%, and 69% 
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yields respectively, with little or no observed dimerization products isolated. It is 
noteworthy to mention that with a much longer alkyl chain (product 2-79c), the E:Z ratio 
was reduced to 3:1. More functionalized olefins also underwent the metathesis 
efficiently, allowing access to 2-79d and 2-79e in good yields. In the case of 2-79e, a 
higher catalyst loading was required to drive the reaction to completion. Disubstituted 
alkyl olefins, including 2,4,4-trimethylpent-1-ene, were also subjected to the reaction 
conditions; however, only cyclopropane dimer was isolated. 
We next examined the effects of styrenes as participants in the cross metathesis reaction. 
The reaction of dimethyl 2-vinylcyclopropane-1,1-dicarboxylate 2-83 and styrene proved 
to be difficult due to the increased reactivity of styrene toward dimerization as well as 
polymerization.45 After several attempts at modifying the reaction conditions, it was 
determined that the required metathesis product 2-79f could be isolated in good yield 
(75%) when 3 equivalents of styrene and 2.5 mol % of catalyst were used. The reaction 
had to be monitored scrupulously by TLC until the cyclopropane starting material was 
consumed, as styrene dimer would form rapidly, making purification extremely difficult. 
When p-methoxy styrene was subjected to the reaction conditions, the styrene dimer 
proved to be the major product allowing for isolation of 2-79g in 29% yield. Many 
modifications were made to increase the yield of 2-79g; however, the p-methoxy styrene 
proved to be too reactive and in all cases the dimer was the major isolated product. 
Finally, electron withdrawing p-nitro styrene underwent the metathesis with success 
giving 2-79h in 60% yield, a result that could be attributed to the lowered reactivity of 
the olefin toward dimerization under these conditions. 
A variety of electron deficient ,β-unsaturated olefins were explored as cross-metathesis 
partners. The initial metathesis between 283 and acrolein led to the desired product 2-79i; 
however, the process occurred in a low yield of 33% with significant decomposition of 
acrolein. To avoid the decomposition of acrolein, (E)-but-2-enal was used as a substitute 
and 2-79i was isolated in 69% yield. Interestingly, methyl vinyl ketone underwent the 
reaction giving 2-79j as the sole product in 82% yield with no sign of starting material 
decomposition. Methyl acrylate also showed great success toward the metathesis 
allowing access to 2-79k in 92% yield. 
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With adducts such as 2-79 in hand, we set forth to compare the reactivity of these 
cyclopropanes against their saturated counterparts. In order to secure the corresponding 
alkyl substituted cyclopropanes 2-85a and 2-85b (Table 2-6), vinyl cyclopropanes 2-79a 
and 2-79f were reduced using mild hydrazine transfer hydrogenation conditions.46 To test 
the reactivity of each cyclopropane, a fundamental and well-studied nitrone cycloaddition 
reaction was performed (Table 2-6).47 Each cyclopropane was subjected to nitrone 2-86 
and catalytic Yb(OTf)3 in CH2Cl2 for an extended reaction period of 18 hours. Both 
alkenyl substituted cyclopropanes 2-79a and 2-79f gave excellent conversions to the 
corresponding tetrahydro-1,2-oxazines (2-87a and 2-87b) in 96% and 92% yields 
respectively. In contrast, saturated cyclopropane 2-85a produced tetrahydro-1,2-oxazines 
2-87c in a 34% yield (based on recovered starting material) as an inseparable mixture of 
product and starting cyclopropane. Saturated cyclopropane 2-85b did not react under the 
standard reaction conditions and only starting material was recovered. 
Table 2-6: Comparative Nitrone Cycloaddition Reactions 
 
Finally, the tetrahydro-1,2-oxazines were reduced in order to access the alkyl substituted 
derivative. Due to the sensitivity of the tetrahydro-1,2-oxazines N-O bond, a mild 
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tosylhydrazine/sodium acetate reduction was utilized (Scheme 2-27). The reductions of 
2-87a and 2-87b were successful, leading to isolations of tetrahydro-1,2-oxazines 2-87c 
and 2-87d in 91% and 98% yields respectively. Due to the observed success of this study, 
in theory, this method could allow access to a range of alkyl substituted substrates which 
would be more difficult to access via other means.   
 
Scheme 2-27: Vinyl-tetrahydro-1,2-oxazine reduction 
2.4.7 Synthesis of (R)-Dodecan-4-olide 
To test the generality of the cross metathesis method and the utility of the butanolide 
synthesis, the natural lactone (R)-dodecan-4-olide was targeted for total synthesis 
(Scheme 2-28). Readily available dimethyl ester vinyl cyclopropane (-)-2-83 was 
subjected to cross metathesis conditions with oct-1-ene in the presence of Grubbs 2nd 
generation ruthenium catalyst (5 mol %) to access the crude octenyl cyclopropane. 
Following monosaponification, cyclopropane hemimalonate 2-55m was isolated in an 
87% yield over two steps. Hemimalonate 2-55m was then exposed to the standard 
butanolide synthesis conditions and alkenyl butanolide 2-88 was isolated in 78% yield. 
Reduction of the π-system proved to be the most difficult step in the synthesis, resulting 
in over reduction of the lactone ring under standard conditions including hydrogenation 
over Pd on carbon or PtO2. The π-system reduction of butanolide 2-88 was finally 
achieved using tosylhydrazide as a diimide source allowing access to (R)-dodecan-4-olide 
2-33 in 98% yield and 94% ee (determined by a Mosher’s ester sequence). 
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Scheme 2-28: Total Synthesis of Dodecanolide 
2.5 Summary and Future Outlook 
In summary, we have developed two new methods for the synthesis of γ-aminobutyric 
ester and γ-butanolides from the unique reactivity of cyclopropane hemimalonates. Both 
methods are catalyst free and work well with a variety of substituted cyclopropanes. 
Additionally, the application of the γ-butanolides method in conjunction with a new cross 
metathesis method has resulted in the 4 step 67% overall yield synthesis of naturally 
occurring (R)-dodecan-4-olide.  
It is envisioned that the future direction of the cyclopropane hemimalonates will focus on 
tandem annulation/decarboxylation reactions (Scheme 2-29). This focus will allow quick 
access to hetero and carbocyclic compounds with a functional ester handle 2-89; this 
would be an invaluable result as many previous routes to target molecules utilizing the 
1,1-cyclopropanediester require a subsequent decarboxylation step. 
 
Scheme 2-29: Possible Future Direction of this Chemistry 
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2.6 Experimental 
General Considerations 
 Infrared spectra were obtained as thin films on NaCl plates using a Bruker Vector 
33 FT-IR instrument. NMR experiments were performed on Varian Mercury 400, Varian 
Inova 600 and Inova 400 instruments and samples were obtained in CDCl3 (referenced to 
7.26 ppm for 1H and 77.0 ppm for 13C). 19F spectra were externally referenced to neat 
trifluorotoluene (referenced to   -63.9 ppm).  Coupling constants (J) are in Hz. The 
multiplicities of the signals are described using the following abbreviations: s = singlet, d 
= doublet, t = triplet, q = quartet, sept = septuplet, m = multiplet, br = broad. High 
resolution mass spectra (HRMS) were obtained on a Finnigan MAT 8200 spectrometer at 
70 eV. Optical rotations were recorded in cells of 10 cm path length using a Perkin-Elmer 
241 digital polarimeter.  
 All reagents and solvents were used as purchased from Aldrich, Strem, Caledon 
or VWR.  Reaction progress was followed by thin layer chromatography (TLC) (EM 
Science, silica gel 60 F254) visualizing with UV light, and the plates developed using 
acidic anisaldehyde. Flash chromatography was performed using silica gel purchased 
from Silicycle Chemical Division Inc. (230-400 mesh). 
General Experimental Procedure for the synthesis of -aminobutyric esters: Sodium 
azide (0.55 mmol, 1.2 equiv.) and ammonium chloride (1.4 equiv.) were added to a 
solution of cyclopropane hemimalonate (1.0 equiv.) in 2-methoxyethanol:water (5.0 
mL:0.5 mL).  The mixture was stirred at reflux (125 °C) until the reaction was complete 
(as determined by TLC analysis). The reaction was then quenched with H2O extracted 3 
times with ether. The organic was dried and the solvent was removed. The residue was 
purified by flash chromatography (EtOAc:Hexanes) to yield the desired product 2-69a-l. 
 
-Aminobutyric ester 2-69c was prepared using general 
experimental procedure. Reagents employed: 2-
 103 
 
(benzo[d][1,3]dioxol-5-yl)-1-(methoxycarbonyl)cyclopropanecarboxylic acid (2-55c) (97 
mg, 0.37 mmol), sodium azide (29 mg, 0.44 mmol), ammonium chloride (27 mg, 0.51 
mmol), and 2-methoxyethanol:water (5.0 mL:0.5 mL). Yielded 2-69c as a clear oil, 87% 
(84 mg, 0.32 mmol). Rf  = 0.58, 30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3):  
= 6.80 (d, J = 1.6 Hz, 1H), 6.78 (s, 1H) 6.76 (d, J = 1.6 Hz, 1H) 5.97 (s, 2H), 4.44 (dd, J = 
7.8, 6.25 Hz, 1H), 3.66 (s, 3H), 3.76 (t, J = 7.4, 2H), 2.11-1.94 (m, 2H); 13C NMR (100 
MHz, CDCl3)  =  173.1, 148.2, 147.7, 132.7, 120.7, 108.3, 106.9, 101.2, 65.1, 51.7, 
31.3, 30.5; IR (thin film): 3459, 3323, 2953, 2101, 1739, 1505, 1490, 1443, 1342, 1328, 
1252, 1170, 1102, 1042, 933, 863, 813, 661; HRMS calc’d for C12H13N3O4 = 263.0906, 
found = 263.0905.  
 
-Aminobutyric ester  2-69d was prepared using general 
experimental procedure. Reagents employed: 1-
(methoxycarbonyl)-2-(4-methoxyphenyl)cyclopropanecarboxylic acid (2-55d) (100 mg, 
0.400 mmol), sodium azide (31 mg, 0.48 mmol), ammonium chloride (30 mg, 0.56 
mmol), and 2-methoxyethanol:water (5.0 mL:0.5 mL). Yielded 2-69d as a clear oil, 95% 
(95 mg, 0.38 mmol). Rf  = 0.54, 30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3):  
= 7.25-7.21 and 6.92-6.89 (m, AA’BB’, 4H), 4.47 (dd, J = 7.8, 6.3 Hz, 1H), 3.80 (s, 3H), 
3.66 (s, 3H), 2.36 (t, J = 7.4, 2H), 2.15-1.98 (m, 2H); 13C NMR (100 MHz, CDCl3)  = 
173.1, 159.6, 130.8, 128.1, 114.2, 64.8, 55.2, 51.6, 31.2, 30.5; IR (thin film): 3451, 3319, 
2953, 2839, 2482, 2101, 1739, 1611, 1529, 1438, 1245, 1174, 1034, 832, 545; HRMS 
(M-N2) calc’d for C12H15N3O3 = 221.1052, found = 221.1050.   
 
-Aminobutyric ester  2-69e was prepared using general 
experimental procedure. Reagents employed: 2-(4-bromophenyl)-
1-(methoxycarbonyl)cyclopropanecarboxylic acid (2-55e) (95 mg, 0.32 mmol), sodium 
azide (25 mg, 0.38 mmol), ammonium chloride (24 mg, 0.45 mmol), and 
2-methoxyethanol:water (4.0 mL:0.4 mL). Yielded 2-69e as a clear oil, 62% (51 mg, 0.20 
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mmol). Rf  = 0.53, 30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3):  = 7.53-7.50 
and 7.20-7.17 (m, AA’BB’, 4H), 4.52 (dd, J = 8.2, 6.3 Hz, 1H), 3.66 (s, 3H), 2.44-2.31 
(m, 2H), 2.12-1.97 (m, 2H); 13C NMR (100 MHz, CDCl3)  = 173.0, 183.0, 132.0, 128.5, 
122.4, 64.6, 51.7, 31.3, 30.3; IR (thin film): 3455, 3319, 2951, 2101, 1737, 1489, 1437, 
1250, 1201, 1171, 1044, 1011, 822, 532; HRMS (M+1) calc’d for C11H12BrN3O2 = 
298.0186, found = 298.0185.  
 
-Aminobutyric ester 2-69f was prepared using general 
experimental procedure. Reagents employed: 2-(4-chlorophenyl)-
1-(methoxycarbonyl)cyclopropanecarboxylic acid (2-55f) (105 mg, 0.410 mmol), sodium 
azide (32 mg, 0.50 mmol), ammonium chloride (30 mg, 0.58 mmol), and 
2-methoxyethanol:water (5.0 mL:0.5 mL). Yielded 2-69f as a clear oil, 60% (62 mg, 0.25 
mmol). Rf = 0.56, 30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3):  = 7.38-7.35 
and 7.26-7.23 (m, AA’BB’, 4H), 4.53 (dd, J = 7.8, 6.3 Hz, 1H), 3.67 (s, 3H), 2.44-2.32 
(m, 2H), 2.13-1.98 (m, 2H); 13C NMR (100 MHz, CDCl3)  = 173.0, 137.5, 134.2, 129.1, 
128.2, 64.5, 51.7, 31.3, 30.3; IR (thin film): 2952, 2101, 1739, 1493, 1437, 1325, 1249, 
1202, 1171, 1092, 1015, 826, 534; HRMS (M+1) calc’d for C11H12ClN3O2 = 254.0691, 
found = 254.0710.  
 
-Aminobutyric ester 2-69i was prepared using general 
experimental procedure. Reagents employed: (E)-1-
(methoxycarbonyl)-2-(4-styrylphenyl)cyclopropanecarboxylic acid (2-55i) (101 mg, 
0.410 mmol), sodium azide (32 mg, 0.49 mmol), ammonium chloride (30 mg, 0.57 
mmol), and 2-methoxyethanol:water (5.0 mL:0.5 mL). Yielded 2-69i as a clear oil, 78% 
(78 mg, 0.32 mmol). Rf = 0.50, 30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3):  = 
7.37 (d, J = 7.4 Hz, 2H), 7.31 (t, J = 7.4 Hz, 2H), 7.26-7.22 (m, 1H), 6.60 (d, J = 15.6 Hz, 
1H), 6.06 (dd, J = 16.0, 8.2 Hz, 1H) 4.08 (dd, J = 14.9, 7.4 Hz, 1H), 3.64 (s, 3H), 2.41 (t, 
J = 7.4 Hz, 2H), 1.94-1.88 (m, 2H); 13C NMR (100 MHz, CDCl3)  =  173.2, 135.7, 
CO2Me
N3
Cl
 105 
 
133.9, 128.6, 128.2, 126.7, 126.1, 63.9, 51.7, 30.2, 29.8; IR (thin film): 3027, 2952, 2105, 
1739, 1493, 1437, 1239, 1170, 1112, 1071, 969, 888, 751, 694; HRMS calc’d for 
C13H15N3O2 = 369.1576, found = 369.1567. 
 
-Aminobutyric ester 2-69l was prepared using general experimental 
procedure. Reagents employed: 2-(4-(furan-3-yl)phenyl)-1-
(methoxycarbonyl)cyclopropanecarboxylic acid (2-55l) (126 mg, 0.600 mmol), sodium 
azide (47 mg, 0.72 mmol), ammonium chloride (45 mg, 0.84 mmol), and 
2-methoxyethanol:water (5.0 mL:0.5 mL). Yielded 2-69l as a clear oil, 63% (79 mg, 0.38 
mmol). Rf  = 0.54, 30% EtOAc in hexanes; 1H-NMR (400 MHz, CDCl3):  = 7.42 (d, J = 
1 Hz, 1H), 6.36 (dd, J = 3.1, 1.8 Hz, 1H), 6.33 (d, J = 3.1 Hz, 1H), 4.53 (dd, 7.2, 7.2 Hz, 
1H), 3.68 (s, 3H), 2.45-2.41 (m, 2H), 2.25-3.12 (m, 2H); 13C NMR (100 MHz, CDCl3)  
=  172.9, 151.5, 143.0, 110.2, 108.1, 57.9, 51.7, 30.2, 27.8; IR (thin film): 2954, 2102, 
1736, 1438, 1338, 1239, 1210, 1173, 1013, 745; HRMS (M-N2) calc’d for C9H11N3O3 = 
181.0739, found = 181.0739.  
General Experimental Procedure for the Synthesis of -Substituted Butanolides: 
Cyclopropane hemimalonates (1 equivalent), LiCl (2 equivalent), and Me3N.HCl (1.4 
equivalent) were added to a microwave vial and dissolved in DMF. The vial was sealed 
and heated for 40 minutes at 150 °C. After the required reaction time the reaction was 
quenched with H2O and extracted 3 times with ether. The organic layer was dried and the 
solvent was removed. The residue was purified by flash chromatography 
(EtOAc/Hexanes) to yield the desired butanolide 2-73a-k. 
 
Lactone 2-73a was prepared using general experimental procedure. Reagents 
employed: (2S)-1-(methoxycarbonyl)-2-phenylcyclopropanecarboxylic acid 
2-55a (75 mg, 0.34 mmol), LiCl (29 mg, 0.68 mmol), Me3N.HCl (46 mg, 0.48 
mmol), and DMF (4 mL). Yielded 2-73a as a clear oil, 82% (45 mg, 0.28 mmol). 
Spectral properties are identical to those previously reported.48 80% ee calculated from a 
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Mosher’s ester via the following procedure: Lactone 2-73a was reduced with excess 
LiAlH4 in THF giving the the crude diol. The crude diol was dissolved in 
dichloromethane and TBSCl (approx. 1 equiv) and NEt3 (approx. 1 equiv) were added. 
Upon completion water was added and the organic was extracted with dichloromethane. 
The crude protected material was subjected to a DCC coupling with Mosher’s acid to 
give the desired Mosher’s ester upon purification by flash chromatography. 19F-NMR 
(376 MHz, CDCl3): δ = -71.31 (s, 90), -71.59 (s, 10).  
 
Lactone 2-73b was prepared using general experimental procedure. Reagents 
employed: 1-(methoxycarbonyl)-2-(4-methoxyphenyl)cyclopropanecarboxylic 
acid 2-55b (77 mg, 0.31 mmol), LiCl (26 mg, 0.61 mmol), Me3N.HCl (41 mg, 
0.43 mmol), and DMF (4 mL). Yielded 2-73b as a yellow oil, 91% (54 mg, 
0.28 mmol). Rf = 0.25, 30% EtOAc/hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.26 (d, J 
= 9.0 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 5.45 (dd, J = 8.6, 6.2 Hz, 1H), 3.80 (s, 3H), 2.68-
2.56 (m, 3H), 2.26-2.14 (m, 1H). 13C-NMR (100 MHz, CDCl3): δ = 176.9, 159.7, 131.1, 
126.9, 114.0, 81.3, 55.3, 30.8, 29.2. IR (thin film, cm-1): 3129, 1771, 1517, 1400, 1250, 
1175, 1141, 1112, 1032. HRMS calc’d for C11H12O3 = 192.0786, found = 192.0783. 
 
Lactone 2-73c was prepared using general experimental procedure. Reagents 
employed: 2-(benzo[d][1,3]dioxol-5-yl)-1-
(methoxycarbonyl)cyclopropanecarboxylic acid 2-55c (78 mg, 0.30 mmol), 
LiCl (25 mg, 0.59 mmol), Me3N.HCl (40 mg, 0.42 mmol), and DMF (4 mL). 
Yielded 2-73c as a brown oil, 90% (55 mg, 0.27 mmol). Rf = 0.22, 30% EtOAc/hexanes; 
1H-NMR (400 MHz, CDCl3): δ = 6.81-6.78 (m, 3H), 5.96 (s, 2H), 5.40 (dd, J = 8.6, 6.2 
Hz, 1H), 2.66-2.54 (m, 3H), 2.22-2.09 (m, 1H). 13C-NMR (100 MHz, CDCl3): δ = 176.7, 
148.0, 147.7, 133.0, 119.1, 108.2, 105.9, 101.2, 81.2, 30.9, 29.0. IR (thin film, cm-1): 
3135, 2992, 1771, 1505, 1446, 1400, 1245, 1141, 1037. HRMS calc’d for C11H10O4 = 
206.0579, found = 206.0575. 
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Lactone 2-73d was prepared using general experimental procedure. Reagents 
employed: 2-(4-chlorophenyl)-1-(methoxycarbonyl)cyclopropanecarboxylic acid 
2-55d  (75 mg, 0.29 mmol), LiCl (25 mg, 0.59 mmol), Me3N.HCl (39 mg, 0.41 
mmol), and DMF (4 mL). Yielded 2-73d as a yellow oil, 81% (47 mg, 0.24 
mmol). Rf = 0.16, 30% EtOAc/hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.36 (d, J = 8.6 
Hz, 2H), 7.27 (d, J = 8.2 Hz, 2H), 5.48 (dd, J = 8.6, 6.2 Hz, 1H), 2.70-2.61 (m, 3H), 2.20-
2.07 (m, 1H). 13C-NMR (100 MHz, CDCl3): δ = 176.5, 137.8, 134.2, 128.9, 126.6, 80.4, 
30.9, 28.8. IR (thin film, cm-1): 3135, 2924, 1773, 1402, 1173, 1138, 1091, 1035. HRMS 
calc’d for C10H9ClO2 = 196.0291, found = 196.0299. 
 
Lactone 2-73e was prepared using general experimental procedure. Reagents 
employed: 2-(4-bromophenyl)-1-(methoxycarbonyl)cyclopropanecarboxylic 
acid 2-55e (76 mg, 0.25 mmol), LiCl (22 mg, 0.52 mmol), Me3N.HCl (35 mg, 
0.37 mmol), and DMF (4 mL). Yielded 2-73e as a yellow oil, 74% (45 mg, 0.19 
mmol). Rf = 0.29, 30% EtOAc/hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.51 (d, J = 8.6 
Hz, 2H), 7.20 (d, J = 8.6 Hz, 2H), 5.46 (dd, J = 8.2, 6.2 Hz, 1H), 2.71-2.61 (m, 3H), 2.21-
2.07 (m, 1H). 13C-NMR (100 MHz, CDCl3): δ = 176.5, 138.4, 131.9, 126.9, 122.3, 80.4, 
30.9, 28.8. IR (thin film, cm-1): 3136, 2923, 1781, 1402, 1173, 1140, 1035, 1010. HRMS 
calc’d for C10H9BrO2 = 239.9786, found = 239.9794. 
 
Lactone 2-73f was prepared using general experimental procedure. Reagents 
employed: 2-(4-cyanophenyl)-1-(methoxycarbonyl)cyclopropanecarboxylic 
acid 2-55f (75 mg, 0.31 mmol), LiCl (26 mg, 0.61 mmol), Me3N.HCl (41 mg, 
0.43 mmol), and DMF (4 mL). Yielded 2-73f as a clear oil, 52% (30 g, 0.16 
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mmol). Rf = 0.11, 30% EtOAc/hexanes; 1H-NMR (600 MHz, CDCl3): δ = 7.69 (d, J = 8.8 
Hz, 2H), 7.45 (d, J = 8.2 Hz, 2H), 5.55-5.51 (m, 1H), 2.76-2.60 (m, 3H), 2.16-2.07 (m, 
1H). 13C-NMR (150 MHz, CDCl3): δ = 176.0, 144.7, 132.6, 125.8, 118.3, 112.3, 79.8, 
30.8, 28.6. IR (thin film, cm-1): 2954, 2924, 1772, 1653, 1457, 1174, 1019, 525. HRMS 
calc’d for C11H9NO2 = 187.0633, found = 187.0639. 
 
Lactone 2-73g was prepared using general experimental procedure. Reagents 
employed: 1-(methoxycarbonyl)-2-(4-
(methoxycarbonyl)phenyl)cyclopropanecarboxylic acid 2-55g (75 mg, 0.27 
mmol), LiCl (23 mg, 0.54 mmol), Me3N.HCl (36 mg, 0.38 mmol), and DMF 
(4 mL). Yielded 2-73g as a clear oil, 39% (23 mg, 0.10 mmol). Rf = 0.16, 30% 
EtOAc/hexanes; 1H-NMR (400 MHz, CDCl3): δ = 8.06 (d, J = 8.6 Hz, 2H), 7.40 (d, J = 
8.2 Hz, 2H), 5.59-5.53 (m, 1H), 3.92 (s, 3H), 2.76-2.63 (m, 3H), 2.21-2.12 (m, 1H). 13C-
NMR (100 MHz, CDCl3): δ = 176.5, 166.5, 144.4, 130.2, 130.1, 125.0, 80.4, 52.2, 30.9, 
28.7. IR (thin film, cm-1): 2998, 1785, 1721, 1613, 1436, 1283, 1178, 1142, 1113, 1019, 
940, 768, 706. HRMS calc’d for C12H12O4 = 220.0736, found = 220.0720. 
 
Lactone 2-73h was prepared using general experimental procedure. Reagents 
employed: 1-(methoxycarbonyl)-2-(1-tosylindol-3-yl)cyclopropanecarboxylic 
acid 2-55h (82 mg, 0.20 mmol), LiCl (17 mg, 0.40 mmol), Me3N.HCl (27 
mg, 0.28 mmol), and DMF (4 mL). Yielded 2-73h as a yellow oil, 85% (60 
mg, 0.17 mmol). Rf = 0.24, 30% EtOAc/hexanes; 1H-NMR (400 MHz, CDCl3): δ =7.99 
(d, J = 8.2 Hz, 1H), 7.77 (d, J = 8.6 Hz, 2H), 7.59 (s, 1H), 7.52 (d, J = 7.8 Hz, 1H), 7.35 
(dt, J = 8.6, 1.2 Hz, 1H), 7.28-7.20 (m, 3H), 5.75-5.69 (m, 1H), 2.72-2.64 (m, 3H), 2.47-
2.35 (m, 1H), 2.33 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 176.4, 145.3, 135.3, 134.9, 
130.0, 128.0, 126.8, 125.3, 123.4, 123.0, 120.5, 119.8, 113.7, 75.4, 28.5, 28.2, 21.5. IR 
(thin film, cm-1): 3115, 1775, 1447, 1400, 1371, 1174, 1124, 1100, 1036. HRMS calc’d 
for C19H17NO4S = 355.0878, found = 355.0879. 
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Lactone 2-73i was prepared using general experimental procedure. Reagents 
employed: 1-(methoxycarbonyl)-2-(thiophene-2-yl)cyclopropanecarboxylic acid 
2-55i (68 mg, 0.30 mmol), LiCl (25 mg, 0.59 mmol), Me3N.HCl (40 mg, 0.42 
mmol), and DMF (4 mL). Yielded 2-73i as an orange oil, 74% (37 mg, 0.22 
mmol). Rf = 0.24, 30% EtOAc/hexanes; 1H-NMR (400 MHz, CDCl3): δ = 7.34 (dd, J = 
5.1, 1.6 Hz, 1H), 7.09 (d, J = 3.5 Hz, 1H), 7.00 (dd, J = 4.7, 3.5 Hz, 1H), 5.76-5.69 (m, 
1H), 2.74-2.60 (m, 3H), 2.45-2.31 (m, 1H). 13C-NMR (100 MHz, CDCl3): δ = 176.1, 
141.7, 126.9, 126.2, 125.9, 77.3, 30.7, 28.9. IR (thin film, cm-1): 3108, 2923, 2851, 1777, 
1401, 1172, 1135, 1015, 921. HRMS calc’d for C8H8O2S = 168.0245, found = 168.0243. 
 
Lactone 2-73j was prepared using general experimental procedure. Reagents 
employed: (E)-1-(methoxycarbonyl)-2-styrylcyclopropanecarboxylic acid 2-
55j (98 mg, 0.40 mmol), LiCl (34 mg, 0.80 mmol), Me3N.HCl (53 mg, 0.56 
mmol), and DMF (4 mL). Yielded 2-73j as a clear oil, 80% (60 mg, 0.32 
mmol). Rf = 0.28, 30% EtOAc/hexanes; 1H-NMR (600 MHz, CDCl3): δ = 7.39 (d, J = 7.6 
Hz, 2H), 7.34 (t, J = 7.6 Hz, 2H), 7.29 (d, J = 7.0 Hz, 1H), 6.68 (d, J = 15.8 Hz, 1H), 6.20 
(dd, J = 15.8, 7.0 Hz, 1H), 5.13-5.09 (m, 1H), 2.62-2.57 (m, 2H), 2.51-2.44 (m, 1H), 
2.13-2.06 (m, 1H). 13C-NMR (100 MHz, CDCl3): δ = 176.8, 135.6, 132.8, 128.6, 128.3, 
126.7, 126.4, 80.6, 28.8, 28.5. IR (thin film, cm-1): 2924, 1768, 1073, 1032, 974, 758. 
HRMS calc’d for C12H12O2 = 188.0837, found = 188.0837. 
 
Lactone 2-73k was prepared using general experimental procedure. Reagents 
employed: 1-(methoxycarbonyl)-2-vinylcyclopropanecarboxylic acid 2-55k (86 
mg, 0.51 mmol), LiCl (43 mg, 1.01 mmol), Me3N.HCl (68 mg, 0.71 mmol), and 
DMF (4 mL). Yielded 2-73k as a clear oil, 60% (34 mg, 0.30 mmol). Rf = 0.33, 30% 
EtOAc/hexanes; 1H-NMR (400 MHz, CDCl3): δ = 5.87 (ddd, J = 16.8, 10.5 Hz, 5.9 Hz, 
1H), 5.36 (dt, J = 17.2, 1.2 Hz, 1H), 5.25 (dt, J = 10.5, 1.2 Hz, 1H), 4.96-4.90 (m, 1H), 
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2.56-2.50 (m, 2H), 2.41 (dt,  J = 12.5, 6.6 Hz, 1 H), 2.04-1.94 (m, 1H). 13C-NMR (100 
MHz, CDCl3): δ = 176.9, 135.5, 117.4, 80.4, 28.2, 28.2. IR (thin film, cm-1): 2957, 2921, 
2851, 1772, 1734, 1558, 1457. HRMS calc’d for C6H8O2 = 112.0524, found = 112.0520 
 
Synthesis of Cyclopropane Hemimalonate 2-55m for 
Dodecanolide: Vinyl cyclopropane (-)-2-83 (250 mg, 1.36 mmol) 
and 1-octene (0.26 mL, 1.6 mmol) were dissolved in DCM (20 mL) 
and the reaction vessel was purged with argon. Grubbs II (56 mg, 
0.068 mmol) was added as one portion. The purple solution was heated to reflux for 3 
hours. Florisil® was added and the mixture was stirred for another 20 minutes. The 
reaction mixture was filtered, concentrated and flushed through a plug of silica. The 
crude octenyl cyclopropane was taken up in MeOH (5 mL) and treated with 1.7 M NaOH 
(1.6 mL, 2.7 mmol). The reaction was stirred at room temperature for 2.5 hours, and then 
H2O was added. The organic was extracted with EtOAc, and the aqueous layer was 
acidified with 5% HCl. The aqueous was extracted 3 times with EtOAc to obtain the 
product. The organic was dried with MgSO4, filtered and concentrated to obtain 2-55m 
(300 mg, 1.18 mmol) in an 87% yield over the two steps. 1H-NMR (400 MHz, CDCl3): δ 
= 5.82 (dt, J = 15.2, 7.0 Hz, 1H), 5.25 (dd, 15.2, 8.6 Hz, 1H), 3.81 (s, 3H), 2.73 (q, 8.6 
Hz, 1H), 2.20-1.90 (m, 4H), 1.36-1.21 (m, 9H), 0.87 (t, 7.0 Hz, 3H). 13C-NMR (100 
MHz, CDCl3): δ = 174.2, 170.5, 138.3, 123.4, 53.0, 40.3, 33.2, 32.6, 31.6, 29.7, 28.9, 
28.7, 23.8, 22.6. IR (thin film, cm-1):  2925, 2855, 1772, 1734, 1456, 1436, 1338, 1262, 
1162, 967. HRMS calc’d for C14H22O4 = 254.1518, found = 254.1524. (Isolated in 7:1 
cis:trans) 
 
Synthesis of Lactone 2-88 for Dodecanolide: Lactone 2-88 was 
prepared using general experimental procedure. Reagents 
employed: 2-55m (130 mg, 0.510 mmol), LiCl (43 mg, 1.02 
mmol), Me3N.HCl (68 mg, 0.71 mmol), and DMF (4 mL). Yielded 
2-88 as a clear oil, 78% (78 mg, 0.40 mmol). Rf = 0.48, 30% EtOAc/hexanes; 1H-NMR 
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(400 MHz, CDCl3): δ = 5.80 (dt, J = 15.3, 7.0 Hz, 1H), 5.48 (dd, J = 15.3, 7.0 Hz, 1H), 
4.88 (dd, J = 7.6, 7.0 Hz, 1H), 2.55-2.50 (m, 2H), 2.39-2.31 (m, 1H), 2.08-2.03 (m, 2H), 
2.01-1.92 (m, 1H), 1.41-1.34 (m, 2H), 1.32-1.22 (m, 6H), 0.87 (t, J = 7.0 Hz, 3H). 13C-
NMR (100 MHz, CDCl3): δ = 177.0, 135.8, 127.3, 110.0, 81.1, 32.1, 31.6, 28.8, 28.8, 
28.7, 22.6, 14.1. IR (thin film, cm-1): 2926, 2855, 1773, 1734, 1457, 1176, 969. HRMS 
calc’d for C12H20O2 = 196.1463, found = 196.1460. (Isolated in 7:1 cis:trans) 
 
Reduction of Olefin 2-33 for Dodecanolide: Lactone 2-88 (175 
mg, 0.892 mmol) was dissolved in THF:H2O (8mL:8mL). 
Tosylhydrazine (1660 mg, 8.910 mmol) and sodium acetate (951 
mg, 11.6 mmol) were added and the reaction mixture was heated to 
reflux for 24 hours. Water was added to quench the reaction and the aqueous was 
extracted with ether 4 times. The organic was dried with MgSO4, filtered and subjected to 
column chromatography. The product 2-33 (173 mg, 0.867 mmol) was isolated in a 98 % 
yield. Rf = 0.49, 30% EtOAc/hexanes; 1H-NMR (600 MHz, CDCl3): δ = 4.51-4.44 (m, 
1H), 2.56-2.48 (m, 2H), 2.35-2.26 (m, 1H), 1.77-1.70 (m, 1H), 1.62-1.55 (m, 1H), 1.49-
1.41 (m, 1H), 1.40-1.22 (m, 12H), 0.88 (t, 7.0 Hz, 3H). 13C-NMR (150 MHz, CDCl3): δ = 
177.3, 81.0, 35.6, 31.8, 29.4, 29.3, 29.2, 28.9, 28.0, 25.2, 22.6, 14.1. IR (thin film, cm-1): 
2926, 2855, 1776, 1458, 1352, 1179, 1017, 914. HRMS calc’d for C12H22O2 = 199.1698, 
found = 199.1703 (M + H). 94% ee calculated from Mosher’s ester. 19F-NMR (376 MHz, 
CDCl3): δ = -71.29 (s, 97), -71.36 (s, 3).  
General Experimental Procedure for the Cross-Metathesis Synthesis of Substituted 
Vinyl Cyclopropane: Dimethyl 2-vinylcyclopropane-1,1-dicarboxylate (1 equivalent) 
and olefin (1.4 - 5 equivalent) were dissolved in anhydrous dichloromethane.  Grubbs 2nd 
generation catalyst (G2) (0.01 equivalent) was then added and a reflux condenser was 
attached.  The reaction vessel was then purged with argon and the reaction brought to 
reflux. Upon completion by TLC analysis the solvent was removed and the residue was 
purified by flash chromatography (EtOAc/Hexanes) to yield the desired cyclopropanes 
2-79a-k. 
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Cyclopropane 2-79a was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-vinylcyclopropane-
1,1-dicarboxylate 2-83 (147 mg, 0.798 mmol), hex-1-ene (99 mg, 1.18 mmol), G2 (7 mg, 
8.24 x 10-3 mmol), and anhydrous CH2Cl2 (15 mL). Yielded 2-79a as a yellow oil, 67% 
(128 mg, 0.533 mmol). Rf = 0.63, 30% EtOAc in hexanes; 1H NMR (400 MHz, CDCl3) δ 
= 5.71 (dt, J = 15.3, 7.0 Hz, 1H), 5.35 (ddt, J = 15.2, 8.2, 1.2 Hz, 1H), 3.72 (s, 6H), 2.54 
(q, J = 8.2 Hz, 1H), 1.99 (q, J = 7.0 Hz, 2H), 1.68 (dd, J = 7.4, 4.7 Hz, 1H), 1.55 (dd, J = 
9.4, 4.7 Hz, 1H) 1.31 – 1.25 (m, 4H), 0.86 (t, J = 7.4 Hz, 3H); 13C NMR (100 MHz, 
CDCl3) δ = 170.2, 168.0, 135.6, 124.2, 52.6, 35.6, 32.1, 31.2, 27.5, 27.0, 22.0, 20.8, 13.9; 
IR (thin film) 3000, 2955, 2929, 2857, 1730, 1437, 1332, 1280, 1260, 1210, 1131; 
HRMS calc’d for C13H20O4 = 240.1362, found = 240.1368. (6:1 Trans to Cis) 
 
Cyclopropane 2-79b was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-
vinylcyclopropane-1,1-dicarboxylate 2-83 (151 mg, 0.820 mmol), oct-1-ene (133 mg, 
1.185 mmol), G2 (7 mg, 8.24 x 10-3 mmol), and anhydrous CH2Cl2 (15 mL). Yielded 
2-79b as a yellow oil, 74% (162 mg, 0.604 mmol). Rf = 0.63, 30% EtOAc in hexanes; 1H 
NMR (400 MHz, CDCl3) δ = 5.71 (dt, J = 15.2, 7.0 Hz, 1H), 5.03 (ddt, J = 15.2, 8.2, 1.6 
Hz, 1H), 3.72 (s, 6H), 2.54 (q, J = 8.2 Hz, 1H), 1.97 (q, J = 6.6 Hz, 2H), 1.68 (dd, J = 7.4, 
4.7 Hz, 1H), 1.55 (dd, J = 9.0, 4.7 Hz, 1H), 1.32 – 1.20 (m, 8H), 0.86 (t, J = 6.6 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ = 170.2, 168.0, 135.7, 124.2, 52.6, 52.4, 35.6, 32.5, 31.7, 
31.2, 29.1, 28.7, 22.6, 20.8, 14.1; IR (thin film) 3000, 2955, 2927, 2855, 1729, 1437, 
1330, 1280, 1210, 1131, 965; HRMS calc’d for C15H24O4 = 268.1675, found = 268.1682. 
(6:1 Trans to Cis) 
 
Cyclopropane 2-79c was prepared using general experimental 
procedure. Reagents employed:  dimethyl 2-vinylcyclopropane-
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1,1-dicarboxylate 2-83 (150 mg, 0.814 mmol), dec-1-ene (274 mg, 1.628 mmol), G2 (7 
mg, 8.24 x 10-3 mmol), and anhydrous CH2Cl2 (15 mL). Yielded 2-79c as a brown oil, 
69% (182 mg, 0.561 mmol). Rf = 0.61, 30% EtOAc in hexanes; 1H NMR (600 MHz, 
CDCl3) δ = 5.71 (dt, J = 15.3, 7.0 Hz, 1H), 5.05 (ddt, J = 15.3, 8.2, 1.2 Hz, 1H), 3.73 (s, 
6H), 2.53 (q, J = 8.2 Hz, 1H), 1.98 (q, J = 7.0 Hz, 2H), 1.69 (dd, J = 7.6, 5.3 Hz, 1H), 
1.55 (dd, J = 8.8, 4.7 Hz, 1H), 1.33 – 1.21 (m, 16H), 0.87 (t, J = 7.0 Hz, 3H); 13C NMR 
(100 MHz, CDCl3) δ = 170.2, 168.0, 135.7, 124.2, 52.6, 52.5, 35.6, 32.5, 31.9, 31.2, 
29.62, 29.60, 29.5, 29.3, 29.2, 29.0, 22.7, 20.8, 14.1; IR (thin film) 3004, 2953, 2925, 
2854, 1731, 1437, 1330, 1280, 1210, 1131, 965; HRMS calc’d for C19H32O4 = 324.2301, 
found = 324.2308. (3:1 Trans to Cis)  
 
Cyclopropane 2-79d was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-vinylcyclopropane-1,1-
dicarboxylate 2-83 (151 mg, 0.820 mmol), 4-bromobut-1-ene (275 mg, 2.037 mmol), G2 
(7 mg, 8.24 x 10-3 mmol), and anhydrous CH2Cl2 (15 mL). Yielded 2-79d as a brown oil, 
78% (185 mg, 0.635 mmol). Rf = 0.58, 30% EtOAc in hexanes; 1H NMR (600 MHz, 
CDCl3) δ = 5.71 (dt, J = 15.3, 7.0 Hz, 1H), 5.19 (ddt, J = 15.3, 8.2, 1.2 Hz, 1H), 3.74 (s, 
3H), 3.73 (s, 3H), 3.34 (dt, J = 7.0, 1.2 Hz, 2H), 2.56 (dq, J = 7.0, 1.2 Hz, 3H), 1.70 (dd, 
J = 7.6, 4.7 Hz, 1H), 1.58 (dd, J = 8.8, 4.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 
170.0, 167.8, 131.3, 127.9, 52.7, 52.65, 35.7, 35.6, 32.0, 30.7, 20.8; IR (thin film) 3004, 
2953, 2848, 1728, 1437, 1331, 1271, 1211, 1131; HRMS calc’d for C11H15BrO4 = 
290.0154, found = 290.0155. (4:1 Trans to Cis) 
 
Cyclopropane 2-79e was prepared using general 
experimental procedure. Reagents employed: dimethyl 2-
vinylcyclopropane-1,1-dicarboxylate 2-83 (107 mg, 0.581 mmol), tert-butyl(hex-5-
enyloxy)dimethylsilane (175 mg, 0.816 mmol), G2 (12 mg, 1.41 x 10-2 mmol), and 
anhydrous CH2Cl2 (11 mL). Yielded 2-79e as a brown oil, 73% (156 mg, 0.421 mmol). 
Rf = 0.71, 30% EtOAc in hexanes; 1H NMR (600 MHz, CDCl3) δ = 5.71 (dt, J = 15.3, 7.0 
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Hz, 1H), 5.06 (ddt, J = 15.3, 8.2, 1.2 Hz, 1H), 3.73 (s, 3H), 3.72 (s, 3H), 3.58 (t, J = 6.5 
Hz, 2H), 2.53 (q, J = 8.2 Hz, 1H), 2.01 (q, J = 6.5 Hz, 2H), 1.68 (dd, J = 7.6, 4.7 Hz, 1H), 
1.55 (dd, J = 8.8, 4.7 Hz, 1H), 1.51 – 1.44 (m, 2H), 1.40 – 1.33 (m, 2H), 0.88 (s, 9H), 
0.03 (s, 6H); 13C NMR (150 MHz, CDCl3) δ = 170.1, 167.8, 135.3, 124.4, 62.9, 52.5, 
52.4, 35.5, 32.2, 32.1, 32.06, 31.0, 26.8, 25.9, 25.6, 25.3, 21.8, 20.7, -5.4; IR (thin film) 
3565, 2997, 2952, 2930, 2857, 1731, 1437, 1330, 1280, 1256, 1210, 1130, 1103, 967, 
836, 776; HRMS calc’d for C19H34O5Si1 = 370.2176, found = 370.2155. (3:1 Trans to 
Cis) 
 
Cyclopropane 2-79f was prepared using general experimental 
procedure. Reagents employed:  dimethyl 2-vinylcyclopropane-1,1-
dicarboxylate 2-83 (350 mg, 1.900 mmol), styrene (591m g, 5.675 
mmol), G2 (40 mg, 4.71 x 10-2 mmol), and anhydrous CH2Cl2 (22 mL). Yielded 2-79f as 
a yellow oil, 75% (373 mg, 1.433 mmol). Rf = 0.56, 30% EtOAc in hexanes; 1H NMR 
(400 MHz, CDCl3) δ = 7.32 – 7.28 (m, 4H), 7.26 – 7.20 (m, 1H), 6.65 (d, J = 16.0 Hz, 
1H), 5.81 (dd, J = 16.0, 9.0 Hz, 1H), 3.77 (s, 3H), 3.73 (s, 3H), 2.76 (q, J = 8.2 Hz, 1H), 
1.85 (dd, J = 7.8, 5.1 Hz, 1H), 1.70 (dd, J = 9.0, 5.1 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ = 169.9, 167.9, 136.7, 133.9, 128.6, 127.6, 126.1, 124.5, 52.8, 52.7, 36.0, 31.7, 
21.3; IR (thin film) 3027, 2953, 2847, 1731, 1494, 1437, 1283, 1252, 1207, 1128, 964, 
770, 744, 694; HRMS calc’d for C15H16O4 = 260.1049, found = 260.1049. (only E olefin 
observed by 1H NMR) 
 
Cyclopropane 2-79g was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-vinylcyclopropane-
1,1-dicarboxylate 2-83 (147 mg, 0.798 mmol), 1-methoxy-4-
vinylbenzene (197 mg, 1.468 mmol), G2 (7 mg, 8.24 x 10-3 mmol), and anhydrous 
CH2Cl2 (15 mL). Yielded 2-79g as a yellow oil, 29% (67 mg, 0.231 mmol). Rf = 0.50, 
30% EtOAc in hexanes; (column purified in CH2Cl2): 1H NMR (400 MHz, CDCl3) δ = 
7.23 (d, J = 8.6 Hz, 2H), 6.82 (d, J = 9.0 Hz, 2H), 6.58 (d, J = 15.6 Hz, 1H), 5.67 (dd, J = 
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15.6, 8.6 Hz, 1H), 3.79 (s, 3H), 3.75 (s, 3H), 3.72 (s, 3H), 2.73 (q, J = 8.6 Hz, 1H), 1.84 
(dd, J = 7.4, 4.7 Hz, 1H), 1.68 (dd, J = 9.0, 4.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
= 170.0, 168.0, 159.2, 133.3, 129.5, 127.3, 122.1, 114.0, 55.3, 52.7, 52.6, 36.0, 31.9, 
21.3; IR (thin film) 3003, 2953, 2838, 1728, 1608, 1512, 1437, 1286, 1255, 1208, 1176, 
1130, 1033, 964, 821; HRMS calc’d for C16H18O5 = 290.1154, found = 290.1148. (only E 
olefin observed by 1H NMR)   
 
Cyclopropane 2-79h was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-vinylcyclopropane-
1,1-dicarboxylate 2-83 (119 mg, 0.646 mmol), 1-nitro-4-
vinylbenzene (135 mg, 0.905 mmol), G2 (6 mg, 7.07 x 10-3 mmol), and anhydrous 
CH2Cl2 (12 mL). Yielded 2-79h as a brown oil, 60% (119 mg, 0.390 mmol). Rf = 0.40, 
30% EtOAc in hexanes; 1H NMR (400 MHz, CDCl3) δ = 7.85 (d, J = 9.0 Hz, 2H), 7.42 
(d, J = 8.6 Hz, 2H), 6.71 (d, J = 15.6 Hz, 1H), 6.00 (dd, J = 15.6, 9.0 Hz, 1H), 3.77 (s, 
3H), 3.75 (s, 3H), 2.77 (q, J = 8.6 Hz, 1H), 1.87 (dd, J = 7.8, 5.1 Hz, 1H), 1.75 (dd, J = 
9.0, 5.1 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ = 169.5, 167.8, 146.9, 142.9, 131.7, 
130.0, 126.6, 124.0, 52.9, 52.8, 36.2, 31.3, 21.5; IR (thin film) 3105, 3027, 2959, 2926, 
2844, 1729, 1593, 1511, 1436, 1342, 1288, 1253, 1205, 1133; HRMS calc’d for 
C15H15NO6 = 305.0899, found = 305.0900. (only E olefin observed by 1H NMR) 
 
Cyclopropane 2-79i was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-vinylcyclopropane-1,1-
dicarboxylate 2-83 (100 mg, 0.543 mmol), acrolein (151 mg, 2.694 mmol), G2 (4 mg, 
4.71 x 10-3 mmol), and anhydrous CH2Cl2 (10 mL). Yielded 2-79i as a yellow oil, 33% 
(38 mg, 0.179 mmol). Rf = 0.23, 30% EtOAc in hexanes; 1H NMR (600 MHz, CDCl3) δ 
= 9.43 (d, J = 6.5 Hz, 1H), 6.38 – 6.29 (m, 2H), 3.76 (s, 3H), 3.75 (s, 3H), 2.76 (q, J = 8.2 
Hz, 1H), 1.86 (dd, J = 7.4, 5.3 Hz, 1H), 1.81 (dd, J = 8.8, 4.7 Hz, 1H); 13C NMR (150 
MHz, CDCl3) δ = 192.7, 168.8, 167.2, 152.1, 134.9, 53.1, 53.0, 29.9, 21.9, 20.8; IR (thin 
CO2MeMeO2C
NO2
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film) 3011, 2957, 2850, 1735, 1688, 1439, 1288, 1217, 1135, 979; HRMS calc’d for 
C10H12O5 = 212.0685, found = 212.0681. (only E olefin observed by 1H NMR) 
 
Cyclopropane 2-79i was prepared using general experimental 
procedure. Reagents employed:  dimethyl 2-vinylcyclopropane-1,1-
dicarboxylate 2-83 (100 mg, 0.543 mmol), (E)-but-2-enal (186 mg, 2.655 mmol), G2 (5 
mg, 5.89 x 10-3 mmol), and anhydrous CH2Cl2 (10 mL). Yielded 2-79i as a yellow oil, 
69% (80 mg, 0.377 mmol): data matched that previously reported above. 
 
Cyclopropane 2-79j was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-vinylcyclopropane-1,1-
dicarboxylate 2-83 (100 mg, 0.543 mmol), but-3-en-2-one (193 mg, 2.754 mmol), G2 (4 
mg, 4.71 x 10-3 mmol), and anhydrous CH2Cl2 (10 mL). Yielded 2-79j as a brown oil, 
82% (101 mg, 0.446 mmol). Rf = 0.19, 30% EtOAc in hexanes; 1H NMR (600 MHz, 
CDCl3) δ =6.30 – 6.23 (m, 2H), 3.71 (s, 6H), 2.65 – 2.56 (m, 1H), 2.15 (s, 3H), 1.78 (dd J 
= 7.6, 5.3 Hz, 1H), 1.72 (dd, J = 8.8, 4.7 Hz, 1H); 13C NMR (150 MHz, CDCl3) δ 
=197.0, 169.0, 167.2, 142.1, 133.3, 52.9, 52.8, 36.5, 29.8, 27.0, 21.5; IR (thin film) 3007, 
2956, 2856, 1731, 1674, 1625, 1438, 1333, 1291, 1253, 1212, 1131, 983; HRMS calc’d 
for C11H14O5 = 226.0841, found = 226.0831. (only E olefin observed by 1H NMR) 
 
Cyclopropane 2-79k was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-vinylcyclopropane-1,1-
dicarboxylate 2-83 (100 mg, 0.543 mmol), methyl acrylate (116 mg, 1.347 mmol), G2 (4 
mg, 4.71 x 10-3 mmol), and anhydrous CH2Cl2 (10 mL). Yielded 2-79k as a brown oil, 
92% (121 mg, 0.500 mmol). Rf = 0.35, 30% EtOAc in hexanes; 1H NMR (600 MHz, 
CDCl3) δ = 6.42 (dd, J = 15.8, 10.0 Hz, 1H), 6.02 (d, J = 15.8 Hz, 1H), 3.72 (m, 6H), 
3.67 (s, 3H), 2.63 (q, J = 7.6 Hz, 1H), 1.77 (dd, J = 7.0, 4.7 Hz, 1H), 1.68 (dd, J = 8.8, 5.3 
CO2MeMeO2C
OMe
O
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Hz, 1H); 13C NMR (150 MHz, CDCl3) δ = 169.1, 167.1, 165.9, 143.3, 123.8, 52.9, 52.8, 
51.5, 36.4, 29.6, 21.4; IR (thin film) 3097, 3005, 2955, 3849, 1718, 1653, 1437, 1382, 
1336, 1255, 1204, 1129; HRMS calc’d for C11H14O6 = 242.0790, found = 242.0792. (8:1 
Trans to Cis) 
 
General Experimental Procedure for Olefin Reduction to Cyclopropane 2-79a,f: 
Vinyl Cyclopropane (2-79a,f) (1 equivalent) was dissolved in (1:1) THF:H2O. 
Tosylhydrazine (10 equivalent) and sodium acetate (13 equivalent) were added and the 
reaction mixture was heated to reflux for 24 hours. Water was added to the reaction and 
the aqueous was extracted with ether 4 times. The organic phase were combined and 
dried with MgSO4, filtered, and the solvent was removed. The residue was purified by 
flash chromatography (EtOAc/Hexanes) to yield the desired cyclopropane (2-85a,b). 
 
Cyclopropane 2-85a was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-(hex-1-
enyl)cyclopropane-1,1-dicarboxylate 2-79a (400 mg, 1.665 mmol), tosylhydrazine (3.100 
g, 16.646 mmol), sodium acetate (1.780 g, 21.699 mmol), and THF:H2O (16:16 mL). 
Yielded 2-85a as a yellow oil, 90% (364 mg, 1.499 mmol). Rf = 0.63, 30% EtOAc in 
hexanes; 1H NMR (600 MHz, CDCl3) δ = 3.71 (s, 3H), 3.67 (s, 3H), 1.89 – 1.82 (m, 1H),  
1.45 – 1.30 (m, 5H), 1.29 – 1.16 (m, 6H), 1.15 – 1.08 (m, 1H), 0.83 (t, J = 7.0 Hz, 3H); 
13C NMR (150 MHz, CDCl3) δ =170.9, 168.7, 52.5, 52.3, 33.9, 31.6, 28.9, 28.8, 28.7, 
28.6, 22.5, 21.3, 14.0; IR (thin film) 3007, 2955, 2927, 2858, 1731, 1437, 1331, 1286, 
1212, 1132; HRMS calc’d for C13H22O4 = 243.1591, found = 243.1603 (M+1). 
 
Cyclopropane 2-85b was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-styrylcyclopropane-1,1-
dicarboxylate 2-79f (150 mg, 0.576 mmol), tosylhydrazine (1.070 g, 
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5.746 mmol), sodium acetate (0.615 g, 7.497 mmol), and THF:H2O (6:6 mL). Yielded 2-
85b as an orange oil, 82% (124 mg, 0.472 mmol). Rf = 0.56, 30% EtOAc in hexanes; 1H 
NMR (400 MHz, CDCl3) δ = 7.31 – 7.25 (m, 2H), 7.21 – 7.14 (m, 3H), 3.76 (s, 3H), 3.72 
(s, 3H), 2.79 – 2.66 (m, 2H), 1.99 – 1.90 (m, 1H), 1.81 – 1.71 (m, 1H), 1.58 – 1.47 (m, 
1H), 1.44 – 1.36 (m, 2H); 13C NMR (100 MHz, CDCl3) δ = 170.8, 168.6, 141.3, 128.4, 
126.0, 110.0, 52.6, 52.5, 35.1, 33.3, 30.8, 28.2, 21.2; IR (thin film) 3085, 3027, 2952, 
2862, 1719, 1652, 1436, 1330, 1289, 1212, 1133, 750, 700; HRMS calc’d for C15H18O4 = 
262.1205, found = 262.1198. 
General Experimental Procedure for the Synthesis of Tetrahydro-1,2-oxazines 
2-87a-d: Yb(OTf)3•xH2O (5 - 20 mol %) was added to a solution of cyclopropane (2-
79a,f and 2-85a-b) (1 equivalent) and nitrone 2-86 (1.2 equivalent) in methylene chloride 
at room temperature for 18 hours. The reaction mixture was wet loaded and purified by 
flash chromatography (EtOAc/Hexanes) to yield the desired tetrahydro-1,2-oxazine 
(2-87a-c). 
  
Cyclopropane 2-87a was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-(hex-1-
enyl)cyclopropane-1,1-dicarboxylate 2-79a (100 mg, 0.416 mmol), nitrone 2-86 (106 mg, 
0.502 mmol), Yb(OTf)3•xH2O (13 mg, 2.10 x 10-2 mmol), and methylene chloride (3.5 
mL). Yielded 2-87a as a yellow oil, 96% (181 mg, 0.401 mmol). Rf = 0.63, 30% EtOAc 
in hexanes; 1H NMR (600 MHz, CDCl3) δ = 7.56 – 7.49 (m, 2H), 7.21 – 7.14 (m, 3H), 
6.98 – 6.91 (m, 4H), 5.97 – 5.88 (m, 1H), 5.76 – 5.64 (m, 1H), 5.62 (s, 1H), 4.47 – 4.40 
(m, 1H), 3.88 (s, 3H), 3.45 (s, 3H), 2.61 – 2.44 (m, 2H), 2.11 – 2.05 (m, 5H), 1.49 – 1.33 
(m, 4H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ = 170.1, 168.4, 146.3, 
135.2, 135.0, 130.8, 130.5, 129.0, 127.9, 127.8, 127.7, 116.0, 77.2, 65.9, 59.2, 53.3, 52.5, 
32.2,  30.8, 22.3, 22.2, 20.5, 13.9; IR (thin film) 3028, 2954, 2927, 2859, 1742, 1509, 
1453, 1434, 1235, 1177, 1149, 1082, 967, 821, 755, 702; HRMS calc’d for C27H33NO5 = 
451.2359, found = 451.2354. (6:1 Trans to Cis) 
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 Cyclopropane 2-87b was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-styrylcyclopropane-1,1-
dicarboxylate 2-79f (100 mg, 0.384 mmol), nitrone 2-83 (97 mg, 
0.46 mmol), Yb(OTf)3•xH2O (12 mg, 1.93 x 10-2 mmol), and methylene chloride (3 mL). 
Yielded 2-87b as a white foam 92% (166 mg, 0.352 mmol). Rf = 0.56, 30% EtOAc in 
hexanes; Data matched that previously reported.47 
 
Cyclopropane 2-87c was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-hexylcyclopropane-
1,1-dicarboxylate 2-85a (100 mg, 0.413 mmol), nitrone 2-86 (106 mg, 0.502 mmol), 
Yb(OTf)3•xH2O (51 mg, 8.2 x 10-2 mmol), and DCE (4 mL). Yielded 2-87c as a brown 
oil, 44% (83 mg, 0.183 mmol). Rf = 0.63, 30% EtOAc in hexanes; 1H NMR (600 MHz, 
CDCl3) δ = 7.54 – 7.50 (m, 2H), 7.20 – 7.14 (m, 3H), 6.96 – 6.90 (m, 4H), 5.64 (s, 1H), 
3.99 – 3.90 (m, 1H), 3.86 (s, 3H), 3.45 (s, 3H), 2.47 – 2.36 (m, 2H), 2.17 (s, 3H), 1.87 – 
1.77 (m, 1H), 1.70 – 1.59 (m, 2H), 1.55 – 1.45 (m, 1H), 1.43 – 1.36 (m, 2H), 1.35 – 1.29 
(m, 4H), 0.91 (t, J = 7.0 Hz, 3H); 13C NMR (150 MHz, CDCl3) δ = 170.3, 168.5, 146.4, 
135.3, 130.52, 130.50, 129.0, 127.9, 127.8, 115.6, 77.04, 65.6, 59.2, 53.3, 52.5, 34.7, 
31.8, 31.0, 29.3, 25.5, 22.6, 20.5, 14.1; IR (thin film) 3028, 2952, 2927, 2858, 1743, 
1510, 1452, 1435, 1234, 1174, 1081, 820, 702; HRMS calc’d for C27H35NO5 = 453.2515, 
found = 453.2512. 
General Experimental Procedure for Olefin Reduction to Tetrahydro-1,2-oxazines 
2-87c-d: Vinyl tetrahydro-1,2-oxazines (2-87a-b) (1 equivalent) were dissolved in (1:1) 
THF:H2O. Tosylhydrazine (10 equivalent) and sodium acetate (13 equivalent) were 
added and the reaction mixture was heated to reflux for 24 hours. Water was added to the 
reaction and the aqueous was extracted with ether 4 times. The organic phases were 
combined and dried with MgSO4, filtered, and the solvent was removed. The residue was 
purified by flash chromatography (EtOAc/Hexanes) to yield the desired tetrahydro-1,2-
oxazines (2-87c-d). 
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Cyclopropane 2-87c was prepared using general experimental 
procedure. Reagents employed: dimethyl 6-(hex-1-enyl)-2-
phenyl-3-p-tolylmorpholine-4,4-dicarboxylate 2-87a (70 mg, 0.155 mmol), 
tosylhydrazine (289 mg, 1.552 mmol), sodium acetate (165 mg, 2.011 mmol), and 
THF:H2O (2:2 mL). Yielded 2-87c as an yellow oil, 91% (64 mg, 0.141 mmol). Rf = 
0.63, 30% EtOAc in hexanes; data matched that previously reported above. 
 
Cyclopropane 2-87d was prepared using general experimental 
procedure. Reagents employed: dimethyl 2-phenyl-6-styryl-3-p-
tolylmorpholine-4,4-dicarboxylate 2-87b (70 mg, 0.148 mmol), 
tosylhydrazine (277 mg, 1.487 mmol), sodium acetate (158 mg, 1.926 mmol), and 
THF:H2O (1.5:1.5 mL). Yielded 2-87d as a yellow foam, 98% (69 mg, 0.146 mmol). Rf = 
0.56, 30% EtOAc in hexanes; 1H NMR (600 MHz, CDCl3) δ = 7.56 – 7.52 (m, 2H), 7.34 
– 7.30 (m, 2H), 7.29 – 7.26 (m, 2H), 7.24 – 7.17 (m, 4H), 7.00 – 6.94 (m, 4H), 5.67 (s, 
1H), 4.07 – 3.98 (m, 1H) 3.85 (s, 3H), 3.46 (s, 3H), 3.04 – 2.96 (m, 1H), 2.91 – 2.83 (m, 
1H), 2.52 – 2.46 (m, 2H), 2.23 – 2.13 (m, 4H), 2.06 – 1.97 (m, 1H); 13C NMR (150 MHz, 
CDCl3) δ = 170.2, 168.5, 146.4, 141.6, 135.2, 130.7, 130.5, 129.1, 128.4, 128.0, 127.9, 
126.0, 115.7, 76.5, 66.0, 59.2, 53.3, 52.5, 36.4, 31.9, 31.0, 20.6 (one carbon missing 
presumably due to overlap in the aromatic region); IR (thin film) 3027, 2951, 2924, 2857, 
1741, 1509, 1453, 1434, 1236, 1166, 1090, 820, 753, 701; HRMS calc’d for C29H31NO5 
= 473.2202, found = 473.2191. 
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Chapter 3 : Progress Toward Aspidospermidine and the 
Formal Synthesis of Quebrachamine 
3 Introduction and Overview  
Our group has had long standing interest in the Aspidosperma family of indole alkaloids. 
Due to the presence of the piperidine/pyrrolidine core of these alkaloids, we have recently 
begun synthetic efforts toward the synthesis of the parent compounds: aspidospermidine 
and quebrachamine. This chapter will focus on the ongoing progress toward indole 
alkaloid aspidospermidine via an intramolecular [3+2] annulation between an imine and 
cyclopropane. Additionally, a discussion on the formal synthesis of quebrachamine will 
be displayed. The latter will also include the current efforts toward completing the total 
synthesis of quebrachamine through a new 9-membered ring closing method.   
3.1 Aspidosperma Alkaloids 
With over 250 different compounds isolated from a variety of different biological 
sources, the aspidosperma alkaloids represent one of the largest classes of indole 
alkaloids (Figure 3-1).1 Among the vast array of these compounds, the parent compound 
aspidospermidine and its structural analogue quebrachamine have been the focused 
synthetic target for many different research groups. The lack of functionality, partnered 
with the quaternary center presented by these molecules, makes them ideal candidates for 
the development of new synthetic methods. Isolated over a century ago from the bark of 
the Aspidosperma quebracho-blanco tree, these alkaloids, along with several other 
structurally similar alkaloids, exhibit a large array of biological activity.2 While the 
parent compound aspidospermidine, is not pharmacologically active, quebrachamine, the 
less structurally complex compound, does display biological activity. In 1994, studies by 
Madsen showed the potent α-adrenergic blocking activity of quebrachamine in urogenital 
tissue.3 The study found that the alkaloid reduced muscle contractions in human prostatic 
tissues, rabbit corpus spongiosum, and guinea pig vas deferens making quebrachamine a 
possible drug candidate for the treatment of erectile dysfunction and benign prostatic 
hyperplasia. Although much of the biological research into the aspidosperma family of 
alkaloids has been focused on quebrachamine, recent reports have shown the potential for 
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aspidospermine and N-formyl-aspidospermidine to treat malaria, due to the synergic 
antiplasmodial activity displayed by these compounds.4   
 
Figure 3-1: Select Aspidosperma Alkaloids 
3.2 Total Synthesis of Aspidospermidine 
Since isolation, aspidospermidine has been synthesized by over 40 different research 
groups utilizing a plethora of different methods.5 To date, one of the most useful and 
unique methods stems from the seminal work in this area by Harley-Mason. In 1967, 
Harley-Mason reported the first racemic total synthesis of aspidospermidine starting from 
substituted aldehyde 3-1 (Scheme 3-1).6 Aldehyde 3-1 was efficiently converted into 
acetal 3-3 through a three step protection, ozonolysis, and reduction sequence. In acetic 
acid the acetal (3-3) was deprotected in situ followed by a Pictet-Spengler reaction with 
tryptamine to furnish indoloquinolizidine intermediate 3-4. This unique intermediate (3-
4) contained not only the desired quaternary center of the target molecule, but also 
contained all the necessary carbons required to build the natural product. 
Indoloquinolizidine 3-4 then underwent a skeletal rearrangement in the presence of 
BF3•OEt2 to give penultimate intermediate 3-5. Final reduction of both the imine and the 
lactam with LiAlH4 gave the desired product, (±)-aspidospermidine 3-6. Among the 
varying approaches to aspidospermidine, the indoloquinolizidine rearrangement approach 
developed by Harley-Mason and co-workers has been a fundamental late stage method 
utilized by several researchers in the synthesis of this natural product.     
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Scheme 3-1: First Total Synthesis of Aspidospermidine 
3.2.1 First Asymmetric Synthesis of Aspidospermidine 
It wasn’t until many years after the seminal work by Harley-Mason, that the first 
asymmetric synthesis of (-)-aspidospermidine 3-6 was completed (Scheme 3-2).7 Readily 
available optically enriched lactone 3-78 was converted to hemiacetal 3-8 via a McMurry 
modification of the Nef reaction.9 The hemiacetal 3-8 was then reduced followed by 
subsequent acid catalyzed cyclization to give lactone 3-9 in good overall yield (75% over 
three steps) with the desired stereocenter set for the natural product. Transformation of 
3-9 to acetal 3-10 was achieved through a three step procedure involving a Jones 
oxidation of the primary alcohol, DIBAL-H reduction of the lactone, followed by 
treatment with acidic methanol to secure the acetal product. Acetal 3-10 was then 
subjected to a Pictet-Spengler reaction followed by lactamization to give tetracyclic 
intermediate (S)-3-4. In a similar manner to Harley-Mason’s work, this intermediate was 
rearranged and reduced in an overall 81% yield to give optically enriched (-)-
aspidospermidine 3-6. Since this report by Fuji, many other researchers have exploited 
the use of enantioenriched starting materials, catalysts, and auxiliaries to synthesize 
effectively both (+) and (-)-3-6.10 
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Scheme 3-2: First Asymmetric Synthesis of Aspidospermidine 
3.2.2 Recent Syntheses of Aspidospermidine 
In 2013, Shao and co-workers reported a novel enantioselective palladium-catalyzed 
decarboxylative allylation approach to (-)-aspidospermidine.11 While there have been 
many recent advances in the area of asymmetric decarboxylative allylation reactions,12 
the use of carbazolones (not previously studied) would allow access to optically active 
allyl carbazolones featuring the α-quaternary carbon center common to many of the 
aspidosperma alkaloids. The authors explored this concept by showing that allyl ester 
3-11 could undergo a palladium-catalyzed decarboxylative allylation in the presence of 
chiral ligand 3-16 to give 3-12 in an excellent yield and very high enantioselectivity 
(Scheme 3-3). With the quaternary center installed, the remainder of the synthesis 
focused on the formation of the last two ring systems. Mild hydrolysis of nitrile 3-12 
followed by a tandem chemoselective reduction of the ketone and a cyclization furnished 
the 6-membered nitrogen containing ring (3-13) of the natural product. Next, the allyl 
group was converted into the desired ethyl group by first creating cyclic dithiane 3-14 
and then subjecting 3-14 to a Raney nickel reduction. Lactam reduction and benzyl group 
deprotection gave tetracyclic intermediate 3-15. Finally, the synthesis was completed 
following a three step procedure developed by Heathcock for the installation of the 
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remaining pyrrolidine ring system.5m The success of this method was also displayed in 
the synthesis of a related alkaloid (+)-kopsihainanine A.    
 
Scheme 3-3: Shao's Approach to (-)-Aspidospermidine 
Most recently, the Zhu group developed a unified approach to a series of indole alkaloids 
including aspidospermidine via a unique palladium-catalyzed decarboxylative vinylation 
followed by an integrated oxidation/reduction/cyclization (iORC) sequence.13  Coupling 
between potassium butanoate 3-17 and vinyl triflate 3-18 followed by work up with 
TBAF afforded primary alcohol 3-19 (Scheme 3-4). Two consecutive Mitsunobu 
reactions under Walker’s conditions14 gave access to macrocycle 3-20 setting up for 
iORC sequence. Oxidative cleavage of the cyclopentene ring gave dialdehyde 3-21, 
followed by deprotection of the secondary amine to give intermediate 3-22. Nitro 
reduction and cyclization then led to the pentacyclic core (3-25) of the target molecule. 
Final imine reduction gave aspidospermidine 3-6 in a 50% yield over the 4 sequential 
transformations. In the same paper, the overall utility of this iORC method displayed 
access to several other indole alkaloids including goniomitine and vincadifformine. 
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Scheme 3-4: iORC Approach to Aspidospermidine 
3.3 Total Synthesis of Quebrachamine 
Unlike aspidospermidine, quebrachamine has attracted significantly less synthetic efforts 
than aspidospermidine, presumably due to the difficulty in creating the medium sized 9-
membered ring.15 Although this alkaloid has seen less synthetic efforts, the first total 
synthesis of ()-quebrachamine was reported 4 years prior to the synthesis of 
aspidospermidine. In 1963, Stork and Dolfini developed a ring-expansion route (a now 
common approach to the 9-membered ring) toward the synthesis of quebrachamine.16 The 
synthesis began with pyrroloenamine (of 3-26) alkylation to give to enone 3-27 (Scheme 
3-5). Bicycle 3-28, furnished through a 4 step sequence from 3-27, was acylated with 2-
chloroacetyl chloride giving 3-29. Base mediated ring-closure followed by selective 
lactam reduction provided tricyclic ketone 3-31. Fischer indolization with 
phenylhydrazine led to pentacyclic 3-25, which then underwent ring-expansion with 
KBH4 to give ()-quebrachamine 3-32.    
 130 
 
 
Scheme 3-5: First Total Synthesis of Quebrachamine 
3.3.1 Asymmetric Syntheses of Quebrachamine 
Over 15 years after the first total synthesis of ()-quebrachamine, Takano and co-workers 
displayed the first asymmetric total synthesis of (+)-quebrachamine.17 Exploiting the 
chiral pool, L-glutamic acid was converted into lactone 3-34 (Scheme 3-6).18 Following 
trityl protection of the primary alcohol, two substrate controlled selective alkylations 
gave quaternary lactone 3-36. Trityl deprotection, base hydrolysis of the lactone, and 
periodate cleavage led to the formation of 3-37 as an inconsequential 1:1 mixture of 
diastereomers. Pictet-Spengler reaction of 3-37 with tryptamine followed by 
hydroboration/oxidation of the allyl group and lactam reduction furnished tetracyclic 
intermediate 3-39 in an overall 34% yield. The tetracyclic intermediate 3-39 was then 
converted into (+)-3-32 via alcohol mesylation and N-alkylation to give the resulting 
iminium ion which then underwent a dissolving metal reductive ring expansion in 65% 
yield over the three steps. One year later, Takano was able to complete the synthesis of 
(-)-3-32, utilizing a similar approach from another optically enriched starting material.19     
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Scheme 3-6: First Asymmetric Synthesis of Quebrachamine 
With advances in both cross metathesis and ring-closing metathesis being developed at an 
increasing rate, Schrock and Hoveyda displayed an elegant enantioselective synthesis of 
(-)-quebrachamine via a stereoselective olefin metathesis.20 Weinreb amide 3-42, secured 
in a 6 step process from keto-lactone 3-40, was subjected to a Pictet-Spengler reaction 
with tryptamine followed by LAH reduction to give tetracyclic indole 3-43 in a modest 
overall yield (Scheme 3-7). Indole 3-43 was then subjected to an N-acylation/reductive 
ring-expansion, installing the 9-membered ring core (3-44) of the natural product. Next, a 
palladium-catalyzed decarboxylative allylation reaction occurred, giving ring-closing 
precursor 3-45 in an excellent yield. With the olefin systems in place, the synthesis of the 
piperidine ring of this natural product became the focus. After scanning several different 
chiral molybdenum catalysts, it was shown that 3-47 could effectively catalyze the 
enantioselective ring-closing metathesis, providing 3-46 in great yield and excellent 
enantioselectivity. Global reduction of the remaining olefins in 3-46 gave (+)-3-32 in a 
high yield. Certainly, the unique ring-closing metathesis shown in this synthesis will have 
a profound effect on current research directed toward asymmetric synthesis of piperidine-
containing target molecules.    
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Scheme 3-7: Enantioselective Ring-Closing Metathesis in the Synthesis of (+)-3-32 
3.3.2 Recent Total Syntheses of Quebrachamine 
In 2009, Pagenkopf and Bajtos showcased their cyclopropane/nitrile [3+2] annulation 
reaction in the synthesis of (±)-quebrachamine.21 Additionally, this synthesis focused on 
a unique 9-membered ring-closing reaction, in contrast to the many ring-expansion 
methods. The synthesis began with the TMSOTf mediated annulation reaction between 
nitrile 3-48 and donor-acceptor cyclopropane 3-49 to give the corresponding pyrrole 
which then underwent an oxidation with catalytic palladium on carbon to afford indole 3-
50 (Scheme 3-8). Microwave-assisted decarboxylation followed by benzyl deprotection 
and lactam reduction secured the formation of piperidine 3-52. Early attempts to close the 
large ring system with N-alkylation, acylation, and Friedel–Crafts methods were met with 
no success. Interestingly, a chloroacetamide Witkop photocyclization22 of acylated 
piperidine 3-53 proceeded in an excellent yield to give the desired 9-membered ring 
product. Lactam reduction gave quebrachamine 3-32 in an overall 17.8% yield in 13 
steps from commercially available starting materials.    
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Scheme 3-8: 9-Membered Ring-Closing Approach to Quebrachamine 
One of the most recent syntheses of quebrachamine reported in 2013 by the Prasad group 
utilized a common quaternary center intermediate in the unified approach to several 
aspidosperma natural products.23 This approach is becoming increasingly popular due to 
the structural similarities not only in aspidosperma alkaloids, but other indole alkaloids as 
well. The synthesis of common intermediate 3-57 began with a two-step procedure 
involving an ester reduction followed by a Wittig reaction of readily available 3-54 to 
access olefin 3-55 (Scheme 3-9). Next, DIBAL-H reduction and MOM protection of the 
resulting primary alcohol was completed followed by desilylation revealed 3-56. The 
desired quaternary center was created via a [3,3]-sigmatropic Johnson-Claisen 
rearrangement giving common intermediate 3-57 in 79% yield. The intermediate 3-57 
was then continued to quebrachamine via an ester reduction and Pictet-Spengler reaction 
to afford tricyclic 3-59 in modest yield. N-allylation of piperidine 3-59 followed by ring-
closing metathesis and olefin reduction gave intermediate 3-61. Finally, deprotection of 
the primary alcohol and mesylation allowed formation of a quaternary salt which could 
then undergo a reductive ring expansion to give (+)-quebrachamine 3-32 in 13% yield 
over the 4 steps.      
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Scheme 3-9: Unified Approach to (+)-3-32 via a Common Intermediate 
3.4 Pyrrolidine Synthesis from Donor-Acceptor 
Cyclopropanes 
In a follow up study on the successful formal cycloaddition between nitrones and DA 
cyclopropanes,24 the Kerr group explored the reactivity of imines in a similar fashion. In 
2005 the Kerr group reported the successful synthesis of substituted pyrrolidines from the 
three-component reaction of DA cyclopropanes, primary amines, and aldehydes (Scheme 
3-10).25 Initial condensation between a primary amine and aldehyde 3-62 gave 
intermediate imine 3-63, which was then reacted with cyclopropane 3-64 in the presence 
of Yb(OTf)3 to give zwitter-ionic intermediate 3-65, followed by a Mannich type ring-
closure to give the desired pyrrolidine 3-66. The reaction conditions were tolerant of a 
variety of different substitutions on the cyclopropane and aldehyde giving good to 
excellent yields of the pyrrolidine products with great diastereoselectivity. 
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Scheme 3-10: Synthesis of Pyrrolidines from DA Cyclopropanes 
The success of this method led to its application in the total synthesis of FR901483 
(Scheme 3-11).26 Readily available cyclopropane 3-67 was converted in a six step 
sequence to the corresponding amine cyclopropane 3-68. At this point, two of the 
required functionalities (primary amine and cyclopropane) were in place and 
intramolecularly connected. Cyclopropane 3-68 was subjected to paraformaldehyde and 
Lewis acid to give bicyclic pyrrolidine 3-71 via sequential imine formation (3-69), 
intramolecular cyclopropane ring-opening (3-70), and Mannich type ring-closure. With 
pyrrolidine 3-71 in hand, the synthesis was completed following another six step 
procedure furnishing the natural product 3-72. 
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Scheme 3-11: Synthesis of FR901483 
3.5 Progress Toward Aspidospermidine 
3.5.1 Retrosynthesis of Aspidospermidine 
The utility of the pyrrolidine forming reaction in the total synthesis of FR901483, 
coupled with our interest in aspidosperma alkaloids, inspired us to continue exploring this 
method in the synthesis of aspidospermidine. It was envisioned that the indole system of 
aspidospermidine could come from a late stage Fischer indolization of 3-73 (after 
decarboxylation), a common intermediate in several approaches to aspidospermidine 
(Scheme 3-12).5q,u,y Tricyclic keto-ester 3-73 could come from an intramolecular 
pyrrolidine forming reaction between the tethered cyclopropane and cyclic imine 3-74, 
which could be formed in situ via a mild acid deprotection of amino-aldehyde 
cyclopropane 3-75. It is believed that the synthesis of key cyclization precursor 3-75 
could be achieved through selective oxidation and homologation reactions of 
commercially available triol 3-76. 
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Scheme 3-12: Aspidospermidine Retrosynthesis 
3.5.2 Synthesis of Key Cyclization Precursor 3-75 
The synthesis of advanced intermediate 3-77 (reported synthesis from a previous Kerr 
group member) was achieved in an 8 step sequence from commercially available triol 
3-76 (Scheme 3-13).27 Smooth protection of the desired aldehyde with 1,3-propanediol in 
toluene with catalytic TsOH gave cyclic acetal 3-78 in near quantitative yields. With the 
protected aldehyde in hand, focus was next directed to installing the required amine 
functionality of the cyclization precursor. 
 
Scheme 3-13: Aldehyde Protection 
Selective base hydrolysis of the benzoyl (Bz) protecting group was achieved using a 
slight excess of sodium hydroxide in methanol (Scheme 3-14). The selectivity of this 
hydrolysis can presumably be attributed to the steric hindrance near the other ester, which 
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occupies a neopentyl position. The unprotected primary alcohol was converted into a 
leaving group in excellent yield. Mesylated alcohol 3-79 was then subjected to potassium 
phthalimide in DMF to yield the desired protected amine 3-80 albeit in modest yield. It 
should be noted that the direct Mitsunobu reaction of the unprotected alcohol with 
phthalimide did give product; however, due to the low yield and cost of the reagents, we 
decided to search for more scalable conditions. All attempts to increase the yield of the 
phthalimide displacement proved unsuccessful and thus use of sodium azide was 
attempted. Gratifyingly, the displacement with sodium azide gave a 95% yield of the 
desired product 3-81 and could efficiently be performed on gram scale with little loss in 
yield. Finally, the Boc-protected amine 3-82 was furnished through a two-step azide 
reduction Boc protection in an overall 84% yield.  
 
Scheme 3-14: Synthesis of the Protected Amine 
With both the aldehyde and amine functionalities of the desired cyclization precursor 
installed, we next moved to appending the cyclopropane moiety. Initially, we believed 
the cyclopropane could be installed through direct enolate alkylation of a geminally 
substituted keto-ester cyclopropane. To this end, saponification of the PMP benzoyl 
group (3-81) with sodium hydroxide in refluxing methanol followed by mesylation gave 
3-83 in 90% yield (Scheme 3-15A). While optimizing the conditions for the synthesis of 
3-83, a model study of the alkylation was performed using cyclopropane 3-84 and 
neopentyl bromide 3-85 (Scheme 3-15B). Unfortunately, under all conditions attempted 
(varying solvent and temperature), no alkylation product was formed and the reaction 
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resulted solely in decomposition of the cyclopropane starting material. Similar results 
were obtained when 3-83 was used in place of neopentyl bromide, leading only to 
recovery of 3-83 (Scheme 3-15C). Due to the decomposition of the nucleophilic 
cyclopropane and the recovery of the electrophile, these results suggest that the bulky 
quaternary center of 3-83 may hinder the alkylation process; thus, we set out to determine 
another method for installing the cyclopropane moiety.     
 
Scheme 3-15: Cyclopropane Alkylation Attempts 
Based on previous success utilizing homologation methods to synthesize intermediate 
3-77, we envisioned the cyclopropane moiety could be installed through a Horner-
Wadsworth-Emmons reaction. This approach required the synthesis of a unique 
phosphonate cyclopropane 3-89 (Scheme 3-16A). Our original approach to this molecule 
applied a three-step sequence from cyclopropane 3-88; however, the yields were 
irreproducible and did not fare well with scale up. A second generation approach was 
developed using a one-step acylation method of dimethyl methylphosphonate and 
cyclopropane 3-88 to give phosphonate cyclopropane 3-89 in modest yield (Scheme 
3-16B).    
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Scheme 3-16: Synthesis of Phosphonate Cyclopropane 3-89 
With phosphonate cyclopropane 3-89 in hand, we performed a model study with 
pivaldehyde to determine the reactivity of the cyclopropane with a sterically contested 
aldehyde (Scheme 3-17A). In contrast to the previous attempts at alkylating the 
cyclopropane, homologation was successful giving 3-91 in an excellent 94% yield. 
Pleased with these results, we set out to install the cyclopropane on the appropriate 
scaffold to furnish the desired cyclization precursor. In this vein, aldehyde 3-92 was 
synthesized through a two-step procedure involving a saponification followed by a Swern 
oxidation in an overall 90% yield from 3-81 (Scheme 3-17B).   
 
Scheme 3-17: Reactivity Study of Cyclopropane 3-89 and the Synthesis of 3-92 
Initial investigations into the synthesis of 3-93 employed the identical conditions used in 
the model study (Table 3-1, entry 1). Unfortunately, these conditions failed to provide 
any desired product 3-93 and only the recovery of both starting materials was observed. 
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We next examined the effect of temperature (entry 2-3); however, both room temperature 
and heating showed no sign of product formation. Similarly, when different solvents were 
explored, only recovery of starting materials (entry 4) or complete decomposition of the 
starting material (entry 5) was observed. High pressure and microwave conditions also 
led to quick decomposition of the starting materials (entry 6-7). The use of different bases 
had little effect on the outcome of the reaction, showing no indication of product 
formation (entry 8-9). In hopes of activating both the phosphate cyclopropane and 
aldehyde, a Masamune-Roush modification was attempted (entry 10); however, once 
again, no reaction was observed.28 Finally, the initial conditions from the model study 
(entry 1) were employed with a variety of sterically hindered aldehydes in hopes of 
installing the cyclopropane moiety at an earlier stage in the synthesis of 3-75 (Figure 3-
2). To our displeasure, the conditions employed resulted only in recovery of starting 
material with each aldehyde tested. With difficulties installing the desired cyclopropane 
functionality, presumably due to the steric bulk of aldehyde 3-92, we were intrigued to 
determine if the cycloaddition reaction could be performed on such a sterically 
demanding substrate.     
Table 3-1: Investigation into the Synthesis of 3-93 
 
entry  additive  solvent  temp (°C)  time (h)  result 
1  KOtBu  THF  zero  5   No rxn 
2  KOtBu  THF  rt  O/Na  No rxn 
3  KOtBu  THF  reflux  O/Na  cyclopropane decomp. 
4  KOtBu  ether  rt  O/Na  No rxn 
5  KOtBu  toluene  rt‐reflux  O/Na  decomp. 
6b  KOtBu  THF  rt  3  decomp. 
7c  KOtBu  THF  140  2  decomp. 
8  NaH  THF  zero  5  No rxn 
9  BuLi  THF  zero  5  decomp. 
10  DBU/LiCl  THF  rt  O/Na No rxn 
aO/N = overnight. breaction performed in a high pressure reactor. creaction performed in 
microwave  
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Figure 3-2: Additionally Tested Aldehydes 
3.5.3 Retrosynthesis of Aspidospermidine Revisited 
To determine if our pyrrolidine synthesis could work with a sterically demanding 
aldehyde starting material, we revised our synthetic path to aspidospermidine 3-6 to 
include an intermolecular [3+2] annulation reaction between a protected amine, 
cyclopropane 3-88, and aldehyde 3-99 (Scheme 3-18). In a similar fashion to the original 
approach, it was envisioned that the indole moiety could come from a late stage Fischer 
indolization reaction of ketone 3-31, which could be furnished via a lactam reduction and 
double decarboxylation of 3-96. Tricyclic intermediate 3-96 could be achieved through 
sequential lactamization and Dieckmann condensation reactions from the corresponding 
pyrrolidine 3-97. Pyrrolidine 3-97 could be achieved via the three component reaction of 
cyclopropane 3-88, amine 3-98, and aldehyde 3-99.    
 
Scheme 3-18: Retrosynthesis Revisited 
To test this route, aldehyde 3-99 was synthesized via exhaustive alkylation of the 
pyrrolidine enamine of butyraldehyde29 and subjected to the three component reaction 
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with a variety of different amines (Table 3-2). The first conditions explored followed the 
general procedure outlined in our 2005 paper utilizing reactive p-methoxy aniline. While 
imine formation did go to completion (determined by NMR), the ring-opening annulation 
event did not take place leaving only recovered starting material upon aqueous workup. 
The use of microwave conditions also failed to produce any of the cycloadduct 3-101 
(entry 2). Varying the amine and Lewis acid also proved unsuccessful, leading to 
recovery of starting materials (entry 3-8). We next explored the use of an activated 
cyclopropane (R = Ph) to determine if the reactivity of the cyclopropane species was at 
fault. Once again however, the cyclopropane ring-opening annulation event did not take 
place (entry 9). Having ruled out the reactivity of the cyclopropane, we next looked at the 
nucleophilic partner by employing the more reactive nitrone species (entry 10). 
Unfortunately, these conditions resulted only in recovery of starting material.       
Table 3-2: Investigating the Synthesis of 3-101 
 
entry  R  aminea  Lewis acid  temperature  time (h)  result 
1  H  PMP  Yb(OTf)3 reflux  O/Nb Imine formationd then no rxn
2c  H  PMP  Yb(OTf)3  150  4 Imine formationd then no rxn
3  H  Bn  Yb(OTf)3  reflux  O/Nb  Imine formationd then no rxn
4 c  H  Bn  Yb(OTf)3  150  4 Imine formationd then no rxn
5  H  PMP  Sc(OTf)3  reflux  O/Nb  Imine formationd then no rxn
6 c  H  Bn  Sc(OTf)3  150  4 Imine formationd then no rxn
7  H  PMP  Sc(OTf)3  reflux  O/Nb  Imine formationd then no rxn
8 c  H  Bn  Sc(OTf)3  150  4 Imine formationd then no rxn
7  H  PMP  In(OTf)3  reflux  O/Nb  Imine formationd then no rxn
8 c  H  PMP  In(OTf)3  150  4 Imine formationd then no rxn
9  Ph  PMP  Yb(OTf)3  reflux  O/Nb  Imine formationd then no rxn
10  H  BnNHOH  Yb(OTf)3  reflux O/Nb  No rxn 
aPMP = p‐methoxyphenyl, Bn = Benzyl. bO/N = overnight. creaction performed in microwave. 
dImine formation determined by NMR (aliquot test). 
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At this point, it was clear to us that steric bulk around the aldehyde was too large to 
promote a three component intermolecular reaction to produce the desired pyrrolidine. 
Thus, we decided to explore an intramolecular imine formation followed by an 
intermolecular cyclopropane annulation (Scheme 3-19A). It was envisioned that cyclic 
imine 3-103 may be slightly more accessible for the annulation event. To this end, we 
started to develop a scalable route to amine 3-102. While attempting to selectively 
convert one of the esters of 3-99 to the corresponding amine, we noticed an interesting 
reductive lactonization process that gave lactone 3-105 in near quantitative yield (Scheme 
3-19B). The potential utility of this transformation sparked our interest and ultimately 
shifted our focus to a different ring system and a different target molecule.   
 
Scheme 3-19: Inspiring Lactone Forming Reaction 
3.6 Progress Toward Quebrachamine 
3.6.1 The Synthesis of 5,5-disubstituted Piperidinones 
Intrigued by the lactone formation, we hypothesized that if an imine was used in place of 
the aldehyde, we would have quick access to quaternary substituted piperidines upon 
lactam reduction 3-107 (Figure 3-3A). Similar to pyrrolidine (previously shown), the 
quaternary substituted piperidine core is not only prevalent in the aspidosperma alkaloids, 
but also a variety of kopsia, vinca, and leuconotis alkaloids (Figure 3-3A).30 Due to the 
reoccurring nature of the 3,3-substituted piperidine core in target molecules, it occurred 
to us that compound 3-99 may be useful as a common intermediate in the synthesis of a 
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series of piperidine containing natural products. Herein, we report our initial findings on 
the utility of intermediate 3-99 and the formal synthesis of quebrachamine. 
 
Figure 3-3: Piperidine Containing Natural Products  
A quick optimization varying solvent, temperature, and reducing agents led to facile 
synthesis of piperidinone 3-108 in excellent overall yield via a one pot scandium triflate 
catalyzed imine condensation followed by a sodium borohydride induced reductive 
amination/lactamization sequence (Table 3-3). Although it was found that imine 
formation was possible in the absence of the catalytic Lewis acid, the reaction times were 
significantly increased and yields decreased when no catalytic additive was used. 
Standard reductive amination conditions using sodium cyanoborohydride, proved to be 
less efficient than sodium borohydride resulting in large amounts of recovered starting 
materials. With ideal conditions in hand, we set out to determine the scope of amines 
suitable for this transformation. 
Tryptamine derivatives were quite compatible with the reaction conditions leading to 
3-108a and 3-108b in good to excellent yields (Table 3-3). These results were 
particularly interesting as they allowed quick access to the indole skeleton prevalent in 
several target alkaloid molecules. Protected ethanolamine underwent the transformation 
giving access to 3-108c in 76% yield while 2-(phenylthio)ethanol led to 3-108d in a 
moderate 64% yield. The future utility of these two compounds (3-108c,d) was 
noteworthy as their functional handles allowed for easy manipulation to more complex 
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scaffolding, as seen in several previous alkaloid syntheses.31 Additionally, benzyl amine 
was suitable as a starting material, giving 3-108e as protected piperidinone in an excellent 
yield. This particular reaction was amenable to scale up.  
Table 3-3: Piperidine Synthesis Reaction Scope 
 
Butyl amine worked well, giving high yields of the desired product 3-108f; however, 
when cyclohexanamine was employed, lower yields of the desired product 3-108i were 
isolated. This result was presumably due to steric effects between the bulky amine and 
the neopentyl aldehyde, resulting in lower formation of the requisite imine. This 
hypothesis was further supported when tertbutylamine proved unreactive toward imine 
condensation with 3-99 under the reaction conditions. P-Methoxyaniline was shown to 
undergo the reaction with 3-108g; however, in the best case, only 31% yield of 3-108g 
 147 
 
could be isolated. This low yield could be attributed to the slow lactam formation step of 
the reaction process since significant amounts of the simple reductive amination product 
were also isolated. Attempts to modify the reaction conditions (including variations in 
temperature) proved unsuccessful in increasing the overall yield for anilines. Finally, 
allylamine successfully led to 3-108h in an 83% yield, providing another useful handle 
for future manipulations. 
In addition to amine substitution, the ester moiety of the product can also be manipulated 
in a one pot sequence (Scheme 3-20). When the reaction conditions were adjusted to use 
excess sodium borohydride in refluxing methanol, the corresponding (3-
hydroxypropyl)piperidinones were isolated as the sole product.32 Interestingly, when 
compared to the initial reaction conditions (see Table 3-3 3-108c,d,e), there was little to 
no effect on the overall yield of product even though an additional reduction event was 
added to the sequence (see Scheme 3-20 3-109a,b,c). This result allowed quick access to 
ideal functional handles on the three position of the piperidine core without loss of yield 
or extraneous purification.  
 
Scheme 3-20: One-pot Reductive Lactamization Ester Reduction 
If necessary, a two-step piperidinone ring formation ester reduction protocol could be 
applied, allowing access to the corresponding (3-hydroxypropyl)piperidinone in excellent 
yields (Scheme 3-21).33 Finally, the piperidine ring system can be accessed through a 
Red-Al mediated lactam/ester reduction (Scheme 3-21). Piperidinone 3-108c containing 
the TBS ether gave piperidine 3-110a in 72% yield while benzyl protected 3-108e gave 
3-110b in a nearly quantitative yield. The decrease in yield seen for 3-110a can be 
attributed to the in situ desilylation of the product under the reaction conditions.    
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Scheme 3-21: Reduction Conditions for the Synthesis of 3-109 and 3-110 
3.6.2 Formal Synthesis of Quebrachamine 
To display the utility of this transformation, the indole alkaloid ()-quebrachamine (3-32) 
was targeted for synthesis. Starting from readily available dimethyl 3-ethyl-3-
formylpimelate, a one-pot global reductive amination/lactamization protocol was 
employed with benzyl amine leading to piperidinone 3-109c in an 81% yield (Scheme 3-
22). Oxidation of the corresponding primary alcohol with IBX gave aldehyde 3-111 
without purification. Homologation of 3-111 with the Bestmann-Ohira reagent led to 
alkyne 3-112 in an excellent yield. Again, these conditions gave clean product upon 
workup. Next, the alkyne was subjected to a two-step cross coupling hydroamination 
protocol to furnish 3-113 in an overall 93% yield. It is noteworthy that all attempts at a 
one-pot Larock type indole synthesis resulted in lower yields of the desired product. With 
the indole core in hand, all that remained was lactam reduction and deprotection to give 
intermediate 3-52 that would merge with Pagenkopf’s synthesis in 2009.21  
 
Scheme 3-22: Synthesis of Indole 3-113 
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Identifying the ideal conditions for the last two steps of the formal synthesis was not 
trivial. Initially, a dissolving metal reduction with sodium metal in ammonia was 
performed to remove the benzyl group (Scheme 3-23A). These results were promising by 
crude 1H-NMR; however, purification proved difficult. Attempts to take the crude 
deprotected product 3-114 forward through the reduction process only resulted in 
decomposition. It was at this point that we focused on first reducing the lactam and then 
deprotecting the piperidine in hopes that these products would be easier to purify. 
Gratifyingly, reduction of the lactam with Red-Al supplied the benzyl protected 
piperidine 3-115 in an exceptional 97% yield (Scheme 3-23B). After several unsuccessful 
attempts to deprotect the benzyl group using standard hydrogenation conditions (H2 with 
Pd/C or PtO2) and dissolving metal conditions, it was found that transfer hydrogenation 
provided piperidine 3-52, thus constituting a formal total synthesis of quebrachamine. 
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Scheme 3-23: Formal Synthesis of Quebrachamine 
3.6.3 Progress Toward the Total Synthesis of Quebrachamine 
With application of our piperidinone method successfully applied to the formal synthesis 
of quebrachamine, we were interested to see if we could complete the total synthesis 
utilizing a new 9-membered ring closing method. Two separate approaches were taken to 
close the 9-membered ring of quebrachamine and complete the total synthesis. The first 
approach involved finding a two carbon unit that could be attached directly to the indole 
3-position and the nitrogen of the piperidine ring (Scheme 3-24A). The second approach 
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required synthesizing intermediate 3-117, thus allowing us to explore direct indole 
alkylation methods to close the 9-membered ring (Scheme 3-24B). 
 
Scheme 3-24: Total Synthesis Approaches 
3.6.3.1 Ring-Closing Approach 1 
The first attempt at ring-closing involved the intramolecular attack of the indole onto an 
alkyne (3-120) (Scheme 3-25B). Precedent for this transformation was supported by the 
work of Fujii and Ohno who showed the synthesis of fused indoles via a cascade 
cyclization of diynes (Scheme 2-25A).34 While their method worked well for the 
formation of smaller 5 and 6-membered ring systems, in our hands, the 9-member ring 
would not close, leading to slow decomposition of 3-120.  
 
Scheme 3-25: Alkyne Ring-Closing Attempted 
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Our next effort to close the ring using intermediate 3-52 paralleled the work of Diez, who 
showed the 6-membered ring closure of intermediate 3-122 with glyoxal (Scheme 3-
26A).35 All attempts to utilize Diez’s conditions were met with decomposition of starting 
material 3-52 (Scheme 3-26B). While several other attempts utilizing a variety of 
different methods were made to attach the required two carbon unit to 3-52, no promising 
results were observed. Although there was ample precedence for the formation of smaller 
5, 6, and 7-membered rings, the difficulty we observed in forming the 9-membered ring 
under the same conditions compelled us to pursue an alternative approach to closing the 
ring system.   
 
Scheme 3-26: Glyoxal Approach 
3.6.3.2   Ring-Closing Approach 2 
To attempt our second approach at ring-closing, intermediates 3-125 and 3-126 were 
synthesized following the same procedure (see Scheme 3-22) used to make intermediate 
3-113 (Scheme 3-27). 3-125 and 3-126 were furnished in overall 55% and 35% yields 
respectively over the 5 step procedure. TBAF deprotection of 3-125 gave the free primary 
alcohol which we initially envisioned could be converted into a leaving group, allowing 
for a direct indole alkylation approach to close the 9-membered ring.  
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Scheme 3-27: Synthesis of 3-125 and 3-126 
Following procedures developed by Bach in the synthesis of aspidospermidine (Scheme 
3-28A),36 we attempted a one pot mesylation/displacement method. Alcohol 3-128 was 
subjected to MsCl in dichloromethane at -20 °C followed by the addition of excess 
tBuOK (Scheme 3-28B). Interestingly, the chloro intermediate 3-129 was isolated instead 
of the ring-closed adduct. This result can be explained by simple displacement of the 
mesylate with the resulting chloride anion. Attempts to close the ring of 3-129 directly 
using forcing conditions (e.g. excess base, microwave heating) resulted in slow 
decomposition of the starting material. Additionally, Friedel-Crafts alkylation37 
conditions of 3-129 also resulted in decomposition of the starting material (Scheme 3-
28C).  
 
Scheme 3-28: Attempted Direct Alkylation Routes 
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With both direct alkylation and Friedel-Crafts approaches proving inadequate for closing 
the 9-membered ring, we next directed our focus to a reductive alkylation approach, 
utilizing aldehyde 3-130 (Scheme 3-29A). This method proved difficult due to the 
instability of 3-128 toward oxidative conditions, leading to decomposition under all 
oxidations attempted, including Swern, Parikh-Doering, IBX, DMP, and PCC oxidation 
methods. In addition to the oxidation attempts, direct Mitsunobu displacement of 3-128 
also proved insufficient at closing the ring system, leading only to small amounts of 
recovered starting material (Scheme 3-29B).  
 
Scheme 3-29: Reductive Alkylation and Mitsunobu Attempts 
In a final attempt to close the 9-membered ring of quebrachamine, we explored the use of 
a Pummerer type reaction of 3-126 due to its previous success in this area in creating 
smaller membered rings.31 It was envisioned that oxidation of sulfide 3-126 to the 
corresponding sulfoxide 3-132, followed by treatment with TFAA and a final reduction 
would furnish the target molecule 3-32 (Scheme 3-30). Unfortunately, once again, 3-126 
proved to be unstable to oxidation conditions leading to undesired byproducts and 
decomposition. Due to the instability of intermediates 3-128 and 3-126 toward oxidation 
chemistry, it is unclear at this point whether the ring-closing process (Scheme 3-29A and 
3-30) would be effective in the synthesis of quebrachamine. Thus, future work in this 
area should involve the protection of the indole nitrogen to limit any unwanted side 
reactions during both oxidation steps.   
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Scheme 3-30: Pummerer Type Ring-Closure Attempt 
3.7 Summary and Future Outlook 
In conclusion, synthetic attempts have been explored into the synthesis of 
aspidospermidine, albeit conditions have yet to be determined to promote the [3+2] 
pyrrolidine forming reaction of sterically restricted aldehydes. Additionally, we have 
developed a method utilizing common starting material 3-99 in the synthesis of a variety 
of N-substituted piperidinone scaffolds via a reductive amination/lactamization sequence, 
and this process has been applied to the short formal synthesis of indole alkaloid 
()-quebrachamine. Although advancing this method to the total synthesis of 
quebrachamine has yet to be achieved, several alternative methods to close the last 
9-membered ring have been left unexplored due to time constraints. The preliminary 
results using common intermediate 3-99 show great promise for the use of a common 
intermediate in the synthesis of a series of nitrogen containing natural products.   
It is envisioned that future efforts in this area of research can be directed toward two 
different areas. First, in the total synthesis of quebrachamine, additional efforts should be 
explored for the ring closing event, including the protection of the indole moiety followed 
by reevaluation of all the oxidation methods, as previously described. Additionally, due 
to the recent advancements in both cross-coupling reactions and C-H activation methods, 
it would be useful to explore this chemistry to close the last ring of quebrachamine 
(Scheme 3-31). 
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Scheme 3-31: Potential Cross-Coupling Strategy 
The second area of future research should focus on exploiting the common structural 
features of the aspidosperma, kopsia, vinca, and leuconotis alkaloids. The similarity of 
these compounds would allow for a unified approach from a common intermediate. 
While the use of 3-99 was successful in the formal synthesis of quebrachamine, it 
possesses structural drawbacks which will ultimately limit the utility of this intermediate 
in the synthesis of other target molecules. In this vein, attention should be directed toward 
a suitable amine intermediate such as 3-135 (Figure 3-4) as a potential ideal starting 
material for the synthesis of a series of alkaloid natural products. 
 
Scheme 3-32: Potential Intermediate for the Synthesis of Alkaloid Natural Products 
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3.8 Experimental  
General Considerations 
 Infrared spectra were obtained as thin films on NaCl plates using a Bruker Vector 
33 FT-IR instrument. NMR experiments were performed on Varian Mercury 400, Varian 
Inova 600 and Inova 400 instruments and samples were obtained in CDCl3 (referenced to 
7.26 ppm for 1H and 77.0 ppm for 13C). 19F spectra were externally referenced to neat 
trifluorotoluene (referenced to   -63.9 ppm).  Coupling constants (J) are in Hz. The 
multiplicities of the signals are described using the following abbreviations: s = singlet, d 
= doublet, t = triplet, q = quartet, sept = septuplet, m = multiplet, br = broad. High 
resolution mass spectra (HRMS) were obtained on a Finnigan MAT 8200 spectrometer at 
70 eV. Optical rotations were recorded in cells of 10 cm path length using a Perkin-Elmer 
241 digital polarimeter.  
 All reagents and solvents were used as purchased from Aldrich, Strem, Caledon 
or VWR.  Reaction progress was followed by thin layer chromatography (TLC) (EM 
Science, silica gel 60 F254) visualizing with UV light, and the plates developed using 
acidic anisaldehyde. Flash chromatography was performed using silica gel purchased 
from Silicycle Chemical Division Inc. (230-400 mesh). 
 
Dimethyl 3-ethyl-3-formylpimelate 3-99 was prepared using the 
following procedure: Pyrrolidine (50.0 mL, 609 mmol) and 
K2CO3 (21.0 g, 150 mmol) were stirred at 0 ̊C. Butyraldehyde (36.4 mL, 406 mmol) was 
added dropwise to the solution. The solution was mixed for 20 h then filtered through 
Celite, and the volatiles were removed. The cured 1-(but-1-enyl)pyrrolidine was 
dissolved in methanol (391 mL). methyl acrylate (118.0 mL, 1302 mmol) was added and 
the solution was heated to reflux for 21 h. The reaction mixture was then cooled and 
acetic acid (24.0 mL) and H2O (156.0 mL) was added and the mixture was heated to 
reflux for an additional 7 hours. The volatiles were then removed and H2O (820.0 mL) 
was added, and the solution was extracted four times with DCM. The organics were then 
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washed with aqueous sodium bicarbonate and brine sequentially. The organic layer was 
dried and the solvent removed. The crude product was purified by fractional distillation 
(140-142 ̊C at 1 mmhg) to yield pure 3-99 as a yellow oil, 54% (54 g, 221 mmol). 1H-
NMR (600 MHz, CDCl3):  = 9.37 (s, 1H), 3.62 (s, 6H), 2.17 (ddd, J = 7.6, 7.6, 3.5 Hz, 
4H), 1.81 (ddd, J = 8.22, 7.1, 1.8 Hz, 4H), 1.51 (q, J = 7.6 Hz, 2H), 0.79 (t, J = 7.0, Hz, 
3H); 13C NMR (150 MHz, CDCl3)  = 205.0, 173.4, 51.9, 51.0, 28.2, 26.0, 24.3, 7.6; IR 
(thin film): 2954, 2708, 1732, 1438, 1377, 13.77, 1120, 991, 886, 784; HRMS (M+1) 
calc’d for C12H20O5 = 245.1384, found = 245.1397.  
 
General Experimental Procedure for the Synthesis of Piperidinones 3-108a-i: 
dimethyl 3-ethyl-3-formylpimelate (1 equivalent) and primary amine (1 equivalent) were 
dissolved in methanol.  Sc(OTf)3 (0.025 equivalent) was then added and the mixture was 
stirred for 1-2 hours, followed by the addition of NaBH4 (1.25 equivalent). Upon 
completion by TLC analysis water was added to the reaction mixture and extracted 3 
times with ethyl acetate.  The organic layer was dried and the solvent was removed. The 
residue was purified by flash chromatography (EtOAc/Hexanes) to yield the desired 
piperidinones 3-108a-i. 
 
Piperidinone 3-108a was prepared using general experimental 
procedure. Reagents employed: dimethyl 3-ethyl-3-formylpimelate 3-99 
(200 mg, 0.820 mmol), 2-(1H-indol-3-yl)ethanamine (144 mg, 0.90 
mmol), Sc(OTf)3 (20 mg, 0.041 mmol), NaBH4 (37 mg, 0.98 mmol), and 
methanol (2 mL). Yielded piperidinone 3-108a as a light yellow oil, 96% (280 mg, 0.79 
mmol). Rf  = 0.33, 100% EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 8.22 (brs, 
1H), 7.65 (d, J = 7.6 Hz, 1H), 7.35 (d, J = 8.2 Hz, 1H), 7.18 (t, J = 8.2 Hz, 1H), 7.12 (t, J 
= 7.6 Hz, 1H), 7.04 (d, J = 2.4 Hz, 1H), 3.70-3.59 (m, 5H), 3.03 (dd, J = 12.3, 7.4 Hz, 
2H), 2.92 (AB system, J = 12.3 Hz, 2H), 2.37 (dd, J = 7.0, 7.0 Hz, 2H), 2.19-2.07 (m, 
2H), 1.66-1.60 (m, 1H), 1.59-1.51 (m, 3H), 1.34-1.27 (m 1H), 1.27-1.20 (m, 1H), 0.74 (t, 
J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 173.9, 169.5, 136.3, 127.5, 122.1, 
N
O
MeO2C
NH
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122.0, 119.3, 118.7, 113.0, 111.2, 57.2, 51.7, 48.5, 34.3, 29.7, 28.9, 28.5, 28.2, 26.8, 23.1, 
7.3; IR (thin film): 3258, 3055, 2929, 2876, 1736, 1624, 1498, 1458, 1435, 1366, 1230, 
1170, 743; HRMS calc’d for C21H28N2O3 = 356.2100, found = 356.2091.  
 
Piperidinone 3-108b was prepared using general experimental 
procedure. Reagents employed: dimethyl 3-ethyl-3-formylpimelate 3-99  
(200 mg, 0.82 mmol), tert-butyl 3-(2-aminoethyl)-1H-indole-1-
carboxylate (234 mg, 0.90 mmol), Sc(OTf)3 (20 mg, 0.041 mmol), 
NaBH4 (37 mg, 0.98 mmol), and methanol (2 mL). Yielded piperidinone 3-108b as a 
light yellow oil, 76% (285 mg, 0.62 mmol). Rf  = 0.43, 100% EtOAc in hexanes;  1H-
NMR (600 MHz, CDCl3):  = 8.12 (brs, 1H), 7.62 (d, J = 7.6 Hz, 1H), 7.41 (brs, 1H), 
7.31 (t, J = 7.6 Hz, 1H), 7.26-7.23 (m, 1H), 3.70-3.63 (m, 4H), 3.59-3.53 (m, 1H), 3.02-
2.91 (m, 4H),  2.38 (dd, J = 7.0, 7.0 Hz, 2H), 2.23-2.13 (m, 2H), 1.70-1.51 (m, 13H), 
1.40-1.32 (m, 1H), 1.31-1.23 (m, 1H), 0.79 (t, J = 7.6 Hz, 3H); 13C NMR (150 MHz, 
CDCl3)  = 173.6, 169.4, 149.5, 135.4, 130.3, 124.3, 123.0, 122.4, 118.9, 117.6, 115.1, 
82.3, 57.2, 51.6, 47.9, 34.3, 29.5, 29.1, 28.4, 28.12, 28.08, 26.5, 22.8, 7.2; IR (thin film): 
2969, 2936, 2879, 1735, 1640, 1618, 1454, 1371, 1256, 1157, 1093, 751; HRMS calc’d 
for C26H36N2O5 = 456.2624, found = 456.2629.  
 
Piperidinone 3-108c was prepared using general experimental procedure. 
Reagents employed: dimethyl 3-ethyl-3-formylpimelate 3-99 (300 mg, 
1.23 mmol), 2-(tert-butyldimethylsilyloxy)ethanamine (237 mg, 1.35 
mmol), Sc(OTf)3 (30 mg, 0.061 mmol), NaBH4 (56 mg, 1.48 mmol), and 
methanol (3 mL). Yielded piperidinone 3-108c as a yellow oil, 76% (346 mg, 0.93 
mmol). Rf  =0.27, 100% EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 3.76 (dd, J 
= 5.9, 5.9 Hz, 2H), 3.67 (s, 3H), 3.49-3.40 (m, 2H), 3.18 (Br s, 2H), 2.35 (dd, J = 7.0, 7.0 
Hz, 2H), 2.25-2.22 (m, 2H), 1.75-1.66 (m, 2H), 1.63-1.55 (m, 2H), 1.44-1.38 (m, 1H), 
1.36-1.30 (m, 1H), 0.89 (s, 9H), 0.84 (t, J = 7.3 Hz, 3H), 0.05 (s, 6H); 13C NMR (150 
TBSO
N
O
MeO2C
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MHz, CDCl3)  = 173.8, 169.6, 61.6, 58.9, 51.7, 50.5, 34.5, 29.7, 28.9, 28.5, 28.3, 26.9, 
25.8, 18.1, 7.4, -5.5; IR (thin film): 2930, 2858, 1740, 1646, 1493, 1470, 1436, 1363, 
1256, 1105, 1054, 1006, 921, 837, 778; HRMS (M+1) calc’d for C19H37NO4Si = 
372.2565, found = 372.2565.  
 
Piperidinone 3-108d was prepared using general experimental procedure. 
Reagents employed: dimethyl 3-ethyl-3-formylpimelate 3-99 (726 mg, 
2.97 mmol), 2-(phenylthio)ethanamine (500 mg, 3.26 mmol), Sc(OTf)3 
(36 mg, 0.073 mmol), NaBH4 (135 mg, 3.57 mmol), and methanol (7 
mL). Yielded piperidinone 3-108d as a red oil, 64% (660 mg, 1.89 mmol). Rf  = 0.23, 
100% EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 7.38 (d, J = 7.0 Hz, 2H), 
7.30 (t, J = 7.6 Hz, 2H), 7.18 (t, J = 7.0 Hz, 1H), 3.67 (s, 3H), 3.57-3.49 (m, 2H), 3.14 
(dd, J = 7.0, 7.0 Hz, 2H), 3.05 (Br s, 2H), 2.33 (dd, J = 7.0, 7.0 Hz, 2H), 2.24-2.21 (m, 
2H), 1.70-1.66 (m, 2H), 1.58-1.50 (m, 2H), 1.41-1.30 (m, 2H), 0.83 (t, J = 7.6 Hz, 3H); 
13C NMR (150 MHz, CDCl3)  = 173.7, 169.8, 129.0, 128.8, 126.0, 58.1, 51.8, 48.1, 
34.6, 30.5, 29.7 29.1, 28.4, 28.3, 26.7, 7.4 (missing 1 carbon presumably due to overlap); 
IR (thin film): 2932, 2876, 1736, 1642, 1492, 1438, 1363, 1295, 1229, 1168, 1025, 741, 
693; HRMS calc’d for C19H27NO3S = 349.1712, found = 349.1719.  
 
Piperidinone 3-108e was prepared using general experimental procedure. 
Reagents employed: dimethyl 3-ethyl-3-formylpimelate 3-99 (200 mg, 0.82 
mmol), phenylmethanamine (88 mg, 0.82 mmol), Sc(OTf)3 (10 mg, 0.020 
mmol), NaBH4 (39 mg, 1.031 mmol), and methanol (2 mL). Yielded 
piperidinone 3-108e as an orange oil, 81% (202 mg, 0.67 mmol). Rf  = 0.28, 100% EtOAc 
in hexanes;  1H-NMR (600 MHz, CDCl3):  = 7.32-7.30 (m, 2H), 7.27-7.24 (m, 3H), 4.57 
(AB system, J = 14.7 Hz, 2H), 3.65 (s, 3H), 2.91 (s, 2H), 2.46 (dd, J = 7.0, 1.2 Hz, 2H), 
2.18-2.12 (m, 1H), 2.04-1.98 (m, 1H), 1.63-1.59 (m, 4H), 1.33-1.22 (m, 2H), 0.71 (t, J = 
7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 173.7, 169.5, 137.1, 128.6, 128.3, 127.5, 
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55.4, 51.7, 50.3, 34.3, 30.0, 28.9, 28.5, 28.2, 26.5, 7.2; IR (thin film): 3454, 3056, 3062, 
3029, 2948, 1736, 1647, 1494, 1454, 1363, 1229, 1069, 1002, 854, 703; HRMS calc’d for 
C18H25NO3 = 303.1834, found = 303.1825.  
 
Piperidinone 3-108f was prepared using general experimental procedure. 
Reagents employed: dimethyl 3-ethyl-3-formylpimelate  3-99 (200 mg, 
0.82 mmol), butan-1-amine (60 mg, 0.82 mmol), Sc(OTf)3 (10 mg, 0.020 
mmol), NaBH4 (39 mg, 1.031 mmol), and methanol (2 mL). Yielded 
piperidinone 3-108f as a yellow oil, 86% (190 mg, 0.71 mmol). Rf  = 0.38, 100% EtOAc 
in hexanes;  1H-NMR (600 MHz, CDCl3):  = 3.67 (s, 3), 3.36-3.26 (m, 2H), 2.99 (s, 2H), 
2.33 (dd, J = 7.0, 7.0 Hz, 2H), 2.27-2.19 (m, 2H), 1.73-1.64 (m, 2H), 1.63-1.54 (m, 2H), 
1.50-1.45 (m, 2H),  1.42-1.27 (m, 4H), 0.91 (t, J = 7.0 Hz, 3H), 0.84 (t, J = 7.6 Hz, 3H); 
13C NMR (150 MHz, CDCl3)  = 173.8, 169.2, 56.5, 51.8, 47.1, 34.4, 29.9, 29.2, 29.1, 
28.5, 28.3, 26.7, 20.1, 13.9, 7.4; IR (thin film): 2957, 2872, 1739, 1644, 1494, 1466, 
1435, 1366, 1317, 1229, 1167, 1000; HRMS calc’d for C15H27NO3 = 269.1991, found = 
269.1986.  
 
Piperidinone 3-108g was prepared using general experimental 
procedure. Reagents employed: dimethyl 3-ethyl-3-formylpimelate 
3-99 (200 mg, 0.82 mmol), 4-methoxyaniline (101 mg, 0.82 mmol), 
Sc(OTf)3 (10 mg, 0.020 mmol), NaBH4 (39 mg, 1.031 mmol), and 
methanol (2 mL). Yielded piperidinone 3-108g as a brown oil, 31% (82 mg, 0.26 mmol). 
Rf  = 0.32, 100% EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 7.12 (d, J = 8.8 
Hz, 2H), 6.90 (d, J = 8.8 Hz, 2H), 3.79 (s, 3H), 3.67 (s, 3H), 3.34 (s, 2H), 2.59 (dd, J = 
7.0, 7.0 Hz, 2H), 2.31-2.21 (m, 2H), 1.84-1.76 (m, 2H), 1.75-1.71 (m, 2H), 1.53-1.41 (m, 
2H), 0.87 (t, J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 173.7, 170.0, 158.1, 
136.2, 127.2, 114.5, 60.4, 55.4, 51.7, 34.9, 30.0, 29.0, 28.9, 28.3, 28.8, 7.4; IR (thin film): 
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2929, 1736, 1656, 1512, 1464, 1295, 1245, 1178, 1033, 832; HRMS calc’d for 
C18H25NO4 = 319.1784, found = 319.1778.  
 
Piperidinone 3-108h was prepared using general experimental procedure. 
Reagents employed: dimethyl 3-ethyl-3-formylpimelate 3-99 (200 mg, 0.82 
mmol), prop-2-en-1-amine (47 mg, 0.82 mmol), Sc(OTf)3 (10 mg, 0.02 
mmol), NaBH4 (39 mg, 1.031 mmol), and methanol (2 mL). Yielded 
piperidinone 3-108h as a yellow oil, 83% (171 mg, 0.68 mmol). Rf  =0.30, 100% EtOAc 
in hexanes;  1H-NMR (600 MHz, CDCl3):  = 5.76-5.69 (m, 1H), 5.17 (ddd, J = 10.0, 
7.0, 1.2 Hz, 2H), 4.08-3.92 (m, 2H), 3.67 (s, 3H), 2.96 (s, 2H), 2.38 (dd, J = 7.0, 7.0 Hz, 
2H), 2.27-2.18 (m, 2H), 1.69 (ddd, J = 10.6, 7.0, 3.5 Hz, 2H),  1.64-1.57 (m, 2H), 1.40-
1.32 (m, 2H), 0.84 (t, J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 173.8, 169.3, 
132.9, 117.9, 55.7, 51.8, 49.6, 34.4, 29.9, 29.1, 28.4, 28.3, 26.7, 7.4; IR (thin film): 3079, 
2949, 2878, 1740, 1636, 1493, 1436, 1364, 1314, 1270, 1228, 1195, 996, 926, 853, 726; 
HRMS calc’d for C14H23NO3 = 253.1678, found = 253.1678.  
 
 Piperidinone 3-108i was prepared using general experimental procedure. 
Reagents employed: dimethyl 3-ethyl-3-formylpimelate 3-99 (200 mg, 0.82 
mmol), cyclohexanamine (81 mg, 0.82 mmol), Sc(OTf)3 (10 mg, 0.020 
mmol), NaBH4 (39 mg, 1.031 mmol), and methanol (2 mL). Yielded 
piperidinone 3-108i as a pale yellow oil, 40% (98 mg, 0.33 mmol). Rf  = 0.29, 100% 
EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 4.50-4.44 (m, 1H), 3.66 (s, 3H), 
2.88 (s, 2H), 2.34 (dd, J = 7.0, 7.0 Hz, 2H), 2.22 (dd, J = 14.7, 7.0 Hz, 2H), 1.77-1.75 (m, 
2H), 1.65-1.63 (m, 3H), 1.61-1.57 (m, 2H), 1.55-1.50 (m, 2H), 1.41-1.23 (m, 6H), 1.08-
1.01 (m, 1H), 0.83 (t, J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 173.8, 169.0, 
51.7, 51.6, 50.1, 34.1, 29.54, 29.50, 29.4, 29.1, 28.8, 28.2, 26.5, 25.51, 25.48, 25.46, 7.3; 
IR (thin film): 2929, 2856, 1739, 1637, 1451, 1296, 1254, 1228, 1196, 1168, 1069; 
HRMS calc’d for C17H29NO3 = 295.2147, found = 295.2151.  
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General Experimental Procedure 1 for the Synthesis of 5-(3-
hydroxypropyl)piperidin-2-one 3-109a-c: Piperidinone 3-108c-e (1 equivalent) was 
dissolved in methanol, followed by the addition of NaBH4 (5 equivalents). The mixture 
was heated to reflux for 10 min, and then cooled to room temperature. Then additional 
NaBH4 (5 equivalents) was added followed by a 10 min reflux period, this process was 
continued until a total of 40 equivalents NaBH4 was added.  Upon complete addition of 
NaBH4, water was slowly added to the reaction mixture and extracted 3 times with ethyl 
acetate.  The organic layer was dried and the solvent was removed. The residue was 
purified by flash chromatography (EtOAc/Hexanes) to yield the desired piperidinones 3-
109a-c. 
General Experimental Procedure 2 for the Synthesis of 5-(3-
hydroxypropyl)piperidin-2-one 3-109a-c: Dimethyl 3-ethyl-3-formylpimelate  (1 
equivalent) and primary amine (1 equivalent) were dissolved in methanol.  Sc(OTf)3 
(0.025 equivalent) was then added and the mixture was stirred for 1-2 hours, followed by 
the addition of NaBH4 (5 equivalents). The mixture was heated to reflux for 10 min, and 
then cooled to room temperature. Then additional NaBH4 (5 equivalents) was added 
followed by a 10 min reflux period, this process was continued until a total of 40 
equivalents NaBH4 was added.  Upon complete addition of NaBH4, water was slowly 
added to the reaction mixture and extracted 3 times with ethyl acetate.  The organic layer 
was dried and the solvent was removed. The residue was purified by flash 
chromatography (EtOAc/Hexanes) to yield the desired piperidinones 3-109a-c. 
 
5-(3-Hydroxypropyl)piperidin-2-one 3-109a was prepared using 
general experimental procedure 1. Reagents employed: piperidinone 3-
108c (677 mg, 1.82 mmol), NaBH4 (2750 mg, 72.88 mmol), and 
methanol (30 mL). Yielded 3-109a as a thick yellow oil, 99% (630 mg, 1.81 mmol). Rf  = 
0.14, 100% EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 3.71 (dd, J = 5.3, 5.3 
Hz, 2H), 3.56 (dd, J = 5.9, 5.9 Hz, 2H), 3.46-3.42 (m, 1H), 3.37-3.33 (m, 1H), 3.14 (AB 
system, J = 12.3 Hz, 2H), 2.47 (brs, 1H), 2.29 (dd, J = 7.0, 7.0 Hz, 2H), 1.55 (dd, J = 7.0, 
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7.0 Hz, 2H), 1.46-1.34 (m, 4), 1.33-1.26 (m, 2H), 0.84 (s, 9H), 0.79 (t, J = 7.6 Hz, 3H), 
0.00 (s, 6H); 13C NMR (150 MHz, CDCl3)  = 170.1, 62.9, 61.4, 59.3, 50.5, 34.5, 30.0, 
29.8, 28.5, 27.1, 26.2, 25.8, 18.1, 7.4, -5.5; IR (thin film): 2930, 2858, 1626, 1497, 1464, 
1418, 1362, 1255, 1101, 1058, 837, 778; HRMS (M+1) calc’d for C18H37NO3Si = 
344.2622, found = 344.2615.  
 
 5-(3-Hydroxypropyl)piperidin-2-one 3-109b was prepared using 
general experimental procedure 1. Reagents employed: piperidinone 3-
108d (540 mg, 1.55 mmol), NaBH4 (2340 mg, 61.80 mmol), and 
methanol (30 mL). Yielded 3-109b as an orange oil, 100% (498 mg, 1.55 mmol). Rf  = 
0.22, 100% EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 7.39 (d, J = 7.0 Hz, 
2H), 7.30 (t, J = 7.6 Hz, 2H), 7.18 (t, J = 7.6 Hz, 1H), 3.63 (dd, J = 6.5 Hz, 2H), 3.53 (dd, 
J = 8.2, 6.5, 2H), 3.31 (dd, J = 7.0, 7.0 Hz, 2H), 3.06 (Br s, 2H), 2.33 (dd, J = 7.0, 7.0 Hz, 
2H), 1.55 (dd, J = 7.0, 7.0 Hz, 2H), 1.51-1.43 (m, 4H), 1.42-1.33 (m, 2H), 0.83 (t, J = 7.6 
Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 170.1, 129.0, 128.7, 126.0, 63.2, 58.4, 48.0, 
34.6, 30.4, 30.0, 29.9, 28.6, 27.1, 26.3, 7.5 (missing 1 carbon presumably due to overlap); 
IR (thin film): 2938, 2866, 1623, 1496, 1438, 1418, 1363, 1297, 1229, 1066, 741, 692; 
HRMS calc’d for C18H27NO2S  = 321.1762, found = 321.1769.  
 
 5-(3-Hydroxypropyl)piperidin-2-one 3-109c was prepared using general 
experimental procedure 1. Reagents employed: piperidinone 3-108e (1600 
mg, 5.30 mmol), NaBH4 (10 x 104 mg, 264.00 mmol), and methanol (79 
mL). Yielded 3-109c as a dark yellow oil, 100% (1459 mg, 5.30 mmol). Rf  = 0.14, 100% 
EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 7.32-7.30 (m, 2H), 7.27-7.24 (m, 
3H), 4.55 (AB system, J = 14.6 Hz, 2H), 3.51 (dd, J = 5.9, 5.9 Hz, 2H), 2.92 (Br s, 2H), 
2.43 (dd, J = 7.0, 7.0 Hz, 2H), 1.62 (m, 3H), 1.43-1.35 (m, 1H), 1.34-1.16 (m, 5H), 0.71 
(t, J = 7.0 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 169.8, 137.3, 128.5, 128.3, 127.4, 
63.1, 55.7, 50.3, 34.3, 30.2, 29.9, 28.5, 26.9, 26.2, 7.3; IR (thin film): 3395, 2939, 2866, 
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1620, 1496, 1454, 1419, 1363, 1308, 1229, 1067, 1028, 703; HRMS calc’d for 
C17H25NO2 = 275.1885, found = 275.1880.  
 
5-(3-Hydroxypropyl)piperidin-2-one 3-109a was prepared using 
general experimental procedure 2. Reagents employed: dimethyl 3-
ethyl-3-formylpimelate 3-99 (633 mg, 2.59 mmol), 2-(tert-
butyldimethylsilyloxy)ethanamine (500 mg, 2.85 mmol), Sc(OTf)3 (32 mg, 0.65 mmol), 
NaBH4 (3920 mg, 103.62 mmol), and methanol (65 mL). Yielded 3-109a as a thick 
yellow oil, 72% (640 mg, 1.86 mmol).  
 
5-(3-Hydroxypropyl)piperidin-2-one 3-109b was prepared using general 
experimental procedure 1. Reagents employed: dimethyl 3-ethyl-3-
formylpimelate 3-99 (1880 mg, 7.70 mmol), 2-(phenylthio)ethanamine 
(1300 mg, 8.48 mmol), Sc(OTf)3 (94 mg, 0.19 mmol), NaBH4 (11650 mg, 308.00 mmol), 
and methanol (98 mL). Yielded 3-109b as an orange oil, 60% (1485 mg, 4.62 mmol).  
 
5-(3-Hydroxypropyl)piperidin-2-one 3-109b was prepared using general 
experimental procedure 1. Reagents employed: dimethyl 3-ethyl-3-
formylpimelate 3-99 (4560 mg, 18.67 mmol), phenylmethanamine (2000 
mg, 18.67 mmol), Sc(OTf)3 (231 mg, 0.47 mmol), NaBH4 (35300 mg, 933.12 mmol), and 
methanol (250 mL). Yielded 3-109c as a dark yellow oil, 81% (4160 mg, 15.11 mmol). 
 
Piperidine 3-110a was prepared using the following procedure: 
Piperidinone 3-108c (250 mg, 0.67 mmol) was dissolved in THF (25 
mL) followed by the addition of Red-Al® (65% by weight) (0.82 mL, 2.69 mmol).  Upon 
completion by TLC analysis water was added to the reaction mixture and extracted 3 
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times with EtOAc.  The organic layer was dried and the solvent was removed. The 
residue was purified by flash chromatography (EtOAc/Hexanes) to yield the desired 
product 3-110a as an orange oil, 72% (160 mg, 0.49 mmol). Rf  = 0.11, 100% EtOAc in 
hexanes;  1H-NMR (600 MHz, CDCl3):  = 3.71 (dd, J = 6.5, 6.5 Hz, 2H), 3.61 (ddd, J = 
6.5, 6.5, 2.3 Hz, 2H), 2.51-2.39 (m, 3H), 2.31-2.19 (m, 2H), 2.08-2.04 (m, 1H), 1.61-1.50 
(m, 2H), 1.49-1.37 (m, 3H), 1.36-1.25 (m, 4H), 1.20-1.16 (m, 1H), 0.88 (s, 9H), 0.77 (t, J 
= 7.0 Hz, 3H), 0.05 (s, 6H); 13C NMR (150 MHz, CDCl3)  = 63.8, 63.6, 61.3, 61.2, 55.4, 
35.3, 33.6, 28.3, 25.9, 21.9, 18.3, 7.3, 5.3 (missing 2 carbon presumably due to overlap); 
IR (thin film): 2933, 2857, 1463, 1255, 1103, 1068, 836, 776; HRMS calc’d for 
C18H39NO2Si = 329.2750, found = 329.2754.  
 
Piperidine 3-110b was prepared using the following procedure: 
Piperidinone 3-108e (131 mg, 0.43 mmol) was dissolved in THF (10 mL) 
followed by the addition of Red-Al® (65% by weight) (0.53 mL, 1.74 mmol).  Upon 
completion by TLC analysis water was added to the reaction mixture and extracted 3 
times with EtOAc.  The organic layer was dried and the solvent was removed. The 
residue was purified by flash chromatography (EtOAc/Hexanes) to yield the desired 
product 3-110b as brown oil, 98% (110 mg, 0.42 mmol). Rf  = 0.23, 100% EtOAc in 
hexanes;  1H-NMR (600 MHz, CDCl3):  = 7.34-7.28 (m, 4H), 7.24-7.22 (m, 1H), 3.60 
(dd, J = 5.9, 5.9 Hz, 2H), 3.46-3.38 (m, 2H), 2.45-2.36 (m, 1H), 2.31-2.22 (m, 1H), 2.17-
2.10 (m, 1H), 2.03-1.94 (m, 1H), 1.65-1.51 (m, 2H), 1.47-1.14 (m, 2H), 1.38-1.23 (m, 
6H), 0.73 (t, J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 128.9, 128.0, 126.8, 63.8, 
63.5, 62.5, 54.8, 35.4, 33.8, 26.2, 21.8, 18.4, 7.2 (missing 2 carbon presumably due to 
overlap); IR (thin film): 2936, 2858, 2793, 2754, 1453, 1350, 1059, 739, 698; HRMS 
calc’d for C17H27NO = 261.2093, found = 261.2097.  
General Experimental Procedure for Alcohol 3-109a-c Oxidation to Aldehyde 
3-111a-c: Alcohol 3-109a-c (1 equivalent) was dissolved in EtOAc, followed by the 
addition of IBX (3 equivalents). The mixture was heated to reflux with rapid stirring until 
consumption of starting material as determined by TLC analysis. The reaction mixture 
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was filter through Celite® with EtOAc and the solvent was removed to yield the desired 
aldehyde 3-111a-c.  
 
 Aldehyde 3-111a was prepared using general experimental procedure. 
Reagents employed: piperidinone 3-109a (200 mg, 0.58 mmol), IBX 
(489 mg, 1.75 mmol), and EtOAc (10 mL). Yielded 3-111a as a pale 
yellow oil, 91% (180 mg, 0.53 mmol). Rf  = 0.26, 100% EtOAc in hexanes;  1H-NMR 
(600 MHz, CDCl3):  = 9.79 (t, J = 1.8 Hz, 1H), 3.77 (dd, J = 5.3 Hz, 2H), 3.49-3.41 (m, 
2H), 3.20 (AB system, J = 12.9 Hz, 2H), 2.39-2.35 (m, 4H), 1.72-1.55 (m, 4H), 1.45-1.39 
(m, 1H), 1.37-1.31 (m, 1H), 0.89 (s, 9H), 0.84 (t, J = 7.0 Hz, 3H), 0.05 (s, 6H); 13C NMR 
(150 MHz, CDCl3)  = 201.4, 169.6, 61.8, 59.0, 50.6, 38.1, 34.4, 29.8, 28.5, 26.9, 25.92, 
25.88, 18.2, 7.4, -5.4; IR (thin film): 2931, 2858, 1724, 1617, 1471, 1419, 1256, 1103, 
1055, 837, 778; HRMS (M+1) calc’d for C18H35NO3Si = 342.2459, found = 342.2460.  
 
Aldehyde 3-111b was prepared using general experimental procedure. 
Reagents employed: piperidinone 3-109b (440 mg, 1.37 mmol), IBX 
(1200 mg, 4.29 mmol), and EtOAc (24 mL). Yielded 3-111b as a red 
oil, 64% (280 mg, 0.88 mmol). Rf  = 0.30, 64% EtOAc in hexanes;  1H-
NMR (600 MHz, CDCl3):  = 9.78 (s, 1H), 7.38 (d, J = 9.4 Hz, 2H), 7.30 (t, J = 7.6 Hz, 
2H), 7.18 (t, J = 7.0 Hz, 1H), 3.54 (ddd, J = 8.2, 8.2, 1.2 Hz, 2H), 3.18-3.11 (m, 2H), 3.06 
(s, 2H), 2.39-2.35 (m, 2H), 2.33 (dd, J = 7.6, 7.6 Hz, 2H), 1.86 (dd, J = 9.4, 7.0 Hz, 2H), 
1.60-1.50 (m, 2H), 1.42-1.31 (m, 2H), 0.83 (t, J = 7.0 Hz, 3H); 13C NMR (150 MHz, 
CDCl3)  = 201.2, 165.2, 129.0, 128.7, 126.1, 58.1, 48.0, 38.0, 34.5, 30.5, 29.7, 28.4, 
28.8, 25.9, 7.4 (missing 1 carbon presumably due to overlap); IR (thin film): 2931, 2877, 
1722, 1640, 1492, 1438, 1363, 1295, 1230, 1088, 1025, 742, 693; HRMS calc’d for 
C18H25NO2S = 319.1606, found = 319.1603. 
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 Aldehyde 3-111c was prepared using general experimental procedure. 
Reagents employed: piperidinone 3-109c (580 mg, 2.11 mmol), IBX (1770 
mg, 6.32 mmol), and EtOAc (40 mL). Yielded 3-111d as a dark yellow oil, 
82% (475 mg, 1.74 mmol). Rf  =0.31, 100% EtOAc in hexanes;  1H-NMR 
(600 MHz, CDCl3):  = 9.65 (s, 1H), 7.33-7.30 (m, 2H), 7.28-7.24 (m, 3H), 4.55 (AB 
system, J = 14.7 Hz, 2H), 2.92 (AB system, J = 12.3 Hz, 2H), 2.46 (dd, J = 7.0, 7.0 Hz, 
2H), 2.27-2.21 (m, 1H), 2.07-2.01 (m, 1H),  1.67-1.59 (m, 2H), 1.58-1.52 (m, 2H), 1.30-
1.22 (m, 2H), 0.70 (t, J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 201.2, 169.5, 
137.1, 128.6, 128.3, 127.5, 55.1, 50.1, 37.8, 34.1, 30.1, 28.4, 26.7, 25.5, 7.2; IR (thin 
film): 2936, 1722, 1603, 1496, 1454, 1420, 1364, 1309, 1265, 1232, 703; HRMS calc’d 
for C17H23NO2 = 273.1729, found = 273.1728.  
General Experimental Procedure for the Synthesis of Alkyne 3-112a-c: Aldehyde 
3-111a-c (1 equivalent) was dissolved in MeOH, followed by the addition of K2CO3 (4.7 
equivalents). Dimethyl 1-diazo-2-oxopropylphosphonate (2.5 equivanlents) as added 
drop wise in MeOH and the mixture was stirred rapidly until  consumption of starting 
material as determined by TLC analysis. Brine was added to the reaction mixture and 
extracted 3 times with ethyl acetate.  The combined organic layer was washed thoroughly 
2 times with water, and once with brine. The organic layer was dried and the solvent was 
removed to yield alkynes 3-112a-c.  
 
 Alkyne 3-112a was prepared using general experimental procedure. 
Reagents employed: piperidinone 3-111a (580 mg, 1.70 mmol), 
K2CO3 (1104 mg, 7.99 mmol), dimethyl 1-diazo-2-
oxopropylphosphonate (816 mg, 4.25 mmol), and MeOH (17 mL). Yielded 3-112a as a 
pale yellow foam, 100% (572 mg, 1.69 mmol). Rf  = 0.18, 50% EtOAc in hexanes;  1H-
NMR (600 MHz, CDCl3):  = 3.77 (dd, J = 5.3, 5.3 Hz, 2H), 3.48-3.42 (m, 2H), 3.20 
(AB system, J = 12.3 Hz, 2H), 2.39-2.33 (m, 2H), 2.13 (ddd, J = 6.5, 6.5, 1.2 Hz, 2H), 
1.95 (t, J = 2.9 Hz, 1H), 1.70-1.59 (m, 4H), 1.46-1.39 (m, 1H), 1.38-1.31 (m, 1H), 0.89 
(s, 9H), 0.84 (t, J = 7.6 Hz, 3H), 0.05 (s, 6H); 13C NMR (150 MHz, CDCl3)  = 169.6, 
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84.1, 68.5, 61.7, 59.0, 50.5, 34.9, 33.0, 29.7, 28.5, 26.9, 25.9, 18.2, 12.8, 7.5, 6.4; IR (thin 
film): 2934, 2879, 1622, 1501, 1465, 1365, 1210, 1234, 1053, 836, 776, 637; HRMS 
(M+1) calc’d for C19H35NO2Si = 338.2510, found = 338.2517.  
 
Alkyne 3-112b was prepared using general experimental procedure. 
Reagents employed: piperidinone 3-111b (232 mg, 0.73 mmol), K2CO3 
(471 mg, 3.41 mmol), dimethyl 1-diazo-2-oxopropylphosphonate (349 
mg, 1.82 mmol), and MeOH (7.3 mL). Yielded 3-112b as a dark yellow foam, 95% (218 
mg, 0.69 mmol). Rf  = 0.5, 100% EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 
7.39 (d, J = 7.6 Hz, 2H), 7.29 (t, J = 7.6 Hz, 2H), 7.18 (t, J = 7.6 Hz, 1H), 3.57-3.49 (m, 
2H), 3.14 (dd, J = 7.0 Hz, 2H), 3.08 (AB system, J = 12.3 Hz, 2H), 2.38-2.28 (m, 2H), 
2.15-2.09 (m, 2H),  1.95 (t, J = 2.9 Hz, 1H), 1.66-1.58 (m, 2H), 1.55 (dd, J = 7.0, 7.0 Hz, 
2H), 1.43-1.32 (m, 2H), 0.83 (t, 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 169.8, 
135.7, 129.0, 128.8, 126.0, 84.0, 68.7, 58.1, 48.0, 35.0, 33.0, 30.4, 29.7, 28.5, 26.7, 12.8, 
7.5; IR (thin film): 3373, 3293, 3056, 2927, 1639, 1482, 1439, 1361, 1252, 1100, 1026, 
925, 741, 692; HRMS calc’d for C19H25NOS = 315.1657, found = 315.1662. 
 
 Alkyne 3-112c was prepared using general experimental procedure. 
Reagents employed: piperidinone 3-111c (430 mg, 1.57 mmol), K2CO3 
(1020 mg, 7.38 mmol), dimethyl 1-diazo-2-oxopropylphosphonate (755 
mg, 3.93 mmol), and MeOH (16 mL). Yielded 3-112c as a pale yellow foam, 97% (410 
mg, 1.52 mmol). Rf  = 0.52, 100% EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 
7.33-7.30 (m, 2H), 7.27-7.23 (m, 3H), 4.56 (AB system, J = 14.1 Hz, 2H), 2.93 (AB 
system, J = 12.3 Hz, 2H), 2.50-2.40 (m, 2H), 2.06-2.00 (m, 1H), 1.94-1.88 (m, 2H), 1.62 
(dd, J = 7.6, 7.6 Hz, 2H),  1.58-1.52 (m, 2H), 1.35-1.23 (m, 2H), 0.72 (t, J = 7.0 Hz, 3H); 
13C NMR (150 MHz, CDCl3)  = 169.5, 137.1, 128.6, 128.2, 127.4, 84.0, 68.5, 55.4, 
50.2, 34.6, 32.6, 29.9, 28.4, 26.5, 12.7, 7.3; IR (thin film): 3290, 3230, 2940, 2877, 1641, 
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1494, 1454, 1420, 1363, 1309, 1264, 1230, 1029, 703, 629; HRMS calc’d for C18H23NO 
= 269.1780, found = 269.1781.  
General Experimental Procedure for the Sonogashira Cross Coupling: Aniline (1.2 
equivalents) was dissolved in THF and the flask was purged with argon.  Alkyne 
3-112a-c (1 equivalent) was then added drop wise in THF and the flask was purged with 
argon.  CuI (0.05 equivalent) and PdCl2(PPh3)2 (0.025 equivalent) were then added to the 
reaction mixture and the flask was purged with argon.  Diisopropylamine was then added 
to the reaction mixture and the solution was stirred in the absence of light for 12 hours.  
The reaction mixture was then diluted with DCM and water. The aqueous was extracted 2 
times with DCM.  The organic layer was dried and the solvent was removed. The residue 
was purified by flash chromatography (EtOAc/Hexanes) to yield the desired 
piperidinones. 
  
The piperidinone was prepared using general experimental 
procedure. Reagents employed: alkyne 3-112a (650 mg, 1.93 
mmol), aniline (506 mg, 2.31 mmol), PdCl2(PPh3)2 (34 mg, 0.048 
mmol), CuI (18 mg, 0.96 mmol), diisopropylamine (1.7 mL), and 
THF (4.5 mL). Yielded the product as a brown oil, 91% (753 mg, 1.76 mmol). Rf  = 0.17, 
75% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3):  = 7.22 (d, J = 6.5 Hz, 1H), 7.10-
7.07 (m, 1H), 6.69-6.65 (m, 2H), 3.78 (dd, J = 5.3, 5.3 Hz, 2H), 3.52-3.48 (m, 1H), 3.44-
3.40 (m, 1H), 3.24 (s, 2H), 2.43-2.37 (m, 4H),  1.80-1.63 (m, 4H), 1.53-1.45 (m, 1H), 
1.43-1.37 (m, 1H), 0.90-0.87 (m, 12H), 0.06 (s, 3H), 0.05 (s, 3H); 13C NMR (150 MHz, 
CDCl3)  = 169.6, 132.1, 129.0, 117.9, 114.2, 94.9, 61.7, 59.1, 50.6, 35.0, 33.5, 29.8, 
28.6, 27.0, 25.9, 25.6, 18.2, 14.1, 7.6, -5.4 (missing 2 carbon presumably due to overlap); 
IR (thin film): 3329, 2927, 2856, 1620, 1495, 1457, 1418, 1311, 1052, 748; HRMS calc’d 
for C25H40N2O2Si = 428.2859, found = 428.2866.  
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The piperidinone was prepared using general experimental 
procedure. Reagents employed: alkyne 3-112b (505 mg, 1.60 
mmol), aniline (421 mg, 1.92 mmol), PdCl2(PPh3)2 (28 mg, 0.040 
mmol), CuI (15 mg, 0.079 mmol), diisopropylamine (1.4 mL), and 
THF (3.8 mL). Yielded the product as a yellow oil, 81% (528 mg, 1.30 mmol). Rf  = 0.43, 
100% EtOAc in hexanes; 1H-NMR (600 MHz, CDCl3):  = 7.38 (d, J = 7.0 Hz, 2H), 7.28 
(t, J = 7.6 Hz, 2H), 7.21 (d, J = 7.6 Hz, 1H), 7.16 (t, J = 7.0 Hz, 1H), 7.07 (t, J = 7.0 Hz, 
1H), 6.67-6.63 (m, 2H), 4.16 (brs, 2H), 3.57-3.49 (m, 2H), 3.16-3.07 (m, 4H), 2.41-2.31 
(m, 4H), 1.74-1.68 (m, 2H), 1.58 (ddd, J = 7.0, 7.0, 1.8 Hz, 2H), 1.47-1.35 (m, 2H), 0.85 
(t, J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 169.7, 147.6, 135.6, 131.9, 128.9, 
128.6, 125.9, 117.7, 114.1, 108.3, 94.7, 77.4, 58.0, 47.9, 34.9, 33.4, 30.3, 29.6, 28.4, 26.7, 
14.0, 7.4 (missing 1 carbon presumably due to overlap); IR (thin film): 3447, 3370, 3055, 
2933, 1633, 1493, 1456, 1362, 1312, 1101, 1025, 925, 745, 692; HRMS calc’d for 
C25H30N2OS = 406.2079, found = 406.2070. 
 
The piperidinone was prepared using general experimental 
procedure. Reagents employed: alkyne 3-112c (330 mg, 1.23 
mmol), aniline (322 mg, 1.47 mmol), PdCl2(PPh3)2 (22 mg, 0.031 
mmol), CuI (12 mg, 0.063 mmol), diisopropylamine (1.1 mL), and 
THF (3 mL). Yielded the product as a dark yellow oil, 93% (413 mg, 1.15 mmol). Rf  = 
0.33, 100% EtOAc in hexanes;  1H-NMR (600 MHz, CDCl3):  = 7.33-7.30 (m, 2H), 
7.27-7.24 (m, 3H), 7.20 (d, J = 7.6 Hz, 1H), 7.08 (t, J = 7.0 Hz, 1H), 6.68-6.65 (m, 2H), 
4.58 (AB system, J = 14.7 Hz, 2H), 4.11 (brs, 2H), 2.99 (AB system, J = 12.3 Hz, 2H), 
2.52-2.45 (m, 2H), 2.36-2.30 (m, 1H), 2.24-2.18 (m, 1H), 1.70-1.60 (m, 4H), 1.41-1.30 
(m, 2H), 0.76 (t, J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 169.5, 147.6, 137.1, 
132.0, 129.0, 128.6, 128.2, 127.4, 117.9, 114.2, 108.5, 94.8, 77.3, 55.6, 50.3, 34.8, 33.5, 
30.1, 28.5, 26.5, 13.9, 7.4; IR (thin film): 3458, 3335, 3029, 2936, 1632, 1493, 1454, 
1311, 1263, 1157, 1029, 748, 702; HRMS calc’d for C24H28N2O = 360.2202, found = 
360.2218.  
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General Experimental Procedure for the Synthesis of Indoles 3-113a-c: The cross 
coupled piperidinone (1 equivalent) was dissolved in toluene. ZnBr2 (1-1.2 equivalent) 
was then added to the reaction mixture and the solution was heated to reflux for 12 hours.  
Water was added and the reaction mixture was extracted 3 times with EtOAc. The 
combined organic layer was washed 2 times with water. The organic layer was dried and 
the solvent was removed to yield the desired indoles 3-113a-c.  
 
Indole 3-113a was prepared using general experimental procedure. 
Reagents employed: piperidinone (60 mg, 0.14 mmol), ZnBr2 (32 
mg, 0.14 mmol), and toluene (0.60 mL). Yielded 3-113a as a yellow 
foam, 90% (54 mg, 0.13 mmol). Rf  = 0.30, 75% EtOAc in hexanes; 
1H-NMR (600 MHz, CDCl3):  = 8.36 (brs, 1H), 7.53 (d, J = 7.6 Hz, 1H), 7.29 (d, J = 8.2 
Hz, 1H), 7.11 (t, J = 7.0 Hz, 1H), 7.07 (t, J = 7.6 Hz, 1H), 6.24 (s, 1H), 3.82-3.76 (m, 
2H), 3.53 (ddd, J = 13.5, 5.3, 5.3 Hz, 1H), 3.41 (ddd, J = 13.5, 5.3, 5.3 Hz, 1H), 3.26 (AB 
system, J = 12.3 Hz, 2H), 2.72-2.86 (m, 2H), 2.42 (ddd, J = 7.6, 7.6, 3.5 Hz, 2H), 1.86-
1.74 (m, 2H), 1.70-1.65 (m, 2H), 1.55-1.43 (m, 2H), 0.92-0.89 (m, 12H), 0.05 (s, 3H), 
0.04 (s, 3H); 13C NMR (150 MHz, CDCl3)  = 169.8, 139.2, 136.0, 128.7, 121.0, 119.7, 
119.6, 110.3, 99.3, 61.7, 59.2, 50.6, 34.9, 33.4, 29.9, 28.6, 27.3, 25.9, 22.2, 18.2, 7.6, -
5.4; IR (thin film): 3270, 2928, 2857, 1623, 1461, 1418, 1362, 1255, 1102, 836, 777, 748; 
HRMS calc’d for C25H40N2O2Si = 428.2859, found = 428.2852.  
 
Indole 3-113b was prepared using general experimental procedure. 
Reagents employed: piperidinone (72 mg, 0.18 mmol), ZnBr2 (44 
mg, 0.20 mmol), and toluene (1.5 mL). Yielded 3-113b as a white 
foam, 83% (60 mg, 0.15 mmol). Rf  = 0.43, 100% EtOAc in hexanes; 
1H-NMR (600 MHz, CDCl3):  = 8.27 (brs, 1H), 7.53 (d, J = 7.6 Hz, 1H), 7.37 (d, J = 7.0 
Hz, 2H), 7.29-7.26 (m, 3H), 7.17 (t, J = 7.6 Hz, 1H), 7.11 (t, J = 7.0 Hz, 1H), 7.07 (t, J 
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=7.6 Hz, 1H), 6.24 (s, 1H), 3.59-3.51 (m, 2H), 3.16-3.12 (m, 4H), 2.69 (dd, J = 10.0, 5.3 
Hz, 2H), 2.42-2.35 (m, 2H), 1.79 (dd J = 10.6, 6.5 Hz, 2H), 1.69-1.58 (m, 2H), 1.50-1.43 
(m, 2H), 0.09 (t J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 170.0, 139.0, 136.0, 
135.7, 129.0, 128.7, 128.6, 126.1, 121.1, 119.8, 119.9, 110.4, 99.4, 58.2, 47.9, 35.0, 33.2, 
30.6, 29.9, 28.5, 27.3, 22.2, 7.54; IR (thin film): 2924, 1617, 1497, 1457, 1417, 1366, 
1286, 1228, 785, 741; HRMS calc’d for C25H30N2OS = 406.2079, found = 406.2074. 
 
Indole 3-113c was prepared using general experimental procedure. 
Reagents employed: piperidinone (375 mg, 1.04 mmol), ZnBr2 (281 
mg, 1.25 mmol), and toluene (8.6 mL). Yielded 3-113c as a yellow 
foam, 100% (375 mg, 1.04 mmol). Rf  = 0.39, 100% EtOAc in 
hexanes; 1H-NMR (600 MHz, CDCl3):  = 7.69 (brs, 1H), 7.51 (d, J = 7.6 Hz, 1H), 7.34-
7.27 (m, 6H), 7.12 (t, J = 7.0 Hz, 1H), 7.06 (t, J = 7.0, 1H), 6.16 (s, 1H), 4.56 (AB 
system, J = 14.7 Hz, 2H), 3.01 (AB system, J = 12.3 Hz, 2H), 2.62-2.57 (m, 1H), 2.48 
(dd, J = 7.0 Hz, 2H), 2.39-2.34 (m, 1H), 1.71-1.85 (m, 4H), 1.42-1.37 (m, 2H), 0.80 (t, J 
= 7.6, 3H); 13C NMR (150 MHz, CDCl3)  = 169.7, 139.1, 137.3, 135.9, 128.8, 128.6, 
128.4, 127.5, 121.0, 119.7, 119.6, 110.3, 99.2, 55.4, 50.3, 34.6, 33.0, 30.3, 28.5, 27.1, 
22.1, 7.3; IR (thin film): 3266, 3058, 2930, 1624, 1495, 1455, 1419, 1363, 1288, 1229, 
736, 701; HRMS calc’d for C24H28N2O = 360.2202, found = 360.2207.  
 
Piperidine 3-115 was prepared using the following procedure: 
Piperidinone 3-113c (99 mg, 0.27 mmol) was dissolved in THF (12 
mL) and cooled to 0 ̊C. Red-Al® (65% by weight) (0.52 mL, 1.71 
mmol) was added drop wise and the solution was mixed for 3.5 hours at 0 ̊C.  Upon 
completion by TLC analysis water was added to the reaction mixture and extracted 3 
times with ether.  The organic layers were combined and washed 2 times with water. The 
organic was dried and the solvent was removed to yield desired product 3-115 as an 
orange oil, 97% (91 mg, 0.26 mmol). Rf  = 0.60, 100% EtOAc in hexanes;  1H-NMR (600 
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MHz, CDCl3):  = 8.04 (brs, 1H), 7.53 (d, J = 8.2 Hz, 1H), 7.36-7.31 (m, 4H), 7.28-7.25 
(m, 2H), 7.11 (t, J = 7.0 Hz, 1H), 7.07 (t, J = 7.6 Hz, 1H), 6.23 (s, 1H), 3.46 (AB system, 
J = 13.5 Hz, 2H), 2.62-2.56 (m, 1H), 2.52-2.46 (m, 1H), 2.31-2.21 (m, 2H), 2.02-1.87 (m, 
2H), 1.71-1.65 (m, 2H), 1.63-1.56 (m, 1H), 1.46-1.40 (m, 2H), 1.37-1.31 (m, 1H), 1.28-
1.24 (m, 2H), 0.81 (t, J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  =140.7, 135.9, 
128.92, 128.85, 128.1, 126.9, 120.8, 119.6, 119.5, 110.2, 99.0, 63.4, 62.1, 55.0, 35.8, 
33.9, 29.7, 22.0, 21.9, 7.3 (missing 2 carbon presumably due to overlap); IR (thin film): 
3408, 2931, 2856, 1457, 12.88, 779, 745, 699; HRMS calc’d for C24H30NO2 = 346.2409, 
found = 346.2408.  
 
3-52 was prepared using the following procedure: Piperidine 3-115 
(290 mg, 0.84 mmol) was dissolved in Methanol (9.5 mL) followed 
by the addition of Pd/C (10% Pd on C) (290 mg). To the slurry was 
then added ammonium formate (264 mg, 4.19 mmol) and the reaction was heated to 
reflux for 3 hours. Upon completion by TLC analysis the reaction mixture was filtered 
through celite washing with chloroform. The volatiles were removed to yield the desired 
product 3-52 as an orange oil, 97% (208 mg, 0.81 mmol). Rf  = 0.12, 10% MeOH in 
EtOAc; (Note that based washed CDCl3 was used to suppress in situ solvent protonation) 
1H-NMR (600 MHz, CDCl3):  = 9.31 (brs, 1H), 7.53 (d, J = 7.6 Hz, 1H), 7.32 (d, J = 7.6 
Hz, 1H), 7.11-7.05 (m, 2H), 6.23 (s, 1H), 4.76 (brs, 1H), 2.97-2.95 (m, 1H), 2.78 (d, J = 
12.9 Hz, 1H), 2.69-2.63 (m, 3H), 2.47 (d, J = 12.32 Hz, 1H), 2.02 (ddd, J = 14.7, 8.2, 8.2 
Hz, 1H), 1.70-1.61 (m, 2H), 1.54-1.49 (m, 2H), 1.46-1.39 (m, 1H), 1.34-1.25 (m, 2H), 
0.86 (t J = 7.6 Hz, 3H); 13C NMR (150 MHz, CDCl3)  = 140.11, 136.1, 128.6, 120.6, 
119.47, 119.2, 110.5, 98.9, 53.3, 46.1, 34.5, 33.6, 32.8, 28.4, 21.9, 21.0, 7.0; IR (thin 
film): 3400, 3275, 2930, 2856, 1458, 1419, 1287, 781, 740; HRMS calc’d for C17H24N = 
256.1939, found = 256.1936.  
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